Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

22
results for

"Medicine"

Article category

Keywords

Publication year

"Medicine"

Review Article

Cardiovascular and Hepatic Outcomes: Prognostic Differences Across MASLD-MetALD-ALD Continuum
Han Ah Lee, Gi-Ae Kim, Won Kim
Received March 25, 2026  Accepted April 29, 2026  Published online May 8, 2026  
DOI: https://doi.org/10.3350/cmh.2026.0367    [Accepted]
A paradigm shift in fatty liver disease nomenclature has introduced steatotic liver disease (SLD) as an umbrella term, encompassing metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-related liver disease (MetALD), and alcohol-associated liver disease (ALD). These SLD subtypes exist along a dynamic continuum shaped by the synergistic interplay of metabolic dysfunction and alcohol exposure. Accumulating evidence indicates that SLD exhibits distinct outcome-based clusters reflecting heterogeneity in pathogenic drivers and clinical trajectories. Cardiometabolic clusters, most prominently observed in MASLD, are characterized by systemic metabolic dysfunction and confer increased risks of cardiovascular disease (CVD). In contrast, liver-specific clusters demonstrate progressive fibrosis and cirrhosis, hepatic decompensation, and hepatocellular carcinoma. In large-scale cohorts, CVD accounts for 40-50% of deaths in MASLD, while liver-related mortality predominates in ALD (>60%). The relative dominance of cardiometabolic versus liver-specific clusters shifts progressively across the MASLD-MetALD-ALD spectrum. While CVD remains a major driver of mortality, particularly in MASLD, hepatic outcomes increase stepwise with advancing fibrosis and greater alcohol exposure. Advanced fibrosis is the predominant shared determinant amplifying both CVD and hepatic risks across subtypes. This review synthesizes cardiovascular and hepatic outcome patterns across the MASLD-MetALD-ALD spectrum, highlighting the prognostic reorientation across the continuum, in which hepatic outcomes rise stepwise with alcohol exposure while cardiovascular risk remains an important but less subtype-differentiated burden. These findings advocate outcome-oriented risk stratification integrating noninvasive fibrosis assessment, alcohol biomarkers (PEth), and cardiovascular risk calculators within the Cardiovascular-Kidney-Metabolic framework. Understanding SLD as a modifiable continuum enables individualized management to optimize multisystem outcomes.
  • 871 View
  • 66 Download

Reply to Correspondence

Reply to correspondence: Sodium-Glucose Cotransporter-2 Inhibitors and Liver Outcomes in Metabolic Dysfunction-associated Steatotic Liver Disease
Yang-Hsiang Lin, Ching-Chih Hu, Chih-Lang Lin
Received January 25, 2026  Accepted February 2, 2026  Published online February 5, 2026  
DOI: https://doi.org/10.3350/cmh.2026.0123    [Accepted]
  • 732 View
  • 30 Download

Editorial

Challenges and Innovations in MASLD and T2DM: Strengthening Personalized Medicine with SGLT2 Inhibitors
Yang-Hsiang Lin, Ching-Chih Hu, Chih-Lang Lin
Received January 2, 2026  Accepted January 17, 2026  Published online January 27, 2026  
DOI: https://doi.org/10.3350/cmh.2026.0002    [Accepted]
  • 780 View
  • 42 Download

Reviews

Clinical applications of immunogenomics in hepatocellular carcinoma
James K. Carter, Daniel C. Cameron, Augusto Villanueva
Clin Mol Hepatol 2026;32(2):511-535.
Published online January 6, 2026
DOI: https://doi.org/10.3350/cmh.2025.1323
Liver cancer is one of the deadliest malignancies, with increasing incidence worldwide. Recent advances in immunotherapy have expanded the options for systemic therapy against advanced hepatocellular carcinoma (HCC), but there are no biomarkers currently available to predict which patients will respond, leading to suboptimal patient selection strategies. Understanding of the genetic and immunologic features of HCC is accelerating rapidly through the use of single cell and spatial transcriptomic techniques. However, there is a need to translate insights gained through these new studies to improve treatment options and improve patient selection. In this review we summarize knowledge of the immunogenomics of HCC, emphasizing recent advances, and discuss progress toward clinical translation.

Citations

Citations to this article as recorded by  Crossref logo
  • Association of NUDT1 expression with the clinical outcomes of primary hepatocellular carcinoma
    Yingda Xie, Xiaochen Ding, Fuqiang Ma
    Asian Journal of Surgery.2026;[Epub]     CrossRef
  • 1,484 View
  • 123 Download
  • Crossref
Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders
Yun Kyung Cho, Chang Hee Jung
Clin Mol Hepatol 2026;32(2):464-486.
Published online November 26, 2025
DOI: https://doi.org/10.3350/cmh.2025.0744
Obesity and its related metabolic comorbidities, including type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and cardiovascular disease, are increasingly recognized as heterogeneous and multisystemic disorders. Despite the significant benefits in glycemic control and weight loss exhibited by GLP-1 receptor agonists (GLP-1RAs), their limitations have initiated the development of engineered multi-agonist therapies targeting additional nutrient-stimulated hormonal (NUSH) pathways. Dual and triple peptide-based co-agonists combining glucagon-like peptide-1 (GLP-1) with glucose-dependent insulinotropic polypeptide (GIP), glucagon, amylin, or peptide YY have demonstrated superior metabolic efficacy in preclinical and clinical studies. Tirzepatide (GLP-1/GIP dual agonist), CagriSema (GLP-1/amylin dual agonist), and retatrutide (GLP-1/GIP/glucagon triple agonist) have achieved unprecedented levels of weight loss and glycemic improvement, with certain agents also demonstrating hepatic, cardiovascular, and inflammatory benefits. Non-peptidyl oral GLP-1 RAs such as orforglipron, offer novel formulation strategies to enhance treatment accessibility and adherence. Multi-agonist incretin-based therapies represent a paradigm shift in the management of obesity and metabolic diseases. These agents offer broad clinical utility beyond glucose lowering by mimicking the pleiotropic hormonal responses observed after bariatric surgery. These therapies are poised to emerge as key components of precision metabolic medicine. This review article explores the mechanistic basis, pharmacological characteristics, and clinical data supporting the use of engineered NUSH-based peptide therapies for obesity and its related metabolic disorders, with particular emphasis on recent progress in the development and clinical application of dual and triple agonists.

Citations

Citations to this article as recorded by  Crossref logo
  • Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research
    Xinyi Lu, Li Yang
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • 5,155 View
  • 193 Download
  • 2 Web of Science
  • Crossref
Novel biomarkers for alcohol-associated liver disease and their implications across clinical settings
Kaanthi Rama, Vinay Jahagirdar, Francisco Idalsoaga, Hanna Blaney, S. Fisher Rhoads, Luis Antonio Díaz, Marco Arrese, Juan Pablo Arab
Clin Mol Hepatol 2026;32(2):443-463.
Published online November 25, 2025
DOI: https://doi.org/10.3350/cmh.2025.0921
Alcohol-associated liver disease (ALD) is a leading cause of preventable cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality, yet current laboratory and imaging tools detect only late-stage disease. This narrative review synthesizes emerging evidence on novel biomarkers that capture the multidimensional pathophysiology of ALD and discusses their utility for routine clinical practice. Traditional serum-based liver fibrosis markers (e.g., cytokeratin-18 fragments, Pro-C3, the enhanced liver fibrosis test) improve non-invasive staging risk beyond aminotransferases, while elastography techniques, such as vibration-controlled transient elastography and magnetic resonance elastography, can also quantify liver stiffness with high precision. Among novel mechanistic biomarkers, genetic polymorphisms in PNPLA3, TM6SF2, MBOAT7, HSD17B13, and polygenic risk scores define lifetime risk, whereas sex-specific hormonal milieus also modify susceptibility and progression. Moreover, gut dysbiosis signatures, including reduced Faecalibacterium prausnitzii, Akkermansia muciniphila, and a lower Firmicutes/Bacteroidetes ratio, and their metabolites (short-chain fatty acids, and bile acids, trimethylamine N-oxide) correlate with liver inflammation and fibrosis. Endocrine imbalances of cortisol, testosterone, and thyroid hormones further stratify metabolic vulnerability. Ultimately, multi-omics platforms (i.e., transcriptomics, lipidomics, proteomics, metabolomics, and epigenomics) can reveal distinct molecular signatures that predict steatohepatitis, fibrogenesis, and early HCC. Integrating these biomarkers enables phase-specific enrichment strategies, earlier intervention windows, adaptive dose-finding, and mechanismbased endpoints in ALD trials. Remaining challenges include assay standardization, validation across diverse cohorts, and incorporation into regulatory frameworks. Future work could evaluate cost-effectiveness and feasibility in routine clinical practice. Widespread adoption promises earlier diagnosis, personalized risk reduction, and more efficient drug development for this globally prevalent disorder.

Citations

Citations to this article as recorded by  Crossref logo
  • Immune Determinants of MASLD Progression: From Immunometabolic Reprogramming to Fibrotic Transformation
    Senping Xu, Zhaoshan Zhang, Zhongquan Zhou, Jiawei Guo
    Biology.2026; 15(2): 148.     CrossRef
  • Review Article on: AI-Driven Precision Medicine in Liver Disease: Microbiome and Nanotechnology Integration
    Rahul Kumar, Amritesh Kumar, Aayush Kumar Tiwari, MD Nasiruddin Khan, Mohit Kumar, Moidul Islam Judder
    Pan-African Journal of Health and Psychological Sciences.2026;[Epub]     CrossRef
  • N-acetylcysteine for patients with alcohol use disorder, post-traumatic stress disorder, and their co-occurrence: a systematic review of placebo-controlled randomized trials
    Mohamed Awad E. Ahmed, Mufreh Amin, Yomna Emad Abdalla, Amr Abdelghani, Nourhan Eid, Aya Samy, Omar Kassar, Khalid Radwan Alsaadany, Mohamed Ezzat M. Mansour
    BMC Psychiatry.2026;[Epub]     CrossRef
  • 4,288 View
  • 303 Download
  • 1 Web of Science
  • Crossref

Special Review

Liver disease trends in the Asia-Pacific region for the next 50 years
Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim
Clin Mol Hepatol 2025;31(3):671-684.
Published online March 4, 2025
DOI: https://doi.org/10.3350/cmh.2025.0043
Liver disease has emerged as a critical and escalating public health concern worldwide, with the Asia-Pacific region at the forefront of this challenge due to its vast population and diverse socioeconomic landscape. Over the coming five decades, this region will experience profound changes in liver disease patterns, shaped by rapid urbanization, lifestyle modifications, advancements in medical technologies, and evolving public health strategies. This article offers an in-depth analysis of six transformative areas defining the trajectory of liver disease in the region. First, it highlights the alarming rise of metabolic dysfunction-associated fatty liver disease and metabolic dysfunction-associated steatohepatitis, diseases driven by modern lifestyle factors and inherent metabolic susceptibilities. Concurrently, it celebrates the declining burden of viral hepatitis, underscoring the success of sustained public health interventions. However, new challenges are emerging, such as the growing impact of environmental and occupational exposures on liver health. Breakthroughs in genomic and epigenetic research promise to advance precision medicine, offering targeted therapeutic solutions. Additionally, the integration of artificial intelligence, big data, and telemedicine is poised to revolutionize liver disease management, improving accessibility and personalized care. Finally, the article emphasizes the critical role of robust health policies, preventive strategies, and cross-border collaboration in shaping a healthier future. By synthesizing these insights, the study aims to guide innovative and effective responses to the evolving liver disease landscape in the Asia-Pacific region.

Citations

Citations to this article as recorded by  Crossref logo
  • Digital divide and healthcare service utilization among older adults with chronic liver disease in China: a nationwide cross-sectional study
    Yang Feng, Ke Pu, Chang Liu
    Scientific Reports.2026;[Epub]     CrossRef
  • Association Between Sarcopenic Obesity–Related Scores and Liver Fibrosis in Patients with Steatotic Liver Disease: A Cross-Sectional Study
    Tatsuki Ichikawa, Satoshi Miuma, Mio Yamashima, Shinobu Yamamichi, Makiko Koike, Yusuke Nakano, Hiroyuki Yajima, Osamu Miyazaki, Tomonari Ikeda, Takuma Okamura, Naohiro Komatsu, Mayuko Kakizoe, Ryusei Tanaka, Hisamitsu Miyaaki
    Diagnostics.2026; 16(2): 324.     CrossRef
  • The role and possible mechanism of intestinal fungi in the progression of chronic liver diseases
    Yirui Hu, Ye Yang, Shuyan Wang, Huikuan Chu
    npj Biofilms and Microbiomes.2026;[Epub]     CrossRef
  • Liver Transplantation Following Immune Checkpoint Inhibitor Therapy: What Do We Need to Know from Clinical and Immunological Perspective?
    Hee Sun Cho, Soon Kyu Lee
    International Journal of Molecular Sciences.2026; 27(6): 2680.     CrossRef
  • Editorial: Residual HCC Risk After Hepatitis C Cure—Can Polygenic Risk Scores Refine Surveillance?
    Heechul Nam, Sung Won Lee
    Alimentary Pharmacology & Therapeutics.2026; 63(10): 1427.     CrossRef
  • Targeting the AMPK/ACC pathway with luteolin suppresses de novo lipogenesis and limits tumor burden in a MASH-HCC mouse model
    Gaoxuan Shao, Chenceng Sun, Chenhao Ye, Ying Liu, Jiashu Pan, Yujing Liu, Lu Lu, Lei Wang, Zemin Lin, Fan Yang, Guang Ji, Hanchen Xu
    Life Sciences.2026; 397: 124440.     CrossRef
  • Trends and future projections of liver cancer attributable to metabolic dysfunction-associated steatohepatitis in China from 1990 to 2050
    Jincheng Tang, Renyi Yang, Kexiong Li, Wei Peng, Zuomei He, Wenhui Gao, Puhua Zeng
    Scientific Reports.2025;[Epub]     CrossRef
  • Bridging the Gap in Elimination of Hepatitis C Virus among People Who Use Drugs in South Korea
    Beom Kyung Kim
    Gut and Liver.2025; 19(5): 635.     CrossRef
  • Precision prevention of liver cancer based on risk factors
    Jian-Guo Chen
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
  • MAFLD in Vietnam: a neglected public health challenge requiring urgent policy action
    Thong Duy Vo, Huong Tu Lam
    Frontiers in Clinical Diabetes and Healthcare.2025;[Epub]     CrossRef
  • 12,592 View
  • 243 Download
  • 9 Web of Science
  • Crossref

Reviews

Artificial intelligence, epidemiology, methodology, or others

Liver organoids: Current advances and future applications for hepatology
Yohan Kim, Minseok Kang, Michael Girma Mamo, Michael Adisasmita, Meritxell Huch, Dongho Choi
Clin Mol Hepatol 2025;31(Suppl):S327-S348.
Published online December 26, 2024
DOI: https://doi.org/10.3350/cmh.2024.1040
The creation of self-organizing liver organoids represents a significant, although modest, step toward addressing the ongoing organ shortage crisis in allogeneic liver transplantation. However, researchers have recognized that achieving a fully functional whole liver remains a distant goal, and the original ambition of organoid-based liver generation has been temporarily put on hold. Instead, liver organoids have revolutionized the field of hepatology, extending their influence into various domains of precision and molecular medicine. These 3D cultures, capable of replicating key features of human liver function and pathology, have opened new avenues for human-relevant disease modeling, CRISPR gene editing, and high-throughput drug screening that animal models cannot accomplish. Moreover, advancements in creating more complex systems have led to the development of multicellular assembloids, dynamic organoid-on-chip systems, and 3D bioprinting technologies. These innovations enable detailed modeling of liver microenvironments and complex tissue interactions. Progress in regenerative medicine and transplantation applications continues to evolve and strives to overcome the obstacles of biocompatibility and tumorigenecity. In this review, we examine the current state of liver organoid research by offering insights into where the field currently stands, and the pivotal developments that are shaping its future.

Citations

Citations to this article as recorded by  Crossref logo
  • NSD2 exacerbates metabolic dysfunction-associated steatotic liver disease progression by suppressing TFEB-mediated autophagy-lysosomal pathway
    Yuan Qiao, Yijia Zhang, Cuiting Sun, Qi Jin, Peng Qu, Zecheng Li, Yang Qiu, Hua Meng, Dantao Peng, Liang Peng
    Metabolism.2026; 174: 156416.     CrossRef
  • Liver Organoid and Liver‐On‐A‐Chip Platforms for Modeling Alcoholic Liver Disease: A Comparative Review
    Qiannan Chen, Chengpan Li, Weiping Ding, Derun Kong
    Advanced Healthcare Materials.2026;[Epub]     CrossRef
  • Engineering liver organoids-on-a-chip
    Jiafei Zhu, Anna Dressman, Kylee Gall, Sunghee Estelle Park
    Frontiers in Lab on a Chip Technologies.2026;[Epub]     CrossRef
  • From initiation to maturation: Mesenchymal stem cells as key facilitators in organoid development
    Shihao Yi, Juan Wen, Tianshun Wang, Wan Yu, Yanlin Liao, Zhengyun Liu, Huan Wang
    Cells & Development.2026; 185: 204071.     CrossRef
  • Transcriptomic Profile of Directed Differentiation of iPSCs into Hepatocyte-like Cells
    Irina Panchuk, Valeriia Kovalskaia, Konstantin Kochergin-Nikitsky, Valentina Yakushina, Natalia Balinova, Oxana Ryzhkova, Alexander Lavrov, Svetlana Smirnikhina
    International Journal of Molecular Sciences.2026; 27(2): 633.     CrossRef
  • Gene Editing of Pluripotent Stem Cell-Derived Hepatic Cells for Liver Disease Modeling and Therapeutic Development
    Donghyun Lim, Hyung-Ryong Kim
    Biomolecules & Therapeutics.2026; 34(1): 102.     CrossRef
  • Alternatives to animal models in gastroenterology and hepatology research
    Elena Gardey, Anja R. Geisler, Alina Löser, Andreas Stallmach, Anna P. Kipp, Stefan Lorkowski, Maria Witt-Wallert
    Frontiers in Pharmacology.2026;[Epub]     CrossRef
  • Translating Pharmacology from Animal Models to Organoids: Advancing Predictive Human Biology in Drug Discovery
    Geeta Patel, Heli Amin
    Stem Cell Reviews and Reports.2026; 22(4): 1764.     CrossRef
  • Organoids as platforms for infectious disease research
    Kuan Liu, Yilan Zhao, Erika M. Joloya, Benedetta Artegiani, Sina Bartfeld, Young Ki Choi, Yuling Han, Delilah Hendriks, Martin J. Hoogduijn, James E. Hudson, Luc J. W. van der Laan, Cun Li, Valeria V. Orlova, Jianhua Qin, Karine Raymond, Lisa E. Wagar, Ji
    Nature Reviews Bioengineering.2026;[Epub]     CrossRef
  • Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression
    Julio Aleman, Lawrence Vernetti, Mark E. Schurdak, Richard DeBiasio, Greg LaRocca, Vijay K. Yechoor, D. Lansing. Taylor, Andrew M. Stern, Mark T. Miedel
    BMC Biotechnology.2026;[Epub]     CrossRef
  • Organoids in Pediatric Congenital Hepatobiliary Diseases: Current Status and Progress in Clinical Translational Research
    Shanshan Zhang, Jingying Jiang, Shan Zheng
    Biomedicines.2026; 14(6): 1233.     CrossRef
  • Advancements, Strategies, and Challenges in Organoid-Based Drug Evaluation for Tissue Engineering and Regenerative Medicine
    Chengbin Xue, Fujia Sun, Hui Zhu, Jianfeng Shi, Jiaqi Wang, Qiuwen Sun, Muyuan Tong, Xiaosong Gu, Qianqian Han, Wei Shi
    Engineering.2025;[Epub]     CrossRef
  • Immunosenescence and organoids: pathophysiology and therapeutic opportunities
    Amirhossein Kamroo, Mahsa Hosseini Kakroudi, Amirreza Jabbaripour Sarmadian, Ayda Firouzabadi, Shaghayegh Mousavi, Niloufar Yazdanpanah, Kiarash Saleki, Nima Rezaei
    Immunity & Ageing.2025;[Epub]     CrossRef
  • Single-cell sequencing and organoids: applications in organ development and disease
    Tiantian Li, Jianmei Yin, Yang Hao, Wei Gao, Qirong Li, Qiang Feng, Boqiang Tao, Ming Hao, Yanxin Liu, Chao Lin, Dongxu Wang
    Molecular Biomedicine.2025;[Epub]     CrossRef
  • Liver Innervation in Health and Disease: Neuroimmune–Neurovascular Interface and Future Therapeutic Implications
    Marcello Trucas, Denis Barry, Melissa J. Conroy, Michela Vincis, Andrea Diana, Claudio Intini, Pietro Gobbi, Clara Gerosa, Daniela Fanni, Andrea Perra
    Biomedicines.2025; 13(12): 3091.     CrossRef
  • Advanced Machine-Assisted Liver Reconditioning in Critical Care
    Yaroslava Longhitano, Giorgia Caputo, Michela Colella Bisogno, Cristian Manuel Perez, Raymond Planinsic, Sabino Mosca, Roberto Balagna, Gabriele Savioli, Christian Zanza
    Journal of Intensive Care Medicine.2025;[Epub]     CrossRef
  • 13,374 View
  • 518 Download
  • 16 Web of Science
  • Crossref

Steatotic liver disease

Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease
Huma Saeed, Luis Antonio Díaz, Antonio Gil-Gómez, Jeremy Burton, Jasmohan S. Bajaj, Manuel Romero-Gomez, Marco Arrese, Juan Pablo Arab, Mohammad Qasim Khan
Clin Mol Hepatol 2025;31(Suppl):S94-S111.
Published online November 28, 2024
DOI: https://doi.org/10.3350/cmh.2024.0811
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a significant global health issue, affecting over 30% of the population worldwide due to the rising prevalence of metabolic risk factors such as obesity and type 2 diabetes mellitus. This spectrum of liver disease ranges from isolated steatosis to more severe forms such as steatohepatitis, fibrosis, and cirrhosis. Recent studies highlight the role of gut microbiota in MASLD pathogenesis, showing that dysbiosis significantly impacts metabolic health and the progression of liver disease. This review critically evaluates current microbiome-centered therapies in MASLD management, including prebiotics, probiotics, synbiotics, fecal microbiota transplantation, and emerging therapies such as engineered bacteria and bacteriophage therapy. We explore the scientific rationale, clinical evidence, and potential mechanisms by which these interventions influence MASLD. The gut-liver axis is crucial in MASLD, with notable changes in microbiome composition linked to disease progression. For instance, specific microbial profiles and reduced alpha diversity are associated with MASLD severity. Therapeutic strategies targeting the microbiome could modulate disease progression by improving gut permeability, reducing endotoxin-producing bacteria, and altering bile acid metabolism. Although promising, these therapies require further research to fully understand their mechanisms and optimize their efficacy. This review integrates findings from clinical trials and experimental studies, providing a comprehensive overview of microbiome-centered therapies’ potential in managing MASLD. Future research should focus on personalized strategies, utilizing microbiome features, blood metabolites, and customized dietary interventions to enhance the effectiveness of these therapies.

Citations

Citations to this article as recorded by  Crossref logo
  • Probiotic-Derived Strain-Specific Metabolites Ameliorate Metabolic Dysfunction–Associated Steatotic Liver Disease through Modulation of the Gut-Liver Axis
    Sang Jun Yoon, Jieun Choi, Sung-Min Won, Jeong Seok Yu, Hee Young Kim, Hyun Chae Joung, In Gyu Park, Jung A Eom, Sang Hak Han, Do Yup Lee, Ki Tae Suk
    Probiotics and Antimicrobial Proteins.2026; 18(3): 4353.     CrossRef
  • Sarcopenia and MASLD: novel insights and the future
    Chang-Hai Liu, Qing-Min Zeng, Won Kim, Seung Up Kim, Zobair M. Younossi, Giovanni Targher, Christopher D. Byrne, Christos S. Mantzoros, Phunchai Charatcharoenwitthaya, Isabelle Anne Leclercq, Manuel Romero-Gómez, Hong Tang, Ming-Hua Zheng
    Nature Reviews Endocrinology.2026; 22(3): 139.     CrossRef
  • Digoxin-induced gut dysbiosis: Mechanistic links to prostaglandin dysregulation and lipid metabolic imbalance
    Nila Ganamurali, Sarvesh Sabarathinam
    Prostaglandins & Other Lipid Mediators.2026; 182: 107055.     CrossRef
  • Guideline comparison for fatty liver disease: European (EASL-EASD-EASO) and Asian (APASL) perspectives
    Ludovico Abenavoli
    Expert Review of Gastroenterology & Hepatology.2026; 20(1): 5.     CrossRef
  • The Metabolic Dysfunction–Associated Steatotic Liver Disease–CKD Axis: Intersecting Pathways and Opportunities for Early Intervention
    Sriram Sriperumbuduri, Prathab Balaji Saravanan, Gaurav Gupta, Arun J. Sanyal
    Kidney International Reports.2026; 11(4): 103757.     CrossRef
  • Exercise-mimicking effects of betaine in chronic disease prevention and management
    Yuhui Xu, Jianhong Gao, Minghui Wang, Hu Zhang
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Bacteroides eggerthii ameliorates metabolic dysfunction-associated steatotic liver disease through host–microbe signaling and highlights 2-hydroxyisocaproate as a potential effector
    Jiyi Choi, Moon Gyeong Yoon, Se Ha Jang, Geum Ok Baek, Hyun Sun Jung, Na-Rae Lee, Choong Hwan Lee, Ji Eun Han, Jae Youn Cheong, Jung Woo Eun, Soon Sun Kim
    Clinical and Molecular Hepatology.2026; 32(1): 239.     CrossRef
  • The Gut Commensal Butyricimonas Virosa Modulates Gut Microbiota‐Dependent Thiamine Metabolism and Attenuates Mouse Steatotic Liver Disease
    Ningning He, Haoyu Wang, Zizhen Yang, Hui Li, Bei Liu, Kaiwei Chen, Zhinan Wu, Xinnan Zhao, Hewei Liang, Mengmeng Wang, Xiaofang Li, Yiyi Zhong, Haifeng Zhang, Liang Xiao, Karsten Kristiansen, Jixing Peng, Yuanqiang Zou, Shangyong Li
    Advanced Science.2026;[Epub]     CrossRef
  • The Gut–Liver Axis in MASLD: From Host–Microbiome Crosstalk to Precision Therapeutics
    Ji Zhou, Bowen Zhu, Ziqian Bing, Tingting Wang, Yue Zhao
    Microorganisms.2026; 14(2): 471.     CrossRef
  • Therapeutic modulation of the gut-liver axis with faecalibacterium prausnitzii in metabolic dysfunction-associated steatohepatitis
    Han Chen, Yan Wang, Wei Su, Yicheng Liu, Shuo Li, Yun Liu, Xiaoying Zhou
    BMC Microbiology.2026;[Epub]     CrossRef
  • MetALD at the crossroads of metabolic and alcohol-related liver disease
    Gustavo Ayares, Luis Antonio Díaz, Juan Pablo Arab, Marco Arrese
    Trends in Endocrinology & Metabolism.2026;[Epub]     CrossRef
  • Prebiotic modulation of FMT donor microbiota enhances MASLD-relevant taxa and functions in an in vitro gut model
    Kait F Al, Suyang Jia, Michael Silverman, Gregor Reid, Jeremy P Burton, Seema Nair Parvathy
    Journal of Applied Microbiology.2026;[Epub]     CrossRef
  • Association of gut microbiota dietary index with MAFLD and the risk of liver fibrosis: the mediating effect of vitamins
    Jinlu Han, Teng Zhou, Jiong Chen, Ling Xu, Wen Shan, Qinghui Zhang
    Journal of Nutritional Science.2026;[Epub]     CrossRef
  • The Microbiome‐Gut‐Liver Axis Drives Post‐Kasai Fibrosis in Biliary Atresia: From Mechanism to Precision Intervention
    Jiwen Cheng
    Hepatology Research.2026; 56(5): 648.     CrossRef
  • Effects of Probiotic and Synbiotic Supplementation on Metabolic and Hepatic Outcomes in Children and Adolescents With Obesity, Including Those With Obesity‐Related Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review and Meta‐Anal
    Pedram Pam, Mohammad Safari, Ali Hojati, Rasoul Zarrin, Amir Hossein Faghfouri
    Journal of Paediatrics and Child Health.2026; 62(5): 678.     CrossRef
  • Correspondence to letter to the editor on “Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease”
    Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
    Clinical and Molecular Hepatology.2026; 32(2): e235.     CrossRef
  • Gut microbiome and metabolic health: mechanisms and precision interventions
    Zhengrui Li, Sudeshna Samui, Ji'an Liu, Yang Yang, Xue Liu, Qingyu Chen, Jing Li, Divya Gopinath, Peng Luo, Dan Shan
    Gut Microbes.2026;[Epub]     CrossRef
  • Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach
    Beom Kyung Kim
    The Kaohsiung Journal of Medical Sciences.2026;[Epub]     CrossRef
  • Microbial dysbiosis in metabolic disorders: linking epigenomic regulation and pathological mechanisms
    Arun K. Sharma, Md Sayeed Akhtar, Khalid Orayj, Sadaf Farooqui, Abida Khan, Gunjan Sharma
    Drug Discovery Today.2026; 31(4): 104698.     CrossRef
  • Impact of probiotics and prebiotics on glucose/lipid metabolism in metabolic dysfunction-associated steatotic liver disease: mechanisms and implications
    Yinan Zhao, Ziyan Li, Guoying Yu
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Maternal-Infant Gut Microbiota Transmission and the Early Origins of Metabolic Liver Diseases: Mechanisms and Interventional Opportunities
    Xinrui Meng, Xueping Wu, Huihui Sun, Jing Cong, Yuchao Gu
    Nutrition Reviews.2026;[Epub]     CrossRef
  • The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Microbiome Interactions and Therapeutic Targets
    Poonam Sahu, Trilochan Satapathy
    Probiotics and Antimicrobial Proteins.2026;[Epub]     CrossRef
  • Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
    Ruizhe Ren, Xiao Liang, Xiyang Wei
    Molecular Biomedicine.2026;[Epub]     CrossRef
  • Nutritional Interventions Targeting the Gut Microbiome in MASLD: From Prebiotics and Probiotics to Postbiotics and Fecal Microbiota Transplantation
    Carlo Acierno, Alfredo Caturano, Fannia Barletta, Luca Rinaldi, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Riccardo Nevola
    Nutrients.2026; 18(11): 1765.     CrossRef
  • Structural characterization of the pectic polysaccharide from corn silk and its protective mechanism against MASLD via regulation of the gut-liver axis
    Haichao Wang, Jiajing Yan, Haolin Jia, Xiaoyan Li, Bingxuan Li, Xuefang Zhang, Shujun Wang, Zheng Li, Yuhong Liu, Yifei Bian
    Carbohydrate Polymers.2026; : 125510.     CrossRef
  • Association between oral microbiome alpha and beta diversity and MASLD risk: a large-scale, population-based retrospective study
    Zeru Liu, Yizhi Mao, Lei Zhang, Beibei Wang, Jiaxuan Tian, Yanjun Li, Shuangshuang Li, Yinglong He, Meiyan Zeng, Pan Meng, Houpan Song
    Frontiers in Cellular and Infection Microbiology.2026;[Epub]     CrossRef
  • Association of prebiotic/probiotic intake with MASLD: evidence from NHANES and randomized controlled trials in the context of prediction, prevention, and a personalized medicine framework
    Senlin Wang, Ruimin Zhang, Peisen Guo, Huawu Yang, Yanjun Liu, Hongmei Zhu
    EPMA Journal.2025; 16(1): 183.     CrossRef
  • Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease
    Meenakshi Vachher, Kohinoor Kaur, Manisha Marothia, Archana Burman, Deepanjana, Savita Bansal
    Human Nutrition & Metabolism.2025; 40: 200305.     CrossRef
  • Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management
    Luigi Elio Adinolfi, Aldo Marrone, Luca Rinaldi, Riccardo Nevola, Antonio Izzi, Ferdinando Carlo Sasso
    Exploration of Medicine.2025;[Epub]     CrossRef
  • Electroacupuncture Attenuates Intestinal Barrier Disruption via the α7nAChR-Mediated HO-1/p38 MAPK/NF-κB Pathway in a Mouse Model of Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized, Single-Blind, Controlled Trial
    Xiao Wang, Jiasen Sun, Peng Wang, Yimin Zhang, Jiuyang Chang, Zhijun Duan
    Biomedicines.2025; 13(4): 802.     CrossRef
  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions
    Carolina Jiménez-González, Marta Alonso-Peña, Paula Argos Vélez, Javier Crespo, Paula Iruzubieta
    Nutrients.2025; 17(9): 1580.     CrossRef
  • Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies
    Claudia Reytor-González, Daniel Simancas-Racines, Martín Campuzano-Donoso, Janeth Castano Jimenez, Náthaly Mercedes Román-Galeano, Gerardo Sarno, Evelyn Frias-Toral
    Food and Agricultural Immunology.2025;[Epub]     CrossRef
  • Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease
    Ting Zhou, Ziwen Jin, Rilei Jiang, Weiwei Li
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Orchestration of Gut–Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic Innovation
    Ao Liu, Mengting Huang, Yuwen Xi, Xiaoling Deng, Keshu Xu
    Biomedicines.2025; 13(6): 1422.     CrossRef
  • Gut microbiota in liver diseases: initiation, development and therapy
    Jian-Xiu Yu, Jun Wu, Xin Chen, Su-gang Zang, Xue-bin Li, Li-Pei Wu, Shi-hai Xuan
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Medical Implications of Renaming Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Yu-Jin Choi, Chang-Gue Son
    Journal of Korean Medicine.2025; 46(2): 40.     CrossRef
  • Metabolic dysfunction-associated steatotic liver disease (MASLD): emerging insights into gut microbiota interactions and therapeutic perspectives
    Wenchu Qian, Ling He, Chenxue Fu, Tiantian Zeng, Hanyu Wang, Haifang Li
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
  • Immune Microenvironment on the Molecular Mechanisms and Therapeutic Targets of MAFLD
    Zhonghao Jiang, Baolin Qian, Tongjie Xu, Junjie Bai, Wenguang Fu
    ImmunoTargets and Therapy.2025; Volume 14: 719.     CrossRef
  • Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Chao Cui, Shuai Gao, Jingfei Shi, Kai Wang
    Gut and Liver.2025; 19(4): 479.     CrossRef
  • Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease
    Wenhao Wu, Zebin Hou
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Cholesterol and the gut-liver axis: unraveling their role in the onset and progression of metabolic-associated steatotic liver disease
    Luis A. Rodríguez-Rojas, Leticia Bucio-Ortiz, Verónica Souza-Arroyo, María Concepción Gutiérrez-Ruiz, Luis E. Gómez-Quiroz, Roxana U. Miranda-Labra
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
  • Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies
    Said A Al-Busafi, Ahmed Alwassief, Ali Madian, Hassan Atalla, Mohamed Alboraie, Ashraf Elbahrawy, Mohammed Eslam
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Present and Future Perspectives in the Treatment of Liver Fibrosis
    Lucia Cerrito, Linda Galasso, Jacopo Iaccarino, Alessandro Pizzi, Fabrizio Termite, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco
    Pharmaceuticals.2025; 18(9): 1321.     CrossRef
  • Mechanism of Huanglian Wendan Decoction in ameliorating non-alcoholic fatty liver disease via modulating gut microbiota-mediated metabolic reprogramming and activating the LKB1/AMPK pathway
    Jianping Zhu, Yuzhen Chen, Yidi Han, Ji Li, Fahrul Nurkolis
    PLOS One.2025; 20(9): e0331303.     CrossRef
  • Genome-Based Mexican Diet Bioactives Target Molecular Pathways in HBV, HCV, and MASLD: A Bioinformatic Approach for Liver Disease Prevention
    Leonardo Leal-Mercado, Arturo Panduro, Alexis José-Abrego, Sonia Roman
    International Journal of Molecular Sciences.2025; 26(18): 8977.     CrossRef
  • Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomy
    Yi-Fan Zou, Yi-Gang Zhang, Zi-Chu Zhao, Zheng Li, Hong-Da Liu, Qing-Ya Li, Ze-Tian Chen, Cheng-Jun Zhu, Hai-Tao Liu, Ji-Wei Wang, Feng-Yuan Li, Lin-Jun Wang, Dian-Cai Zhang, Li Yang, Hao Xu, Ze-Kuan Xu, Sen Wang
    World Journal of Gastrointestinal Surgery.2025;[Epub]     CrossRef
  • Recent research advances in RNA m5C methylation modification in liver diseases
    Wenjuan Chen, Lifan Zhang, Xinyu Gu, Yafeng Liu, Shujun Zhang, Xinjun Hu, Penghui Li
    Frontiers in Molecular Biosciences.2025;[Epub]     CrossRef
  • Integrative gut microbiota and metabolomics reveals the mechanism of chicory extract in improving metabolic dysfunction-associated steatotic liver disease via gut-liver axis
    Haifeng Wang, Songlin Liu, Yonggang Chen, Weiwei Fang, Ying Cheng, Zhigang Zhang, Haiming Hu, Baifei Hu, Hongtao Liu
    Phytomedicine.2025; 148: 157404.     CrossRef
  • Harnessing Gut Microbiome–Brain–Liver Crosstalk: Novel Therapeutic Strategies for Metabolic Dysfunction‐Associated Steatotic Liver Disease
    Xingtao Zhao, Ruolan Li, Jingdong Zhao, Ruiqi Sun, Shuo Zhang, Qiong Pan, Hongyan Lu, Jin Chai
    Medicine Bulletin.2025; 1(2): 136.     CrossRef
  • Honeysuckle-derived exosome-like nanovesicles ameliorate metabolic-associated fatty liver disease by modulating gut microbiota and its metabolites
    Ping Li, Qingyuan Wu, Yuanhao Zhou, Xiaojuan Hu, Yan Tang, Yuanyuan Wang, Weijiao Fan, Yiyi Shan, Kexin Yu, Jie Wang, Shibing Wang, Xiao Ye, Huiyu Liu, Xiaozhou Mou
    Nano Research.2025; 18(12): 94907986.     CrossRef
  • Perturbed microbial ecology in pediatric systemic lupus erythematosus: Evidence from the gut microbiome and serum metabolome
    Bo Li, Tao Ma, Yanjun Jia, Chunfeng Mou, Meng Zeng, Jie Yu, Lin Zou, Xiaoqiang Li, Han Wang
    Genes & Diseases.2025; : 101932.     CrossRef
  • The Gut-Liver Axis: Molecular Mechanisms and Therapeutic Targeting in Liver Disease
    Liang Ma, He Wang, Qiuyu Jin, Zhiwen Sun, Shuang Yu, Yang Zhang
    International Journal of General Medicine.2025; Volume 18: 7531.     CrossRef
  • Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD
    Xiaoxue Long, Hui Wang, Yuwei Lu, Xiaojing Gao, Yuanyuan Xiao, Mingliang Zhang, Jingyi Guo, Jingyi Yang, Ruiqi Zhang, Qian Li, Guiyun Zhou, Ruibao Yang, Feng Chen, Qingqing Wu, Liming Sun, Chengshuang Chu, Xuexue Zhu, Zhengjun Wu, Quanlu Ren, Chunping You
    Cell Metabolism.2025; 37(12): 2342.     CrossRef
  • Gut microbiota in hepatic encephalopathy: a 3PM-guided three-tier health strategy
    Jing Chen, Mingliao Niu, Longjiang Zhang
    EPMA Journal.2025; 17(1): 135.     CrossRef
  • An umbrella meta-analysis of microbial therapy on hepatic steatosis, fibrosis, and liver stiffness in metabolic dysfunction-associated steatotic liver disease
    Gvzalnur Kurban, Xiangjun Chen, Xingyi Jin, Hui Xia, Shaokang Wang, Guiju Sun
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Drug treatment of MASH from none to (too) many options?
    Amedeo Lonardo, Ralf Weiskirchen
    Exploration of Medicine.2025;[Epub]     CrossRef
  • Prebiotic and Probiotic Foods in MASLD: Microbiome-Mediated Therapeutic Strategies
    Cui Beiming, Liu Yujie, Hui-Eun Chang Joyce, Chen Jieying, Xu Jiahang, Teoh Jian-Peng, Loong Ho Chun
    Synthetic Biology and Engineering.2025; 3(4): 10018.     CrossRef
  • 15,744 View
  • 479 Download
  • 48 Web of Science
  • Crossref

Editorial

Hepatic neoplasm

Citations

Citations to this article as recorded by  Crossref logo
  • Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma
    Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi
    Clinical and Molecular Hepatology.2026; 32(1): e38.     CrossRef
  • Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”
    Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee
    Clinical and Molecular Hepatology.2025; 31(1): e84.     CrossRef
  • T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells
    Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, Safia Obaidur Rab, Suhas Ballal, Abhayveer Singh, Anima Nanda, Subhashree Ray, Ahmed Hjazi, Hatif Abdulrazaq Yasin
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(8): 10007.     CrossRef
  • Genetic insights into sarcomatoid hepatocellular carcinoma: Critical role of ARID2 in pathogenesis and immune feature: Editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma”
    Naoshi Nishida
    Clinical and Molecular Hepatology.2025; 31(2): 635.     CrossRef
  • Addressing the Complexities of Pre-Liver Transplant Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Response to Recent Commentaries
    Mohammad Saeid Rezaee-Zavareh, Zhiyong Guo, Ju Dong Yang
    Journal of Hepatology.2024;[Epub]     CrossRef
  • 8,602 View
  • 95 Download
  • 4 Web of Science
  • Crossref

Correspondences

Liver fibrosis, cirrhosis, and portal hypertension

Citations

Citations to this article as recorded by  Crossref logo
  • Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions
    Jiaorong Qu, Wenqing Qin, Minghang Dong, Zhi Ma, Si Li, Runping Liu, Ranyun Chen, Changmeng Li, Xiaojiaoyang Li
    MedComm.2026;[Epub]     CrossRef
  • 6,584 View
  • 63 Download
  • 1 Web of Science
  • Crossref

Artificial intelligence, epidemiology, methodology, or others

Citations

Citations to this article as recorded by  Crossref logo
  • Prompt engineering with ChatGPT3.5 and GPT4 to improve patient education on retinal diseases
    Hoyoung Jung, Jean Oh, Kirk A.J. Stephenson, Aaron W. Joe, Zaid N. Mammo
    Canadian Journal of Ophthalmology.2025; 60(3): e375.     CrossRef
  • The application of artificial intelligence-based tools in the management of hepatocellular carcinoma: current status and future perspectives
    Ciro Celsa, Alessio Quartararo, Marcello Maida, Gaetano Giusino, Valeria Gaudioso, Alba Sparacino, Guido Cusimano, Sofia Rao, Alessandro Grova, Roberta Ciccia, Mauro Salvato, Francesco Mercurio, Claudia La Mantia, Gabriele Di Maria, Giuseppe Cabibbo, Calo
    Hepatoma Research.2025;[Epub]     CrossRef
  • Appropriateness and Comprehensiveness of Using ChatGPT for Perioperative Patient Education in Thoracic Surgery in Different Language Contexts: Survey Study
    Chen-ye Shao, Hui Li, Xiao-long Liu, Chang Li, Li-qin Yang, Yue-juan Zhang, Jing Luo, Jun Zhao
    Interactive Journal of Medical Research.2023; 12: e46900.     CrossRef
  • 11,321 View
  • 57 Download
  • 2 Web of Science
  • Crossref

Original Article

Artificial intelligence, epidemiology, methodology, or others

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
Clin Mol Hepatol 2023;29(3):721-732.
Published online March 22, 2023
DOI: https://doi.org/10.3350/cmh.2023.0089
Background/Aims
Patients with cirrhosis and hepatocellular carcinoma (HCC) require extensive and personalized care to improve outcomes. ChatGPT (Generative Pre-trained Transformer), a large language model, holds the potential to provide professional yet patient-friendly support. We aimed to examine the accuracy and reproducibility of ChatGPT in answering questions regarding knowledge, management, and emotional support for cirrhosis and HCC.
Methods
ChatGPT’s responses to 164 questions were independently graded by two transplant hepatologists and resolved by a third reviewer. The performance of ChatGPT was also assessed using two published questionnaires and 26 questions formulated from the quality measures of cirrhosis management. Finally, its emotional support capacity was tested.
Results
We showed that ChatGPT regurgitated extensive knowledge of cirrhosis (79.1% correct) and HCC (74.0% correct), but only small proportions (47.3% in cirrhosis, 41.1% in HCC) were labeled as comprehensive. The performance was better in basic knowledge, lifestyle, and treatment than in the domains of diagnosis and preventive medicine. For the quality measures, the model answered 76.9% of questions correctly but failed to specify decision-making cut-offs and treatment durations. ChatGPT lacked knowledge of regional guidelines variations, such as HCC screening criteria. However, it provided practical and multifaceted advice to patients and caregivers regarding the next steps and adjusting to a new diagnosis.
Conclusions
We analyzed the areas of robustness and limitations of ChatGPT’s responses on the management of cirrhosis and HCC and relevant emotional support. ChatGPT may have a role as an adjunct informational tool for patients and physicians to improve outcomes.

Citations

Citations to this article as recorded by  Crossref logo
  • Appropriateness of Artificial Intelligence Chatbots in Diabetic Foot Ulcer Management
    Makoto Shiraishi, Haesu Lee, Koji Kanayama, Yuta Moriwaki, Mutsumi Okazaki
    The International Journal of Lower Extremity Wounds.2026; 25(2): 462.     CrossRef
  • The rise of multidisciplinary clinics in hepatology: A practical, how-to-guide, and review of the literature
    Nicholas Lim, Deepika Devuni, Margarita German, Jennifer Guy, Atoosa Rabiee, Pratima Sharma, Alexandra Shingina, Hersh Shroff, Anjana Pillai
    Hepatology.2026; 83(5): 1287.     CrossRef
  • Utilizing advanced language models to identify industrial symbiosis opportunities within the circular economy: capabilities and challenges
    Olcay Genc
    Engineering, Construction and Architectural Management.2026; 33(4): 3076.     CrossRef
  • Artificial Intelligence Chatbots as Sources of Implant Dentistry Information for the Public: Validity and Reliability Assessment
    Tahani Mohammed Binaljadm, Ahmed Yaseen Alqutaibi, Esam Halboub, Muhammad Sohail Zafar, Samah Saker
    European Journal of Dentistry.2026; 20(02): 466.     CrossRef
  • Responses of ChatGPT-4 on intraocular lenses: an evolving artificial intelligence assessment
    Fahri Onur Aydin, Serhat Ermis
    Clinical and Experimental Optometry.2026; 109(2): 329.     CrossRef
  • Evaluating ChatGPT-4.0’s accuracy and potential in idiopathic scoliosis conservative treatment: a preliminary study on clarity, validity, and expert perceptions
    Francesco Negrini, Calogero Malfitano, Giorgio Ferriero, Giovanni Morone, Alberto Negrini, Fabio Zaina, Irene Ferrario, Carlotte Kiekens, Stefano Negrini, Jacopo Vitale
    European Spine Journal.2026; 35(2): 422.     CrossRef
  • Assessment of the Utility of Artificial Intelligence-Based Chatbots in Patient Education: A Systematic Review and Meta-Analysis
    Sameh Hany Emile, Nir Horesh, Zoe Garoufalia, Rachel Gefen, Marylise Boutros, Steven D. Wexner
    The American Surgeon™.2026; 92(1): 258.     CrossRef
  • Language proficiency assessment of autistic children using large language models
    Saige Qin, Min Liu, Tongquan Wei, Qiaoyun Liu
    Expert Systems with Applications.2026; 298: 129712.     CrossRef
  • “Can We Trust Them?” An Expert Evaluation of Large Language Models to Provide Sleep and Jet Lag Recommendations for Athletes
    Jacopo Vitale, Alan McCall, Andrea Cina, Juan-Manuel Alonso, Amy Bender, Michelle Biggins, Jonathan Charest, Michiko Dohi, Aleksandra Filip-Stachnik, Hugh Fullagar, Micheal Grandner, Luke Gupta, Michele Lastella, Dean Miller, Mathieu Nedelec, Audrey Janse
    Sports Medicine.2026; 56(1): 257.     CrossRef
  • Easing the burden: A pilot study evaluating AI-generated In-Basket message drafts to streamline perioperative endocrine surgical care
    Katherine R. Whitehouse, Ryan T. Heslin, Alexis Desir, Rajam Raghunathan, Ana K. Islam, Sarah Lallky, Priscilla Philip, Nicole Reedy, Ankeeta Mehta, Megan Parmer, Marlen V. Piersall, Sarah C. Oltmann, Alan P.B. Dackiw, Naim M. Maalouf, Vivek R. Sant
    Surgery.2026; 189: 109700.     CrossRef
  • Exploration of the assessment of clinical decision-making capabilities in Clinical Oncology based on generative large language models
    Li Zhao, Chunyan Yang, Chunhui Chen, Tingting Wang, Nana Xiang, Lei Peng, Shaohua Zhang
    European Journal of Surgical Oncology.2026; 52(1): 111175.     CrossRef
  • Artificial intelligence, real questions: ChatGPT and cochlear implants
    Antiga Muradova
    European Archives of Oto-Rhino-Laryngology.2026; 283(2): 1169.     CrossRef
  • Comparing ChatGPT with healthcare provider responses to home parenteral nutrition questions
    Regina Barrera, Heather Stanner, Nancy Stoner, Kristy Poindexter, Anushka Sharma, Marion F. Winkler, Hassan S. Dashti
    Nutrition in Clinical Practice.2026; 41(2): 574.     CrossRef
  • Performance of AI chatbots in responding to geriatric patient questions on denture issues: A mixed method study of accuracy and empathy
    Indumathi Sivakumar, Sivakumar Arunachalam, Praveen Gadde, Jitendra Sharan
    The Journal of Prosthetic Dentistry.2026; 135(5): e170.     CrossRef
  • How large language model responds to common depression questions: A comparative analysis of ChatGPT-4.0, DeepSeek, Google Gemini and Perplexity
    Qian You, Yuqin Luo, Zengli Chen, Xiaozhen Song, Feng Wang, Shouqin Wen, Qin Ding, Juan Chen
    Nurse Education in Practice.2026; 90: 104668.     CrossRef
  • Evaluation of the accuracy and readability of large language model responses on menopause and hormone therapy
    Jana Karam, Chrisandra Shufelt, Nancy Safwan, Ekta Kapoor, Monica M. Christmas, Stephanie S. Faubion
    Menopause.2026; 33(5): 515.     CrossRef
  • Comparative Performance Evaluation of Large Language Models and Human Teachers in Answering Optometry Questions from Medical Undergraduates
    Zijing Huang, Tian Lin, Huini Lin, Yuanjin Zheng, Man Pan Chin, Hongxi Wang, Peigeng Xu, Haoyu Chen
    Journal of Medical Education and Curricular Development.2026;[Epub]     CrossRef
  • Patient Perceptions of Artificial Intelligence-Generated Kidney Transplant Information: Comparing ChatGPT With the National Kidney Foundation
    Hwarang Stephen Han, Jihye Lee
    Kidney Medicine.2026; 8(3): 101247.     CrossRef
  • The evolving landscape of artificial intelligence in patient education: A bibliometric knowledge mapping study
    Jingyu Zhou, Wei Zhang, Shichao Liu
    DIGITAL HEALTH.2026;[Epub]     CrossRef
  • Generative AI for patient education in cancer care: A scoping review of evaluation practices and emerging trends
    Aidan Leong, Keita Ormsby
    Technical Innovations & Patient Support in Radiation Oncology.2026; 37: 100373.     CrossRef
  • Accuracy, Readability, Understandability, and Actionability of ChatGPT Responses to Patient Questions on Systemic Isotretinoin Treatment
    Ruveyda Küçük, Cemre Berin Güngör, İlteriş Oğuz Topal, Ramazan Bahadır Küçük, Ayşe Serap Karadağ
    Indian Dermatology Online Journal.2026; 17(1): 27.     CrossRef
  • Generative AI and Extension Program Planning and Evaluation: Do General Large Language Models Answer Domain-specific Questions Accurately?
    Emmanuel Anobir Mensah, Kirk A. Swortzel
    Journal of Agricultural Education.2026; 67(1): 4.     CrossRef
  • Comparative Analysis of Large Language Models in Hemodialysis Vascular Access: ChatGPT-5, Gemini-2.5, and DeepSeek-V3
    Muhammet Hüseyin Erkan, Ömer Faruk Rahman, Abdullah Güner, Fevzi Ayyıldız, Emin Barbarus
    The European Research Journal.2026; : 730.     CrossRef
  • Can artificial intelligence debunk health misinformation more effectively than humans? A three‐dimensional persuasion analysis
    Xinyu Ji, Xing Zhang
    Journal of the Association for Information Science and Technology.2026; 77(4): 563.     CrossRef
  • Patient safety and quality implications of large language model use in healthcare: a risk-stratified assessment of artificial intelligence-assisted medical consultations
    Pouyan Esmaeilzadeh
    International Journal for Quality in Health Care.2026;[Epub]     CrossRef
  • ChatGPT-4o assists emergency physicians in enhancing diagnostic accuracy for fever of unknown origin: retrospective analysis
    Hui Long, Guoqing Huang, Xinbo Yin, Xiaojie Zheng, Sijia Cao, Nan Wang, Xiangmin Li, Xiaokai Wang
    BMC Emergency Medicine.2026;[Epub]     CrossRef
  • Attitudes toward large language model-based Artificial Intelligence systems as an information source for shared decision-making in radiation oncology
    Rebecca Moser, Lena M Buchecker, Jana Nano, Nina A Mayr, Sophie T Behzadi, Sophia Kiesl, Sophie Maier, Luisa Allwohn, Jacqueline Lammert, Lisa C Adams, Max Tschochohei, Stephanie E Combs, Kai J Borm
    The Oncologist.2026;[Epub]     CrossRef
  • Evaluating the clinical utility of large language models for hepatocellular carcinoma treatment recommendations: A nationwide retrospective registry study
    Keungmo Yang, Jaejun Lee, Jeong Won Jang, Pil Soo Sung, Ji Won Han, Amit Singal
    PLOS Medicine.2026; 23(1): e1004855.     CrossRef
  • Accelerating dataset generation for machine learning using large language models: a pharmaceutical additive manufacturing case
    Paola Carou-Senra, Lucía Rodríguez-Pombo, Carmen Alvarez-Lorenzo, Alvaro Goyanes
    International Journal of Pharmaceutics.2026; 691: 126587.     CrossRef
  • ChatGPT in liver transplantation: Current applications, limitations, and future directions
    Eleni Avramidou, Nikolaos Kougianos, George Chiotis-Miehe, Stella Vasileiadou, Georgios Katsanos, Georgios Tsoulfas
    World Journal of Transplantation.2026;[Epub]     CrossRef
  • Decoupled quality and readability in skin cancer education from large language models
    Yanping Zhang, Lei Wang, Weiqiang Zhang, Weifeng Lan
    Frontiers in Public Health.2026;[Epub]     CrossRef
  • A Survey on Medical Competence Evaluation Benchmarks for Large Language Models
    Qiting Wang, Huiru Zou, Haobin Zhang, Yongshun Huang, Junzhang Tian, Weibin Cheng
    Health Care Science.2026; 5(1): 4.     CrossRef
  • Exploring evaluation measures of large language models for family caregiver use: A scoping review
    Soojeong Han, Hannah Cho, Yong K Choi, Gregory L Alexander
    DIGITAL HEALTH.2026;[Epub]     CrossRef
  • From Artificial Intelligence to Real-Life Practice: Can ChatGPT be a Guide About Pediatric Dysphagia?
    Esra Ülgen Kıratlıoğlu, Emre Adıgüzel
    International Journal of Child Health and Nutrition.2026; 15(1): 37.     CrossRef
  • Physician Perspectives on ChatGPT-4o as a Patient Resource for Abdominal Cancer Surgeries: Cross-Sectional Survey
    Christina V Lindsay, Devika A Shenoy, Allison N Martin, Christie L Clipper, Kevin N Shah, Michael E Lidsky, Daniel P Nussbaum, Ralph Snyderman
    JMIR Perioperative Medicine.2026; 9: e81374.     CrossRef
  • Comparing large language models and human experts in interpreting MRI reports for personalized patient education
    Kai Du, Ao Li, Qi -Heng Zuo, Chen -Yu Zhang, Ren Guo, Ping Chen, Wei -Shuai Du, Yong -Li Zuo, Shu-Ming Li
    International Journal of Medical Informatics.2026; 214: 106409.     CrossRef
  • Evaluation of Information Generated by ChatGPT on Preventing Peripheral Venous Catheter‐Related Infections
    Seda Pehlivan, Derya Akça Doğan, Öznur Erbay Dallı
    Nursing Open.2026;[Epub]     CrossRef
  • Evaluating Generative Artificial Intelligence Models’ Responses to Questions About Scaphoid Fracture and Scaphoid Nonunion
    Armaan Dhanoa, Ann-Sophie Lafreniere, Carl M. Harper, Grace Y. Kim, Laura Saenz, Jonathan Persitz, Kevin J. Zuo
    Journal of Hand Surgery Global Online.2026; 8(3): 100978.     CrossRef
  • Safety and user perception of general-purpose large language models in pediatric healthcare: Evaluations of ChatGPT by doctors and parents
    Jing Tan, Lin Wang, Guanghai Wang, Yonghong Yang, Feiyong Jia, Xia Chi, Xiaoli Xie, Tingyu Li, Binrang Yang, Huifeng Zhang, Min Gong, Yuxin Wu, Xiuyu Shi, Li Chen
    DIGITAL HEALTH.2026;[Epub]     CrossRef
  • ChatGPT in precision medicine
    Chengliang Yin, Xiaochun Sun, Anlin Dai, Xin-yao Ye, Yi Lu, Wanling Wang, Yuanyuan Chen, Hong Jiang, Juan Yu, Siomui Chong, Mingming Jiang, Jiayu Xu, Bing Yang, Rajeswari Chappa, Santosh Chokkakula, Kunlun He
    APL Bioengineering.2026;[Epub]     CrossRef
  • Evaluating ChatGPT-4 as a digital patient education tool in anesthesia: A multi-rater quality assessment
    Yasemin Akçaalan, Ezgi Erkilic, Handan Gulec, Tulin Gumus, Orhan Kanbak, Levent Ozturk
    DIGITAL HEALTH.2026;[Epub]     CrossRef
  • Precision and Personalization: How Large Language Models Redefining Diagnostic Accuracy in Personalized Medicine — A Systematic Literature Review
    A. K. N. L. Aththanagoda, K. A. S. H. Kulathilake, N. A. Abdullah
    IEEE Journal of Biomedical and Health Informatics.2026; 30(4): 3102.     CrossRef
  • A Review on Artificial Intelligence as a Solution to Burnout in Interventional Radiology
    Henry Zhang, Aria Torkpour, Boroumand Zeidaabadi, Nader Ashraf, Anousha Yazdabadi, Shams I. Iqbal, Hamed Asadi, Roberto Luigi Cazzato, Robert Morgan, Behnam Shaygi
    CardioVascular and Interventional Radiology.2026;[Epub]     CrossRef
  • Leveraging ChatGPT to assist junior physicians in standardizing ultrasound report writing: A promising tool
    Li Zhu, Huohu Zhong, Jing Bai, Xiaoying Wang, Peifeng Huang, Zhenhong Xu
    DIGITAL HEALTH.2026;[Epub]     CrossRef
  • Large language models’ capabilities in responding to oto-rhino-laryngology clinical vignettes: testing ChatGPT, Gemini, and Grok
    Tejaswi Mishra, M Mohan Raj, Pradosh Kumar Sarangi, Swaha Panda, K. S. B. S. Krishna Sasanka
    Indian Journal of Otolaryngology and Head & Neck Surgery.2026;[Epub]     CrossRef
  • Generative artificial intelligence in education: a comprehensive analysis based on bibliometrics
    Xiaojie Ma, Wenlong Zhu
    Data Science and Management.2026; : 100181.     CrossRef
  • Responsible use of large language models in gastroenterology and hepatology
    Sahil Khanna
    Therapeutic Advances in Gastroenterology.2026;[Epub]     CrossRef
  • Fine-tuned lightweight language models for structured extraction of liver cancer imaging free-text report: a comparative analysis with existing large language models
    Yang-Di Luo, Yong Sun, Shi-Le Tang, Lu-Jun Shen, Xuxiazi Zou, Hong-Liang Zou, Hua-Lin Shen, Tong-Tong Yang, Jia-Yun Wu, Rong-Yu Lu, Chao-Feng Li, Jin-Hua Huang, Jing Cai, Yi-Quan Jiang, Ge Ren
    BMC Medical Imaging.2026;[Epub]     CrossRef
  • Is ChatGPT's Knowledge on Rhinology Accurate? Can It Be Utilized in Medical Education and Patient Information?
    Aykut Özdoğan, Burçay Tellioğlu, Oğuzhan Katar, Serdar Özer
    European Journal of Rhinology and Allergy.2026; 9(1): 21.     CrossRef
  • A framework for generative AI-driven extraction of clinical user needs in pediatric device development
    Abdelrahman Abdou, Niraj Mistry, Douglas M. Campbell, Sridhar Krishnan
    Frontiers in Digital Health.2026;[Epub]     CrossRef
  • Artificial intelligence in gastroenterology clinical practice: Scoping review of large language model applications
    Yigit Yazarkan, Gamze Sonmez, Cem Simsek
    International Journal of Medical Informatics.2026; 214: 106413.     CrossRef
  • New horizons in artificial intelligence-assisted pain management: Evaluation of Gemini performance in the older adults
    Halil Ibrahim Tuna
    Geriatric Nursing.2026; 70: 104045.     CrossRef
  • Prevention of frailty in the elderly: an expert-based evaluation of measures proposed by artificial intelligence
    Sébastien Couarraze, Pierre Roda, Jiao Jiao, Martine Duclos, Nike Lu, David Thivel, Hijrah Nasir, Marek Zak, Camille Joannès, Frédéric Dutheil
    Geriatric Nursing.2026; 70: 104023.     CrossRef
  • Assessment of Large Language Models for Tracheostomy Care in Pediatrics: ChatGPT vs Claude
    Burak Celik, Ozgenur Kocak, Ali Ozturk
    Journal of Pediatric Health Care.2026;[Epub]     CrossRef
  • Compare the features of several mainstream AI software programmes: explore their accuracy and repeatability in solving queries related to pancreatic cysts
    Xiaoyi Zheng, Yongkang Lai, Jinhui Yi, Zhaoshen Li, Jiulong Zhao, Lianghao Hu
    BMC Gastroenterology.2026;[Epub]     CrossRef
  • Large Language Models for Diagnosis and Prognosis of Chronic Liver Diseases: A Systematic Review
    Basile Njei, Yazan A. Al‐Ajlouni, Abisola Ajayi, Farah Shahin, Omar Al Ta'ani, Sarpong Boateng, Gyanprakash Ketwaroo, Petr Protiva
    Health Science Reports.2026;[Epub]     CrossRef
  • Performance of Large Language Models in Answering Osteoporosis-Related Frequently Asked Questions: A Systematic Comparative Evaluation Based on International Associations
    Xuhui Wu, Jing Li, Shuying Liu, Yue Li, Qinyi Wang, Chuo Luo, Linke Shi, Yanfen Zheng, Lingqiong Meng, Min Fan, Zhifeng Sheng, Na Ouyang
    Calcified Tissue International.2026;[Epub]     CrossRef
  • Artificial Intelligence Chatbots for Dysphagia Patient Education: A Multi‐Center International Expert Evaluation
    Luisa Bertin, Afrin K. Rahman, John Clarke, Amir Mari, Frank Zerbib, C. Prakash Gyawali, Silvia Carrión, Jérôme R. Lechien, Sabine Roman, Elisa Marabotto, Ram Dickman, Vincenzo Savarino, Edoardo Vincenzo Savarino
    Neurogastroenterology & Motility.2026;[Epub]     CrossRef
  • AI-driven Medical Care: Evaluation of Large Language Models in Generating Personalized Stroke Education Materials
    Surim Yoon, Woo-Keun Seo, Kyungseo Kim, Seongvin Ju, Hyun Kyung Kim, Hyung Jun Kim, Jong-Won Chung, Oh Young Bang, Gyeong-Moon Kim, Eun Young Lee, Youngrak Choi, Soyoung Yoo
    Healthcare Informatics Research.2026; 32(2): 179.     CrossRef
  • Performance comparison of large language models for medication counseling in people living with HIV
    Can Huang, Yanfang Sun, Meng Chen, Lin Zhang, Wei Liu
    Frontiers in Public Health.2026;[Epub]     CrossRef
  • ChatGPT and Patients With Heart Failure
    Fotis Dimitriadis, Stelina Alkagiet, Lamprini Tsigkriki, Panagiota Kleitsioti, George Sidiropoulos, Dimitris Efstratiou, Taisa Askalidi, Adam Tsaousidis, Michail Siarkos, Pinelopi Giannakopoulou, Angeliki-Despoina Mavrogianni, John Zarifis, George Koulaou
    Angiology.2025; 76(8): 796.     CrossRef
  • Examining the role of ChatGPT in promoting health behaviors and lifestyle changes among cancer patients
    Fahad Alanezi
    Nutrition and Health.2025; 31(2): 739.     CrossRef
  • Comparing ChatGPT's and Surgeon's Responses to Thyroid-related Questions From Patients
    Siyin Guo, Ruicen Li, Genpeng Li, Wenjie Chen, Jing Huang, Linye He, Yu Ma, Liying Wang, Hongping Zheng, Chunxiang Tian, Yatong Zhao, Xinmin Pan, Hongxing Wan, Dasheng Liu, Zhihui Li, Jianyong Lei
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(3): e841.     CrossRef
  • Evaluation of four chatbots in autoimmune liver disease: A comparative analysis
    Jimmy Daza, Lucas Soares Bezerra, Laura Santamaría, Roberto Rueda-Esteban, Heike Bantel, Marcos Girala, Matthias Ebert, Florian Van Bömmel, Andreas Geier, Andres Gomez Aldana, Kevin Yau, Mario Alvares-da-Silva, Markus Peck-Radosavljevic, Ezequiel Ridruejo
    Annals of Hepatology.2025; 30(1): 101537.     CrossRef
  • Assessing the Performance of ChatGPT’s Responses to Questions Related to Atopic Dermatitis
    Yan Yu, Qian Zhao, Yiming Zhang, JinRu Lin, Huiping Wang
    Dermatitis®.2025;[Epub]     CrossRef
  • Evaluating the Accuracy, Comprehensiveness, and Validity of ChatGPT Compared to Evidence-Based Sources Regarding Common Surgical Conditions: Surgeons’ Perspectives
    Hazem Nasef, Heli Patel, Quratulain Amin, Samuel Baum, Asanthi Ratnasekera, Darwin Ang, William S Havron, Don Nakayama, Adel Elkbuli
    The American Surgeon™.2025; 91(3): 325.     CrossRef
  • Assessment of the reliability and usability of ChatGPT in response to spinal cord injury questions
    Fatma Özcan, Merve Örücü Atar, Özlem Köroğlu, Bilge Yılmaz
    The Journal of Spinal Cord Medicine.2025; 48(5): 852.     CrossRef
  • Decoding the NCCN Guidelines With AI: A Comparative Evaluation of ChatGPT-4.0 and Llama 2 in the Management of Thyroid Carcinoma
    Shivam Pandya, Tamir E. Bresler, Tyler Wilson, Zin Htway, Manabu Fujita
    The American Surgeon™.2025; 91(1): 94.     CrossRef
  • Patient education resources for oral mucositis: a google search and ChatGPT analysis
    Nathaniel Hunter, David Allen, Daniel Xiao, Madisyn Cox, Kunal Jain
    European Archives of Oto-Rhino-Laryngology.2025; 282(3): 1609.     CrossRef
  • Unveiling the risks of ChatGPT in diagnostic surgical pathology
    Vincenzo Guastafierro, Devin N. Corbitt, Alessandra Bressan, Bethania Fernandes, Ömer Mintemur, Francesca Magnoli, Susanna Ronchi, Stefano La Rosa, Silvia Uccella, Salvatore Lorenzo Renne
    Virchows Archiv.2025; 486(4): 663.     CrossRef
  • Evaluating the accuracy, time and cost of GPT-4 and GPT-4o in liver disease diagnoses using cases from “What is Your Diagnosis”
    Yusheng Guo, Tianxiang Li, Jiao Xie, Miao Luo, Chuansheng Zheng
    Journal of Hepatology.2025; 82(1): e15.     CrossRef
  • Assessing the quality of ChatGPT's responses to questions related to radiofrequency ablation for varicose veins
    Muhammad Anees, Fareed Ahmed Shaikh, Hafsah Shaikh, Nadeem Ahmed Siddiqui, Zia Ur Rehman
    Journal of Vascular Surgery: Venous and Lymphatic Disorders.2025; 13(1): 101985.     CrossRef
  • A comparative analysis of generative artificial intelligence responses from leading chatbots to questions about endometriosis
    Natalie D. Cohen, Milan Ho, Donald McIntire, Katherine Smith, Kimberly A. Kho
    AJOG Global Reports.2025; 5(1): 100405.     CrossRef
  • Assessment of Hypospadias Patient Education Using Large Language Models
    Rüya Naz, Hasan Deliağa, Mete Kaya
    Journal of Pediatric Surgical Nursing.2025; 14(1): 25.     CrossRef
  • Enhanced PROcedural Information READability for Patient-Centered Care in Interventional Radiology With Large Language Models (PRO-READ IR)
    Tarig Elhakim, Allison R. Brea, Wilton Fidelis, Sriram S. Paravastu, Mira Malavia, Mustafa Omer, Ana Mort, Shakthi Kumaran Ramasamy, Satvik Tripathi, Michael Dezube, Sara Smolinski-Zhao, Dania Daye
    Journal of the American College of Radiology.2025; 22(1): 84.     CrossRef
  • Exploring the Efficacy of Artificial Intelligence: A Comprehensive Analysis of CHAT‐GPT's Accuracy and Completeness in Addressing Urinary Incontinence Queries
    Jordana Barbosa‐Silva, Patricia Driusso, Elizabeth A. Ferreira, Raphael M. de Abreu
    Neurourology and Urodynamics.2025; 44(1): 153.     CrossRef
  • KI-gestützte Entscheidungsfindung in der Geburtshilfe – eine Machbarkeitsstudie über die medizinische Genauigkeit und Zuverlässigkeit von ChatGPT
    Simon Bader, Michael O. Schneider, Iason Psilopatis, Daniel Anetsberger, Julius Emons, Sven Kehl
    Zeitschrift für Geburtshilfe und Neonatologie.2025; 229(01): 15.     CrossRef
  • Evaluating for Evidence of Sociodemographic Bias in Conversational AI for Mental Health Support
    Yee Hui Yeo, Yuxin Peng, Muskaan Mehra, Jamil Samaan, Joshua Hakimian, Allistair Clark, Karisma Suchak, Zoe Krut, Taiga Andersson, Susan Persky, Omer Liran, Brennan Spiegel
    Cyberpsychology, Behavior, and Social Networking.2025; 28(1): 44.     CrossRef
  • Trials and Tribulations: Responses of ChatGPT to Patient Questions About Kidney Transplantation
    Jingzhi Xu, Michal Mankowski, Karen B. Vanterpool, Alexandra T. Strauss, Bonnie E. Lonze, Babak J. Orandi, Darren Stewart, Sunjae Bae, Nicole Ali, Jeffrey Stern, Aprajita Mattoo, Ryan Robalino, Irfana Soomro, Elaina Weldon, Eric K. Oermann, Yin Aphinyanap
    Transplantation.2025; 109(3): 399.     CrossRef
  • The Role of Artificial Intelligence and Big Data for Gastrointestinal Disease
    Nicholas Mathew Holt, Michael Francis Byrne
    Gastrointestinal Endoscopy Clinics of North America.2025; 35(2): 291.     CrossRef
  • Utility of Generative Artificial Intelligence for Patient Care Counseling for Mandibular Fractures
    Ariana L. Shaari, Disha P. Patil, Saad Mohammed, Parsa P. Salehi
    Journal of Craniofacial Surgery.2025; 36(5): 1459.     CrossRef
  • Exploring the potential of large language models in identifying metabolic dysfunction‐associated steatotic liver disease: A comparative study of non‐invasive tests and artificial intelligence‐generated responses
    Wanying Wu, Yuhu Guo, Qi Li, Congzhuo Jia
    Liver International.2025;[Epub]     CrossRef
  • ChatGPT for parents' education about early childhood caries: A friend or foe?
    Rawan Elkarmi, Suha Abu‐Ghazaleh, Hawazen Sonbol, Ola Haha, Alaa AL‐Haddad, Yazan Hassona
    International Journal of Paediatric Dentistry.2025; 35(4): 717.     CrossRef
  • Performance of Artificial Intelligence Chatbots on Ultrasound Examinations: Cross-Sectional Comparative Analysis
    Yong Zhang, Xiao Lu, Yan Luo, Ying Zhu, Wenwu Ling
    JMIR Medical Informatics.2025; 13: e63924.     CrossRef
  • A comparison of drug information question responses by a drug information center and by ChatGPT
    Samantha Triplett, Genevieve Lynn Ness-Engle, Erin M Behnen
    American Journal of Health-System Pharmacy.2025; 82(8): 448.     CrossRef
  • Evaluating the quality and readability of ChatGPT-generated patient-facing medical information in rhinology
    Alexander Z. Fazilat, Camille Brenac, Danae Kawamoto-Duran, Charlotte E. Berry, Jennifer Alyono, Michael T. Chang, David T. Liu, Zara M. Patel, Stéphane Tringali, Derrick C. Wan, Maxime Fieux
    European Archives of Oto-Rhino-Laryngology.2025; 282(4): 1911.     CrossRef
  • Exploring GPT‐4.0's efficiency in handling paediatric appendicitis questions
    Defeng Zeng, Guoqiang Chen, Guoyong Wang, Hai Zhou, Chunbao Guo
    Surgical Practice.2025; 29(1): 13.     CrossRef
  • ChatGPT and frequently asked patient questions for upper eyelid blepharoplasty surgery
    Arjun Watane, Brittany M. Perzia, Madison E. Weiss, Andrea A. Tooley, Emily Li, Larissa A. Habib, Phillip A. Tenzel, Michelle M. Maeng
    Orbit.2025; 44(3): 295.     CrossRef
  • Assessing the performance of chat generative pretrained transformer (ChatGPT) in answering chronic kidney disease‐related questions
    Başak Can, Esra Deniz Kahvecioğlu, Fatih Palıt, Egemen Cebeci, Mehmet Küçük, Zeynep Karaali
    Therapeutic Apheresis and Dialysis.2025; 29(5): 760.     CrossRef
  • Exploring the performance of large language models on hepatitis B infection-related questions: A comparative study
    Yu Li, Chen-Kai Huang, Yi Hu, Xiao-Dong Zhou, Cong He, Jia-Wei Zhong
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • GAI identity threat: When and why do individuals feel threatened?
    Jing Zhou, Yaobin Lu, Qian Chen
    Information & Management.2025; 62(2): 104093.     CrossRef
  • Can artificial intelligence improve patient educational material readability? A systematic review and narrative synthesis
    Mohamed Nasra, Rimsha Jaffri, Davor Pavlin‐Premrl, Hong Kuan Kok, Ali Khabaza, Christen Barras, Lee‐Anne Slater, Anousha Yazdabadi, Justin Moore, Jeremy Russell, Paul Smith, Ronil V. Chandra, Mark Brooks, Ashu Jhamb, Winston Chong, Julian Maingard, Hamed
    Internal Medicine Journal.2025; 55(1): 20.     CrossRef
  • Large Language Model Evaluation Criteria Framework in Healthcare: Fuzzy MCDM Approach
    Hamzeh Mohammad Alabool
    SN Computer Science.2025;[Epub]     CrossRef
  • Can Artificial Intelligence Create an Accurate Colonoscopy Bowel Preparation Prompt?
    Marni H. Wilkoff, Nicholas R. Piniella, Rashmi Advani
    Gastro Hep Advances.2025; 4(2): 100566.     CrossRef
  • Large language models in cancer: potentials, risks, and safeguards
    Md Muntasir Zitu, Tuan Dung Le, Thanh Duong, Shohreh Haddadan, Melany Garcia, Rossybelle Amorrortu, Yayi Zhao, Dana E Rollison, Thanh Thieu
    BJR|Artificial Intelligence.2025;[Epub]     CrossRef
  • Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence
    Youcef Derbal
    Clinical Medicine Insights: Oncology.2025;[Epub]     CrossRef
  • Patient- and clinician-based evaluation of large language models for patient education in prostate cancer radiotherapy
    Christian Trapp, Nina Schmidt-Hegemann, Michael Keilholz, Sarah Frederike Brose, Sebastian N. Marschner, Stephan Schönecker, Sebastian H. Maier, Diana-Coralia Dehelean, Maya Rottler, Dinah Konnerth, Claus Belka, Stefanie Corradini, Paul Rogowski
    Strahlentherapie und Onkologie.2025; 201(3): 333.     CrossRef
  • Assessing the Efficacy of ChatGPT Prompting Strategies in Enhancing Thyroid Cancer Patient Education: A Prospective Study
    Qi Xu, Jing Wang, Xiaohui Chen, Jiale Wang, Hanzhi Li, Zheng Wang, Weihan Li, Jinliang Gao, Chen Chen, Yuwan Gao
    Journal of Medical Systems.2025;[Epub]     CrossRef
  • Comparing the performance of ChatGPT and ERNIE Bot in answering questions regarding liver cancer interventional radiology in Chinese and English contexts: A comparative study
    Xue-ting Yuan, Chen-ye Shao, Zhen-zhen Zhang, Duo Qian
    DIGITAL HEALTH.2025;[Epub]     CrossRef
  • Assessing the Current Limitations of Large Language Models in Advancing Health Care Education
    JaeYong Kim, Bathri Narayan Vajravelu
    JMIR Formative Research.2025; 9: e51319.     CrossRef
  • ChatGPT and oral cancer: a study on informational reliability
    Mesude Çi̇ti̇r
    BMC Oral Health.2025;[Epub]     CrossRef
  • Evaluating the Reliability of ChatGPT for Health-Related Questions: A Systematic Review
    Mohammad Beheshti, Imad Eddine Toubal, Khuder Alaboud, Mohammed Almalaysha, Olabode B. Ogundele, Hamza Turabieh, Nader Abdalnabi, Suzanne A. Boren, Grant J. Scott, Butros M. Dahu
    Informatics.2025; 12(1): 9.     CrossRef
  • Emerging applications of NLP and large language models in gastroenterology and hepatology: a systematic review
    Mahmud Omar, Salih Nassar, Kassem SharIf, Benjamin S. Glicksberg, Girish N. Nadkarni, Eyal Klang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Comparing answers of ChatGPT and Google Gemini to common questions on benign anal conditions
    C. M. Maron, S. H. Emile, N. Horesh, M. R. Freund, G. Pellino, S. D. Wexner
    Techniques in Coloproctology.2025;[Epub]     CrossRef
  • A Comparison of Prostate Cancer Screening Information Quality on Standard and Advanced Versions of ChatGPT, Google Gemini, and Microsoft Copilot: A Cross-Sectional Study
    Otis L. Owens, Michael Leonard
    American Journal of Health Promotion.2025; 39(5): 766.     CrossRef
  • Evaluating the Evolution of ChatGPT as an Information Resource in Shoulder and Elbow Surgery
    Benjamin Nieves-Lopez, Alexandra R. Bechtle, Jennifer Traverse, Christopher Klifto, Bradley S. Schoch, Keith T. Aziz
    Orthopedics.2025;[Epub]     CrossRef
  • Benefits, limits, and risks of ChatGPT in medicine
    Jonathan A. Tangsrivimol, Erfan Darzidehkalani, Hafeez Ul Hassan Virk, Zhen Wang, Jan Egger, Michelle Wang, Sean Hacking, Benjamin S. Glicksberg, Markus Strauss, Chayakrit Krittanawong
    Frontiers in Artificial Intelligence.2025;[Epub]     CrossRef
  • Performance assessment of ChatGPT 4, ChatGPT 3.5, Gemini Advanced Pro 1.5 and Bard 2.0 to problem solving in pathology in French language
    Georges Tarris, Laurent Martin
    DIGITAL HEALTH.2025;[Epub]     CrossRef
  • Can ChatGPT-4o Really Pass Medical Science Exams? A Pragmatic Analysis Using Novel Questions
    Philip M. Newton, Christopher J. Summers, Uzman Zaheer, Maira Xiromeriti, Jemima R. Stokes, Jaskaran Singh Bhangu, Elis G. Roome, Alanna Roberts-Phillips, Darius Mazaheri-Asadi, Cameron D. Jones, Stuart Hughes, Dominic Gilbert, Ewan Jones, Keioni Essex, E
    Medical Science Educator.2025; 35(2): 721.     CrossRef
  • Large Language Models for Chatbot Health Advice Studies
    Bright Huo, Amy Boyle, Nana Marfo, Wimonchat Tangamornsuksan, Jeremy P. Steen, Tyler McKechnie, Yung Lee, Julio Mayol, Stavros A. Antoniou, Arun James Thirunavukarasu, Stephanie Sanger, Karim Ramji, Gordon Guyatt
    JAMA Network Open.2025; 8(2): e2457879.     CrossRef
  • Investigating the Accuracy and Consistency of ChatGPT in the Management of Achilles Tendon Ruptures
    Christopha J Knee, Ryan J Campbell, Brahman S Sivakumar, Andrew Wines, Michael J Symes
    Cureus.2025;[Epub]     CrossRef
  • Evaluating Generative AI in Mental Health: Systematic Review of Capabilities and Limitations
    Liying Wang, Tanmay Bhanushali, Zhuoran Huang, Jingyi Yang, Sukriti Badami, Lisa Hightow-Weidman
    JMIR Mental Health.2025; 12: e70014.     CrossRef
  • Evolutionary game analysis of stakeholder privacy management in the AIGC model
    Yali Lv, Jian Yang, Xiaoning Sun, Huafei Wu
    Operations Research Perspectives.2025; 14: 100327.     CrossRef
  • Evaluation of the Performance of Three Large Language Models in Clinical Decision Support: A Comparative Study Based on Actual Cases
    Xueqi Wang, Haiyan Ye, Sumian Zhang, Mei Yang, Xuebin Wang
    Journal of Medical Systems.2025;[Epub]     CrossRef
  • The reliability of freely accessible, baseline, general-purpose large language model generated patient information for frequently asked questions on liver disease: a preliminary cross-sectional study
    Madunil A. Niriella, Pathum Premaratna, Mananjala Senanayake, Senerath Kodisinghe, Uditha Dassanayake, Anuradha Dassanayake, Dileepa S. Ediriweera, H. Janaka de Silva
    Expert Review of Gastroenterology & Hepatology.2025; 19(4): 437.     CrossRef
  • ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges
    Zihan Zhou, Peng Qin, Xi Cheng, Maoxuan Shao, Zhaozheng Ren, Yiting Zhao, Qiunuo Li, Lingxiang Liu
    Current Oncology Reports.2025; 27(4): 336.     CrossRef
  • Artificial intelligence in hepatology: a comparative analysis of ChatGPT-4, Bing, and Bard at answering clinical questions
    Sama Anvari, Yung Lee, David Shiqiang Jin, Sarah Malone, Matthew Collins
    Journal of the Canadian Association of Gastroenterology.2025; 8(2): 58.     CrossRef
  • Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care
    Nicola Pugliese, Arianna Bertazzoni, Cesare Hassan, Jörn M. Schattenberg, Alessio Aghemo
    Cancers.2025; 17(5): 722.     CrossRef
  • The double-edged sword of generative AI: surpassing an expert or a deceptive “false friend”?
    Franziska C.S. Altorfer, Michael J. Kelly, Fedan Avrumova, Varun Rohatgi, Jiaqi Zhu, Christopher M. Bono, Darren R. Lebl
    The Spine Journal.2025; 25(8): 1635.     CrossRef
  • Bridging the Gap in Neonatal Care: Evaluating AI Chatbots for Chronic Neonatal Lung Disease and Home Oxygen Therapy Management
    Weiqin Liu, Hong Wei, Lingling Xiang, Yin Liu, Chunyi Wang, Ziyu Hua
    Pediatric Pulmonology.2025;[Epub]     CrossRef
  • Leveraging Large Language Models for Predicting Postoperative Acute Kidney Injury in Elderly Patients
    Hanfei Zhu, Ruojiang Wang, Jiajie Qian, Yuhao Wu, Zhuqing Jin, Xishen Shan, Fuhai Ji, Zixuan Yuan, Tingrui Pan
    BME Frontiers.2025;[Epub]     CrossRef
  • Through the Thicket: A Study of Number-Oriented LLMS Derived from Random Forest Models
    Michał Romaszewski, Przemysław Sekuła, Przemysław Głomb, Michał Cholewa, Katarzyna Kołodziej
    Journal of Artificial Intelligence and Soft Computing Research.2025; 15(3): 279.     CrossRef
  • Comparing Artificial Intelligence–Generated and Clinician-Created Personalized Self-Management Guidance for Patients With Knee Osteoarthritis: Blinded Observational Study
    Kai Du, Ao Li, Qi-Heng Zuo, Chen-Yu Zhang, Ren Guo, Ping Chen, Wei-Shuai Du, Shu-Ming Li
    Journal of Medical Internet Research.2025; 27: e67830.     CrossRef
  • Unveiling the Potential of Large Language Models in Transforming Chronic Disease Management: Mixed Methods Systematic Review
    Caixia Li, Yina Zhao, Yang Bai, Baoquan Zhao, Yetunde Oluwafunmilayo Tola, Carmen WH Chan, Meifen Zhang, Xia Fu
    Journal of Medical Internet Research.2025; 27: e70535.     CrossRef
  • Thinking outside the box: unconventional artificial intelligence algorithms in the detection and management of liver cirrhosis
    Ahmed Hashim, Bernardo Stefanini, Fabio Piscaglia
    Expert Review of Gastroenterology & Hepatology.2025; 19(5): 443.     CrossRef
  • Evaluating large language models and agents in healthcare: key challenges in clinical applications
    Xiaolan Chen, Jiayang Xiang, Shanfu Lu, Yexin Liu, Mingguang He, Danli Shi
    Intelligent Medicine.2025; 5(2): 151.     CrossRef
  • Ability of ChatGPT to Replace Doctors in Patient Education: Cross-Sectional Comparative Analysis of Inflammatory Bowel Disease
    Zelin Yan, Jingwen Liu, Yihong Fan, Shiyuan Lu, Dingting Xu, Yun Yang, Honggang Wang, Jie Mao, Hou-Chiang Tseng, Tao-Hsing Chang, Yan Chen
    Journal of Medical Internet Research.2025; 27: e62857.     CrossRef
  • Enhanced Artificial Intelligence in Bladder Cancer Management: A Comparative Analysis and Optimization Study of Multiple Large Language Models
    Kun-peng Li, Li Wang, Shun Wan, Chen-yang Wang, Si-yu Chen, Shan-hui Liu, Li Yang
    Journal of Endourology.2025; 39(5): 494.     CrossRef
  • Performance in answering orthodontic patients’ frequently asked questions: Conversational artificial intelligence versus orthodontists
    Xinlianyi Zhou, Yao Chen, Ehab A. Abdulghani, Xu Zhang, Wei Zheng, Yu Li
    Journal of the World Federation of Orthodontists.2025; 14(4): 202.     CrossRef
  • AI-driven patient support: Evaluating the effectiveness of ChatGPT-4 in addressing queries about ovarian cancer compared with healthcare professionals in gynecologic oncology
    Hung-Hsueh Chou, Yi Hua Chen, Chiu-Tzu Lin, Hsien-Tsung Chang, An-Chieh Wu, Jia-Ling Tsai, Hsiao-Wei Chen, Ching-Chun Hsu, Shu-Ya Liu, Jian Tao Lee
    Supportive Care in Cancer.2025;[Epub]     CrossRef
  • The use of large language models to enhance cancer clinical trial educational materials
    Mingye Gao, Aman Varshney, Shan Chen, Vikram Goddla, Jack Gallifant, Patrick Doyle, Claire Novack, Maeve Dillon-Martin, Teresia Perkins, Xinrong Correia, Erik Duhaime, Howard Isenstein, Elad Sharon, Lisa Soleymani Lehmann, David Kozono, Brian Anthony, Dmi
    JNCI Cancer Spectrum.2025;[Epub]     CrossRef
  • Utilizing large language models for gastroenterology research: a conceptual framework
    Parul Berry, Rohan Raju Dhanakshirur, Sahil Khanna
    Therapeutic Advances in Gastroenterology.2025;[Epub]     CrossRef
  • A comparison of the responses between ChatGPT and doctors in the field of cholelithiasis based on clinical practice guidelines: a cross-sectional study
    Tianyang Mao, Xin Zhao, Kangyi Jiang, Qingyun Xie, Manyu Yang, Ruoxuan Wang, Fengwei Gao
    DIGITAL HEALTH.2025;[Epub]     CrossRef
  • Evaluating the agreement between ChatGPT-4 and validated questionnaires in screening for anxiety and depression in college students: a cross-sectional study
    Jiali Liu, Juan Gu, Mengjie Tong, Yake Yue, Yufei Qiu, Lijuan Zeng, Yiqing Yu, Fen Yang, Shuyan Zhao
    BMC Psychiatry.2025;[Epub]     CrossRef
  • The Role of ChatGPT in osteoporosis management: a comparative analysis with clinical expertise
    Ömer Faruk Bucak, Cigdem Cinar
    Archives of Osteoporosis.2025;[Epub]     CrossRef
  • Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial
    Orhun Akdogan, Galip Can Uyar, Enes Yesilbas, Kadriye Baskurt, Nuri Alperen Malkoc, Nuriye Ozdemir, Ozan Yazici, Berna Oksuzoglu, Aytug Uner, Ahmet Ozet, Osman Sutcuoglu
    European Journal of Cancer.2025; 221: 115408.     CrossRef
  • An Assessment of the Accuracy and Consistency of ChatGPT in the Management of Midshaft Clavicle Fractures
    Christopha J Knee, Ryan J Campbell, Brahman S Sivakumar, Michael J Symes
    Cureus.2025;[Epub]     CrossRef
  • Evaluating Accuracy and Readability of Responses to Midlife Health Questions: A Comparative Analysis of Six Large Language Model Chatbots
    Himel Mondal, Devendra Nath Tiu, Shaikat Mondal, Rajib Dutta, Avijit Naskar, Indrashis Podder
    Journal of Mid-life Health.2025; 16(1): 45.     CrossRef
  • Évaluation des modèles d’intelligence artificielle dans la gestion clinique de la lombalgie commune
    Frédéric André, Philippe Armengaud, Guillaume Couquet
    Kinésithérapie, la Revue.2025; 25(282): 28.     CrossRef
  • Evaluating the Potential of Large Language Models for Vestibular Rehabilitation Education: A Comparison of ChatGPT, Google Gemini, and Clinicians
    Yael Arbel, Yoav Gimmon, Liora Shmueli
    Physical Therapy.2025;[Epub]     CrossRef
  • Assessing the Accuracy of ChatGPT in Answering Questions About Prolonged Disorders of Consciousness
    Sergio Bagnato, Cristina Boccagni, Jacopo Bonavita
    Brain Sciences.2025; 15(4): 392.     CrossRef
  • AI-Driven Information for Relatives of Patients with Malignant Middle Cerebral Artery Infarction: A Preliminary Validation Study Using GPT-4o
    Mejdeddine Al Barajraji, Sami Barrit, Nawfel Ben-Hamouda, Ethan Harel, Nathan Torcida, Beatrice Pizzarotti, Nicolas Massager, Jerome R. Lechien
    Brain Sciences.2025; 15(4): 391.     CrossRef
  • Assessing the Quality and Reliability of ChatGPT’s Responses to Radiotherapy-Related Patient Queries: Comparative Study With GPT-3.5 and GPT-4
    Ana Grilo, Catarina Marques, Maria Corte-Real, Elisabete Carolino, Marco Caetano
    JMIR Cancer.2025; 11: e63677.     CrossRef
  • Women’s Preferences and Willingness to Pay for AI Chatbots in Women’s Health: Discrete Choice Experiment Study
    Jing Wang, Hewei Min, Tao Li, Jiaheng Li, Yang Jiang, Jingbo Zhang, Yibo Wu, Xinying Sun
    Journal of Medical Internet Research.2025; 27: e67303.     CrossRef
  • Assessing ChatGPT for Clinical Decision-Making in Radiation Oncology, With Open-Ended Questions and Images
    Wei-Kai Chuang, Yung-Shuo Kao, Yen-Ting Liu, Cho-Yin Lee
    Practical Radiation Oncology.2025; 15(5): e412.     CrossRef
  • Evaluating the Agreement Between ChatGPT-4 and Validated Mental Health Scales in Older Adults: A Cross-Sectional Study
    Jiali Liu, Juan Gu, MengJie Tong, YaKe Yue, Yufei Qiu, Lijuan Zeng, Yiqing Yu, Fen Yang
    The American Journal of Geriatric Psychiatry.2025; 33(10): 1049.     CrossRef
  • ChatGPT-Assisted Decision-Making: An In-Depth Exploration of the Human–AI Interaction
    Marinel-Adi Mustață, Dragoș Iliescu, Eugen Mavriș, Cornelia-Rodica Jude, Laviniu Bojor, Paul Tudorache, Ionuț-Alin Cîrdei, Daniela-Elena Hrab, Alina-Cerasela Aluculesei, Ivona Răpan, Ştefan-Antonio Dan-Șuteu, Daniel Roman, Constantin Tudor Urseiu
    International Journal of Human–Computer Interaction.2025; 41(24): 15584.     CrossRef
  • ChatGPT struggles to recognize reproducible science
    Jose R. Chang, Torbjörn E. M. Nordling
    Knowledge and Information Systems.2025; 67(8): 6825.     CrossRef
  • Discussion of the ability to use chatGPT to answer questions related to esophageal cancer of patient concern
    Fengxia Yu, Mingyu Lei, Shiyu Wang, Miao Liu, Xiao Fu, Yuan Yu
    Journal of Family Medicine and Primary Care.2025; 14(4): 1384.     CrossRef
  • Assessing ChatGPT’s Educational Potential in Lung Cancer Radiotherapy From Clinician and Patient Perspectives: Content Quality and Readability Analysis
    Cedric Richlitzki, Sina Mansoorian, Lukas Käsmann, Mircea Gabriel Stoleriu, Julia Kovacs, Wulf Sienel, Diego Kauffmann-Guerrero, Thomas Duell, Nina Sophie Schmidt-Hegemann, Claus Belka, Stefanie Corradini, Chukwuka Eze
    JMIR Cancer.2025; 11: e69783.     CrossRef
  • Artificial Intelligence Augmentation: Performance of GPT-4 and GPT-3.5 on the Plastic Surgery In-service Examination
    Daniel Najafali, Erik Reiche, Sthefano Araya, Manuel Orellana, Farrah C. Liu, Justin M. Camacho, Sameer A. Patel, Justin M. Broyles, Amir H. Dorafshar, Shane D. Morrison, Leonard Knoedler, Paige M. Fox
    Plastic and Reconstructive Surgery - Global Open.2025; 13(4): e6645.     CrossRef
  • Evaluation of ChatGPT Responses About Sexual Activity After Total Hip Arthroplasty: A Comparative Study with Observers of Different Experience Levels
    Batuhan Gencer, Ufuk Arzu, Serdar Satılmış Orhan, Turgut Dinçal, Mehmet Ekinci
    Journal of Clinical Medicine.2025; 14(9): 2942.     CrossRef
  • Comparative evaluation of the accuracy and reliability of ChatGPT versions in providing information on Helicobacter pylori infection
    Yi Ye, En-dian Zheng, Qiao-li Lan, Le-can Wu, Hao-yue Sun, Bei-bei Xu, Ying Wang, Miao-miao Teng
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • The Diagnostic Performance of Large Language Models and Oral Medicine Consultants for Identifying Oral Lesions in Text-Based Clinical Scenarios: Prospective Comparative Study
    Sarah AlFarabi Ali, Hebah AlDehlawi, Ahoud Jazzar, Heba Ashi, Nihal Esam Abuzinadah, Mohammad AlOtaibi, Abdulrahman Algarni, Hazzaa Alqahtani, Sara Akeel, Soulafa Almazrooa
    JMIR AI.2025; 4: e70566.     CrossRef
  • Artificial Intelligence as a Partner in Ankylosing Spondylitis Care: Evaluating ChatGPT’s Role and Performance
    Ömer Faruk Bucak, Cigdem Cinar
    Medical Records.2025; 7(2): 339.     CrossRef
  • Predicting Immunotherapy Response in Unresectable Hepatocellular Carcinoma: A Comparative Study of Large Language Models and Human Experts
    Jun Xu, Junjie Wang, Junjun Li, Zhangxiang Zhu, Xiao Fu, Wei Cai, Ruipeng Song, Tengfei Wang, Hai Li
    Journal of Medical Systems.2025;[Epub]     CrossRef
  • Medical accuracy of artificial intelligence chatbots in oncology: a scoping review
    David Chen, Kate Avison, Saif Alnassar, Ryan S Huang, Srinivas Raman
    The Oncologist.2025;[Epub]     CrossRef
  • Performance of ChatGPT and Microsoft Copilot in Bing in answering obstetric ultrasound questions and analyzing obstetric ultrasound reports
    Yanran Du, Chao Ji, Jiale Xu, Minyan Wei, Yunyun Ren, Shujun Xia, JianQiao Zhou
    Scientific Reports.2025;[Epub]     CrossRef
  • Evaluating Large Language Models in Addressing Patient Questions on Endodontic Pain: A Comparative Analysis of Accessible Chatbots
    Sanaa Aljamani, Yazan Hassona, Hoda A. Fansa, Hiba M. Saadeh, Kifah Dafi Jamani
    Journal of Endodontics.2025; 51(11): 1617.     CrossRef
  • Assessing the diagnostic accuracy of ChatGPT-4 in the histopathological evaluation of liver fibrosis in MASH
    Davide Panzeri, Thiyaphat Laohawetwanit, Reha Akpinar, Camilla De Carlo, Vincenzo Belsito, Luigi Terracciano, Alessio Aghemo, Nicola Pugliese, Giuseppe Chirico, Donato Inverso, Julien Calderaro, Laura Sironi, Luca Di Tommaso
    Hepatology Communications.2025;[Epub]     CrossRef
  • Assessing information provided via artificial intelligence regarding distal biceps tendon repair surgery
    Suhasini Gupta, Brett D. Haislup, Ryan A. Hoffman, Anand M. Murthi
    Journal of Experimental Orthopaedics.2025;[Epub]     CrossRef
  • Investigating the interpretability of ChatGPT in mental health counseling: An analysis of artificial intelligence generated content differentiation
    Yang Liu, Fan Wang
    Computer Methods and Programs in Biomedicine.2025; 268: 108864.     CrossRef
  • Identifying Kidney Stone Risk Factors Through Patient Experiences With a Large Language Model: Text Analysis and Empirical Study
    Chao Mao, Jiaxuan Li, Patrick Cheong-Iao Pang, Quanjing Zhu, Rong Chen
    Journal of Medical Internet Research.2025; 27: e66365.     CrossRef
  • Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study
    Fengqi He, Mei Yang, Jun Liu, Ting Gong, Jinhua Ma, Tian Yang, Dandong Zhao, Shaunglian Li, Daiyin Tian
    BMC Public Health.2025;[Epub]     CrossRef
  • Evaluating the Accuracy, Clarity, and Safety of Artificial Intelligence–Generated Information on Clubfoot
    Akram Al Ramlawi, Daniel J. Over, Daniel Weltsch, Michael Assayag, Philip K McClure, Renee J. Hunter
    Journal of the American Academy of Orthopaedic Surgeons.2025; 33(12): 663.     CrossRef
  • Large language models’ capabilities in responding to tuberculosis medical questions: testing ChatGPT, Gemini, and Copilot
    Meisam Dastani, Jalal Mardaneh, Morteza Rostamian
    Scientific Reports.2025;[Epub]     CrossRef
  • Evaluation of ChatGPT-4 as an Online Outpatient Assistant in Puerperal Mastitis Management: Content Analysis of an Observational Study
    Fatih Dolu, Oğuzhan Fatih Ay, Aydın Hakan Kupeli, Enes Karademir, Muhammed Huseyin Büyükavcı
    JMIR Medical Informatics.2025; 13: e68980.     CrossRef
  • Exploring the medical ethical limitations of GPT-4 in clinical decision-making scenarios: a pilot survey
    Yu-Tao Xiong, Yu-Min Zeng, Hao-Nan Liu, Ya-Nan Sun, Wei Tang, Chang Liu
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • Artificial Intelligence and Gynecological Oncology: A Comparative Study of ChatGPT Omni and Gemini Pro across Repeated Intervals with Case-Scenario and Open-Ended Queries
    Seckin Tuna Kaplan
    Oncology Research and Treatment.2025; 48(6): 325.     CrossRef
  • Improving Patient Communication by Simplifying AI-Generated Dental Radiology Reports With ChatGPT: Comparative Study
    Daniel Stephan, Annika S Bertsch, Sophia Schumacher, Behrus Puladi, Matthias Burwinkel, Bilal Al-Nawas, Peer W Kämmerer, Daniel GE Thiem
    Journal of Medical Internet Research.2025; 27: e73337.     CrossRef
  • Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study
    Sebastian Daniel Boie, Esther Glastetter, Michael Patrick Lux, Felix Balzer, Christof von Kalle, Christian Lenz, Ulrike Müller
    JMIR Cancer.2025; 11: e68426.     CrossRef
  • Evaluation of Chat Generative Pretrained Transformer (ChatGPT) Performance in Answering Kidney Transplant Related Questions
    Yunus Çolakoğlu, Ali Ayten, Çağlar Sertkaya, Kağan Toksal, Serdar Karadağ
    The New Journal of Urology.2025; 20(1): 21.     CrossRef
  • Comparing ChatGPT3.5 and Bard recommendations for colonoscopy intervals: Bridging the gap in healthcare settings
    Maziar Amini, Patrick W. Chang, Rio O. Davis, Denis D. Nguyen, Jennifer L Dodge, Jennifer Phan, James Buxbaum, Ara Sahakian
    Endoscopy International Open.2025;[Epub]     CrossRef
  • Evaluation of the accuracy of ChatGPT in answering asthma-related questions
    Bruno Pellozo Cerqueira1, Vinicius Cappellette da Silva Leite1, Carla Gonzaga França1, Fernando Sergio Leitão Filho2, Sonia Maria Faresin2, Ricardo Gassmann Figueiredo3, Andrea Antunes Cetlin4, Lilian Serrasqueiro Ballini Caetano2, José Baddini-Martinez2
    Jornal Brasileiro de Pneumologia.2025; : e20240388.     CrossRef
  • Areas of research focus and trends in the research on the application of AIGC in healthcare
    Chen Wang, Yingying Zhu, Xuejiao Zhang, Xueqing Chen, Yilin Li, Yongjie Tan, Huiying Qi
    Journal of Health, Population and Nutrition.2025;[Epub]     CrossRef
  • Evaluating Large Language Models for Preoperative Patient Education in Superior Capsular Reconstruction: Comparative Study of Claude, GPT, and Gemini
    Yukang Liu, Hua Li, Jianfeng Ouyang, Zhaowen Xue, Min Wang, Hebei He, Bin Song, Xiaofei Zheng, Wenyi Gan
    JMIR Perioperative Medicine.2025; 8: e70047.     CrossRef
  • Consulting the Digital Doctor: Efficacy of ChatGPT-3.5 in Answering Questions Related to Diabetic Foot Ulcer Care
    Rachel N. Rohrich, Karen R. Li, Christian X. Lava, Isabel Snee, Sami Alahmadi, Richard C. Youn, John S. Steinberg, Jayson M. Atves, Christopher E. Attinger, Karen K. Evans
    Advances in Skin & Wound Care.2025; 38(9): E74.     CrossRef
  • Evaluating the Reliability of OpenAI’s ChatGPT-4 in Providing Pre-colonoscopy Patient Guidance
    Akash Patel, Adewale Ajumobi
    Cureus.2025;[Epub]     CrossRef
  • Evaluating the Quality and Understandability of Radiology Report Summaries Generated by ChatGPT: Survey Study
    Alexis Sunshine, Grace H Honce, Andrew L Callen, David A Zander, Jody L Tanabe, Samantha L Pisani Petrucci, Chen-Tan Lin, Justin M Honce
    JMIR Formative Research.2025; 9: e76097.     CrossRef
  • Identification and Categorization of the Top 100 Articles and the Future of Large Language Models: Thematic Analysis Using Bibliometric Analysis
    Ethan Bernstein, Anya Ramsamooj, Kelsey L Millar, Zachary C Lum
    JMIR AI.2025; 4: e68603.     CrossRef
  • Assessing the Success of Chatgpt-4o in Oral Radiology Education and Practice: A Pioneering Research
    Fatma Akkoca, Melih Özdede, Günnur İlhan, Emre Koyuncu, Hülya Ellidokuz
    Cumhuriyet Dental Journal.2025; 28(2): 210.     CrossRef
  • Clinical applications of large language models in medicine and surgery: A scoping review
    Eric Nan Liang, Sophia Pei, Phillip Staibano, Benjamin van der Woerd
    Journal of International Medical Research.2025;[Epub]     CrossRef
  • ChatGPT Performance Deteriorated in Patients with Comorbidities When Providing Cardiological Therapeutic Consultations
    Wen-Rui Hao, Chun-Chao Chen, Kuan Chen, Long-Chen Li, Chun-Chih Chiu, Tsung-Yeh Yang, Hung-Chang Jong, Hsuan-Chia Yang, Chih-Wei Huang, Ju-Chi Liu, Yu-Chuan (Jack) Li
    Healthcare.2025; 13(13): 1598.     CrossRef
  • Is ChatGPT more Humane than Humans?—Accuracy, Relevance and humanness of the Answers Provided by ChatGPT for Patient Education for Total Knee Replacement
    Khushi Bafna, Amit Kumar Yadav, Shaurya Bagaria, Ayushi Gianchandani, Murali Poduval, Vaibhav Bagaria
    Indian Journal of Orthopaedics.2025; 59(11): 1880.     CrossRef
  • A bibliometric analysis of large language model-based AI chatbots in surgery
    Zhiyan Wang, Hongru Zhou, Tao Song
    Annals of Medicine & Surgery.2025; 87(7): 4127.     CrossRef
  • The potential utility of CHATGPT4.0 as an AI assistant in the education and management of patients with Barrett’s esophagus
    Frances Dang, Josh Kwon, Andy Lin, Shoujit Banerjee, Trevor McCracken, Amirali Tavangar, Shravani R Reddy, Alyssa Y Choi, Jennifer Phan, Jeffrey D Mosko, Samir C Grover, Tyler M Berzin, Jason Samarasena
    Diseases of the Esophagus.2025;[Epub]     CrossRef
  • Improving the Readability of Institutional Heart Failure–Related Patient Education Materials Using GPT-4: Observational Study
    Ryan C King, Jamil S Samaan, Joseph Haquang, Vishnu Bharani, Samuel Margolis, Nitin Srinivasan, Yuxin Peng, Yee Hui Yeo, Roxana Ghashghaei
    JMIR Cardio.2025; 9: e68817.     CrossRef
  • Comparison of Responses from ChatGPT-4, Google Gemini, and Google Search to Common Patient Questions About Ankle Sprains: A Readability Analysis
    Hetsinhji Chavda, Tarun R. Sontam, William C. Skinner, Eitan M. Ingall, Jacob R. Zide
    Journal of the American Academy of Orthopaedic Surgeons.2025; 33(16): 924.     CrossRef
  • To take a different approach: Can large language models provide knowledge related to respiratory aspiration?
    Yirou Niu, Shuojin Fu, Zehui Xuan, Ruifu Kang, Zhifang Ren, Shuai Jin, Yanling Wang, Qian Xiao
    DIGITAL HEALTH.2025;[Epub]     CrossRef
  • GutGPT: A multidimensional knowledge-enhanced large language model for gastrointestinal medicine
    Rui-Ya Zhang, Peng-Peng Qiang, Yu-Xia Hao, Hong-Ye Tan, Kai Zhao, Ling-Jun Cai, Jun-Ping Wang
    Journal of Biomedical Informatics.2025; 169: 104885.     CrossRef
  • Clinical Performance and Communication Skills of ChatGPT Versus Physicians in Emergency Medicine: Simulated Patient Study
    ChulHyoung Park, Min Ho An, Gyubeom Hwang, Rae Woong Park, Juho An
    JMIR Medical Informatics.2025; 13: e68409.     CrossRef
  • Potential Applications of ChatGPT in the Healthcare Industry of Low- and Middle-Income Countries
    Mehrzad MohsseniPour, Setareh Parsakian, Esmaeil Mehraeen
    Shiraz E-Medical Journal.2025;[Epub]     CrossRef
  • Large language model integrations in cancer decision-making: a systematic review and meta-analysis
    Yuexing Hao, Zhiwen Qiu, Jason Holmes, Corinna E. Löckenhoff, Wei Liu, Marzyeh Ghassemi, Saleh Kalantari
    npj Digital Medicine.2025;[Epub]     CrossRef
  • A review of ChatGPT in medical education: exploring advantages and limitations
    Yuan Cheng, Lingling Zhu
    International Journal of Surgery.2025; 111(7): 4586.     CrossRef
  • Clinical evaluation of camrelizumab combined with transarterial chemoembolization in the interventional therapy of hepatocellular carcinoma with liver cirrhosis
    Jian Chen, Mengshan Huang
    Journal of Chemotherapy.2025; : 1.     CrossRef
  • Deciphering cancer therapy resistance via patient-level single-cell transcriptomics with CellResDB
    Tianyuan Liu, Huiyuan Qiao, Liping Ren, Xiucai Ye, Quan Zou, Yang Zhang
    Communications Biology.2025;[Epub]     CrossRef
  • ChatGPT-4o vs. oncologists in addressing endometrial cancer patient inquiries: A prospective comparative study in primary and secondary care
    Serra Akar İnan, Muhammed İnan, Osman Türkmen
    European Journal of Oncology Nursing.2025; 77: 102930.     CrossRef
  • ChatGPT as an information source for cochlear implants: A study on accuracy and reproducibility
    Ozlem Icoz, Aysun Parlak Kocabay
    European Archives of Oto-Rhino-Laryngology.2025; 282(12): 6161.     CrossRef
  • Comparative Analysis of Large Language Model and Physician-Generated Responses in Bariatric Patient Inquiries: Assessing the Accuracy and Patient Satisfaction
    Katharina Vedder, Susanne Blank, Tea Wilhelm, Darick Fidan, Ihor Pachkiv, Han Cao, Christel Weiß, Chengpeng Li, Marion Rung-Friebe, Christoph Reissfelder, Mirko Otto, Cui Yang
    Obesity Surgery.2025; 35(9): 3801.     CrossRef
  • A Survey on Integration of Empathy Cues Into Empathetic Text Generation
    Edwin C. Montiel-Vázquez, Christian Arzate Cruz, Jorge Adolfo Ramírez Uresti, Miguel González Mendoza, Randy Gomez
    IEEE Access.2025; 13: 140791.     CrossRef
  • Supervised Learning and Large Language Model Benchmarks on Mental Health Datasets: Cognitive Distortions and Suicidal Risks in Chinese Social Media
    Hongzhi Qi, Guanghui Fu, Jianqiang Li, Changwei Song, Wei Zhai, Dan Luo, Shuo Liu, Yijing Yu, Bingxiang Yang, Qing Zhao
    Bioengineering.2025; 12(8): 882.     CrossRef
  • Evaluating the Performance of State-of-the-Art Artificial Intelligence Chatbots Based on the WHO Global Guidelines for the Prevention of Surgical Site Infection: Cross-Sectional Study
    Tianyi Wang, Ruiyuan Chen, Baodong Wang, Congying Zou, Ning Fan, Shuo Yuan, Aobo Wang, Yu Xi, Lei Zang
    Journal of Medical Internet Research.2025; 27: e75567.     CrossRef
  • GastroGPT: Development and controlled testing of a proof-of-concept customized clinical language model
    Cem Simsek, Mete Ucdal, Enrique de-Madaria, Alanna Ebigbo, Petr Vanek, Omar Elshaarawy, Theodor Alexandru Voiosu, Giulio Antonelli, Román Turró, Javier P Gisbert, Olga P. Nyssen, Cesare Hassan, Helmut Messmann, Rajiv Jalan
    Endoscopy International Open.2025;[Epub]     CrossRef
  • Exploring Taiwanese Dietitians' Acceptance and Use of ChatGPT in Nutrition Practice: A Cross‐Sectional Survey
    Li‐Ling Liao, I‐Ju Lai, Li‐Chun Chang
    Journal of Human Nutrition and Dietetics.2025;[Epub]     CrossRef
  • When ChatGPT Speaks About Health: Examining Perceptions of Warmth and Competence Toward AI as a Health Information Source
    Buduo Wang, Bruce Wang Shibo, Jiwan Kafle
    Journal of Health Communication.2025; 30(10-12): 285.     CrossRef
  • Assessing the Role of Large Language Models Between ChatGPT and DeepSeek in Asthma Education for Bilingual Individuals: Comparative Study
    Yaxin Liu, Fangfei Yu, Xiaofei Zhang, Xiaohan Tong, Kui Li, Weikuan Gu, Baiquan Yu
    JMIR Medical Informatics.2025; 13: e65365.     CrossRef
  • Generative AI in Education: Mapping the Research Landscape Through Bibliometric Analysis
    Sai-Leung Ng, Chih-Chung Ho
    Information.2025; 16(8): 657.     CrossRef
  • Large language models for clinical decision support in gastroenterology and hepatology
    Isabella Catharina Wiest, Mamatha Bhat, Jan Clusmann, Carolin V. Schneider, Xiaofeng Jiang, Jakob Nikolas Kather
    Nature Reviews Gastroenterology & Hepatology.2025; 22(11): 773.     CrossRef
  • Liver Cysts and Artificial Intelligence: Is AI Really a Patient-Friendly Support?
    Enrico Spalice, Chiara D’Alterio, Maria Lanzone, Immacolata Iannone, Cristina De Padua, Matteo De Pastena, Alessandro Coppola
    Surgeries.2025; 6(3): 73.     CrossRef
  • Performance of large language models on veterinary undergraduate multiple-choice examinations: a comparative evaluation
    Santiago Alonso Sousa, Syed Saad Ul Hassan Bukhari, Paulo Vinicius Steagall, Paweł M. Bęczkowski, Antonio Giuliano, Kate J. Flay
    Frontiers in Veterinary Science.2025;[Epub]     CrossRef
  • CHAT GPT VS. RHEUMATOLOGISTS: DO WE STILL NEED THE CLINICIAN?
    Çisem Yıldız, Batuhan Küçükali, Nuran Belder, Merve Kutlar, Nihal Karaçayır, Pelin Esmeray Şenol, Deniz Gezgin Yıldırım, Sevcan Bakkaloğlu
    Kırıkkale Üniversitesi Tıp Fakültesi Dergisi.2025; 27(2): 211.     CrossRef
  • Can Large Artificial Intelligence‐Based Linguistic Models Help to Obtain Information About Burning Mouth Syndrome?
    Paula Benito López, Daniela Adamo, Vito Carlo Alberto Caponio, José González‐Serrano, Alan Roger dos Santos Silva, Miguel de Pedro Herráez, Rui Albuquerque, María Pía López Jornet, Vlaho Brailo, Arwa Farag, Márcio Diniz Freitas, Noburo Noma, Richeal Ni Ri
    Oral Diseases.2025;[Epub]     CrossRef
  • Large language models enable tumor-type classification and localization of cancers of unknown primary from genomic data
    Jilei Liu, Meng Yang, Yajing Bi, Junqing Zhang, Yichen Yang, Yang Li, Hongru Shen, Kexin Chen, Xiangchun Li
    Cell Reports Medicine.2025; 6(9): 102332.     CrossRef
  • Advantages and Limitations of ChatGPT in Healthcare: A Scoping Review
    Seyyede Fateme Ghasemi, Parastoo Amiri, Zahra Galavi
    Health Science Reports.2025;[Epub]     CrossRef
  • From Evidence to Recommendations With Large Language Models: A Feasibility Study
    Weilong Zhao, Danni Xia, Ziying Ye, Honghao Lai, Mingyao Sun, Jiajie Huang, Jiayi Liu, Jianing Liu, Long Ge
    Journal of Evidence-Based Medicine.2025;[Epub]     CrossRef
  • Generative chatbots in headache education and research: A narrative review
    Marina Romozzi, David García-Azorín, Eloisa Rubio-Beltran, Alejandro Labastida-Ramírez
    Cephalalgia.2025;[Epub]     CrossRef
  • Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach
    Mario Romeo, Carmine Napolitano, Paolo Vaia, Fiammetta Di Nardo, Silvio Borrelli, Carlo Garofalo, Luca De Nicola, Alessandro Federico, Marcello Dallio
    Livers.2025; 5(3): 46.     CrossRef
  • Revolutionizing inflammatory bowel disease healthcare communication: a head-to-head comparison of gastroenterologist and ChatGPT responses
    Zixuan He, Yilong Liu, Zhaoming Wang, Xiaoyu Zhou, Xuanming Fan, Miao He, Chengcheng Wang, Hongyu Fu, Zhijie Wang, Yu Bai
    Gastroenterology Report.2025;[Epub]     CrossRef
  • Patient trust in artificial intelligence for orthodontic advice
    Sanjana Santhosh Kumar, Dimitrios Michelogiannakis, Xiuhui Xu, Rachel Chacko, Junad Khan
    The Journal of the American Dental Association.2025; 156(11): 931.     CrossRef
  • The early wave of ChatGPT research: A review and future agenda
    Peter André Busch, Geir Inge Hausvik, Jeppe Agger Nielsen
    Computers in Human Behavior: Artificial Humans.2025; 6: 100213.     CrossRef
  • Expert Consensus Best Practices for the Safe, Ethical, and Effective Design and Implementation of Artificially Intelligent Conversational Agent (i.e., Chatbot/Virtual Human) Systems in Health Care Applications
    Albert Rizzo, Sharon Mozgai, Alexandros Sigaras, John E. Rubin, Rohan Jotwani
    Journal of Medical Extended Reality.2025; 2(1): 209.     CrossRef
  • What patients want from healthcare chatbots: insights from a mixed-methods study
    Natalia S Dellavalle, Jessica R Ellis, Annie A Moore, Marlee Akerson, Matt Andazola, Eric G Campbell, Matthew DeCamp
    Journal of the American Medical Informatics Association.2025; 32(11): 1735.     CrossRef
  • Assessing the ability of ChatGPT 4.0 in generating check-up reports
    Yikai Chen, Yuxin Liu, Yuanchang Huang, Xiujie Huang, Zhuoqun Zheng, Fangjie Yang, Haiming Lin, Haoyu Lin, Xinxin Li, Aosi Xie, Yiteng Huang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Comparative performance evaluation of large language models in answering esophageal cancer-related questions: a multi-model assessment study
    Zijie He, Lilan Zhao, Genglin Li, Jintao Wang, Songyu Cai, Pengjie Tu, Jingbo Chen, Jianman Wu, Juan Zhang, Ruiqi Chen, Yangyun Huang, Xiaojie Pan, Wenshu Chen
    Frontiers in Digital Health.2025;[Epub]     CrossRef
  • Critical Appraisal Tools for Evaluating Artificial Intelligence in Clinical Studies: Scoping Review
    Juan B Cabello, Vicente Ruiz Garcia, Miguel Torralba, Miguel Maldonado Fernandez, Marimar Ubeda, Eukene Ansuategui, Luis Ramos-Ruperto, Jose I Emparanza, Iratxe Urreta, Maria Teresa Iglesias, Jose I Pijoan, Amanda Burls
    Journal of Medical Internet Research.2025; 27: e77110.     CrossRef
  • Assessing the Usefulness and Quality of Artificial Intelligence-Generated Content on Bone Graft Materials in Dentistry Based on Patient Questions
    Zeynep Hazan Yildiz
    Journal of Dental Health and Oral Research.2025; : 1.     CrossRef
  • Perspectives of Patients Seeking Bariatric Surgery: The Impact of Early Patient-Provider Communication on Bariatric Surgery Utilization
    Nitin Srinivasan, Jamil Samaan, Nithya Rajeev, Agnes Premkumar, Kelvin Alvarez, Lucy Harvey, Stephanie Nguyen, Ashley Tran, Kamran Samakar
    Obesity Surgery.2025; 35(11): 4639.     CrossRef
  • Comparative Evaluation of Large Language Models in Addressing Autism-Related Information Queries: Insights from ChatGPT, Gemini, and Copilot
    Gamze Demir, Mehmet Sevri, Cafer Doğan Hacıosmanoğlu, Dicle Büyüktaşkın, Ahmet Özaslan
    Gazi Medical Journal.2025; 36(4): 407.     CrossRef
  • Evaluating chat generative pretrained transformer in answering questions on endoscopic mucosal resection and endoscopic submucosal dissection
    Shi-Song Wang, Hui Gao, Peng-Yao Lin, Tian-Chen Qian, Ying Du, Lei Xu
    World Journal of Gastrointestinal Oncology.2025;[Epub]     CrossRef
  • Comparative Evaluation of Artificial Intelligence Chatbots in Delivering Palliative Care Education to Intensive Care Unit Caregivers— A Cross-platform Analysis: A Brief Communication
    Ram Singh, Prakash G Gondode, Sakshi Duggal, Sudhansu S Nayak
    Indian Journal of Critical Care Medicine.2025; 29(10): 865.     CrossRef
  • Comparing traditional and AI-enhanced strategies for developing patient decision aids: a multiple case study
    Anik Giguere, Delphine Auclair-Rochon, Maéva Robin, Lidiya Augustine, Julie Ayre, Kirsten McCaffery
    BMJ Evidence-Based Medicine.2025; : bmjebm-2025-113675.     CrossRef
  • Generative AI-Derived Information About Opioid Use Disorder Treatment During Pregnancy: An Exploratory Evaluation of GPT-4’s Steerability for Provision of Trustworthy Person-Centered Information
    Drew Herbert, Jerald Westendorf, Matthew Farmer, Blaine Reeder
    Journal of Studies on Alcohol and Drugs.2025; 86(6): 894.     CrossRef
  • Reliability and Readability Assessment of Atrial Fibrillation Patient Information Delivered by Artificial Intelligence-Based Language Models (ChatGPT, YouChat, Gemini, and Perplexity AI) in English and Spanish
    Emilio Jose Juan Juan-Guardela, Jesús Andrés Beltrán-España, María Paula Ravagli-Baquero, Cristian Orlando Porras-Bueno, Edward Cáceres-Méndez, Daniel Fernandez Ávila, Oscar Muñoz-Velandia, Ángel Alberto García-Peña
    Clinical Medicine Insights: Cardiology.2025;[Epub]     CrossRef
  • SMART 2.0 Statistical Metabolomics Analysis: An R Tool 2.0
    Yu-Jen Liang, Chih-Ting Yang, Chia-Wei Chen, Yin-Chun Lin, Shu-Yao Lin, Yi Sheng Wang, Hsin-Chou Yang
    Analytical Chemistry.2025; 97(46): 25453.     CrossRef
  • Artificial intelligence meets medical rarity: evaluating ChatGPT’s responses on post-orgasmic illness syndrome
    Doğukan Sökmen, Ahmet Tevfik Albayrak, Zülfü Sertkaya, Yaşar Başağa, Ege Can Serefoglu
    International Journal of Impotence Research.2025;[Epub]     CrossRef
  • Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma
    Muhammad Masroor Hussain, Bi Feng, Ju‐Mei Wang, Ao‐Qiang Zhai, Fu‐yu Li, Hai‐jie Hu
    Cancer Medicine.2025;[Epub]     CrossRef
  • Can co-designed educational interventions help consumers think critically about asking ChatGPT health questions? Results from a randomised-controlled trial
    Julie Ayre, Melody Taba, Brooke Nickel, Geoffrey Edlund, Trang Vu, Julia Yan, Lorna Butters, Ivan C. K. Ma, Kirsten J. McCaffery
    npj Digital Medicine.2025;[Epub]     CrossRef
  • Review of Large Language Models for Patient and Caregiver Support in Cancer Care Delivery
    Ramez Kouzy, Elaine E. Cha, Allison Rosen, Danielle S. Bitterman
    JCO Clinical Cancer Informatics.2025;[Epub]     CrossRef
  • Evaluation of ChatGPT as a supplementary tool for pituitary adenomas: An observational study based on simulated consultations
    Yuhui Chen, Yuyang Chen, Li Chen, Tianshun Feng, Shousen Wang
    Medicine.2025; 104(46): e45928.     CrossRef
  • Could artificial intelligence-powered colonoscopies change the future of colorectal cancer screening?
    Mircea Mănuc, Cătălin-Andrei Duței, Teodora-Ecaterina Mănuc, Andreea-Elena Chifulescu, Florin Andrei Grama
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Can large language models exhibit cognitive and affective empathy as humans?
    Tengfei Yu, Siyu Pan, Caoyun Fan, Siyang Luo, Yaohui Jin, Binglei Zhao
    Computers in Human Behavior: Artificial Humans.2025; 6: 100233.     CrossRef
  • Large Language Models in Critical Care Medicine: Scoping Review
    Tongyue Shi, Jun Ma, Zihan Yu, Haowei Xu, Rongxin Yang, Minqi Xiong, Meirong Xiao, Yilin Li, Huiying Zhao, Guilan Kong
    JMIR Medical Informatics.2025; 13: e76326.     CrossRef
  • Reimagining Cancer Care With Generative Artificial Intelligence: The Promise of Large Language Models
    Ji-Eun Irene Yum, Syed Arsalan Ahmed Naqvi, Ben Zhou, Irbaz Bin Riaz
    JCO Clinical Cancer Informatics.2025;[Epub]     CrossRef
  • Assessing the accuracy and reproducibility of artificial intelligence-generated medical responses by ChatGPT on Scheuermann’s kyphosis
    Esra Giray, Özge Gülsüm Illeez, Merve Damla Korkmaz, Nalan Capan, Evrim Karadag Saygi, Resa Aydın
    Turkish Journal of Physical Medicine and Rehabilitation.2025; 71(4): 457.     CrossRef
  • Exploring the Educational Applications of Large Language Models: A Systematic Review and Topic Analysis
    Bianca-Raluca Cibu, Liliana Crăciun, Anca Gabriela Molănescu, Liviu-Adrian Cotfas
    Electronics.2025; 14(23): 4683.     CrossRef
  • Evaluating the competence of large language models in ophthalmology clinical practice: a multi-scenario quantitative study
    Mu-Yang Wei, Yu-Lin Li, Shu-Yan Liu, Guang-Yu Li
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Comparison of the information of generative artificial intelligence large language models and professional guidelines regarding nutritional advice for orthodontic patients
    Tevhide Sokmen, İrem Kar, Cumhur Tuncer, Burcu Baloş Tuncer
    BMC Oral Health.2025;[Epub]     CrossRef
  • Let’s chat (GPT) about adolescent idiopathic scoliosis: accuracy and reliability of chat responses to frequently asked questions
    Esra Giray, Merve Damla Korkmaz, Ozge Gulsum Illeez, Nalan Capan, Evrim Karadag Saygi, Ayse Resa Aydin
    BMC Musculoskeletal Disorders.2025;[Epub]     CrossRef
  • Thyroid Nodule Experts Evaluating ChatGPT’s Assessment of Thyroid Nodules Classified by the Bethesda System for Reporting Thyroid Cytopathology
    Alexander Moise, Luiza Tatar, Noa Sela, Sabrina Daniela da Silva, Jasmine Kouz, Michael Tamilia, Michael P. Hier, Veronique-Isabelle Forest, Richard J. Payne
    Journal of Otolaryngology - Head & Neck Surgery.2025;[Epub]     CrossRef
  • The waiting room of uncertainty: digital patient support for potentially bad news—a scoping review
    Martina Kellermann, Charlotte Wetterauer, Gerd A. Kullak-Ublick, Marcus Cheetham
    Frontiers in Digital Health.2025;[Epub]     CrossRef
  • Professional Quality and Empathy of Responses Provided by AI and Dentists: A Cross-Sectional Study
    Thekla J. Pfeiffer-Grötz, Luisa Schäfer, Anke Hollinderbäumer, Dominik Haag, Lisa Zöll, James Deschner
    Healthcare.2025; 13(23): 3099.     CrossRef
  • The evaluation of tooth whitening from a perspective of artificial intelligence: a comparative analytical study
    Alaa Al-Haddad, Mikel Alrabadi, Othman Saadeh, George Alrabadi, Yazan Hassona
    Frontiers in Digital Health.2025;[Epub]     CrossRef
  • Is It Getting Better? An Evaluation of Two Successive Generations of ChatGPT in Answering Specialized Vascular Surgery Questions
    Dongjin Suh, Quang Le, Leana Dogbe, Kedar Lavingia, Michael Amendola
    Vascular Specialist International.2025;[Epub]     CrossRef
  • Performance of large language models in reporting oral health concerns and side effects in head and neck cancer: a comparative study
    Jonas Rast, Susanne Wiegand, Jana Biermann, Annette Wiegand, Felix Marschner
    Journal of Cancer Research and Clinical Oncology.2025;[Epub]     CrossRef
  • Foundation models: Insights and implications for gastrointestinal cancer
    Lei Shi, Rui Huang, Li-Ling Zhao, An-Jie Guo
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • TCMEval-PA: a question-answering benchmark dataset for the prescription audit of Traditional Chinese Medicine
    Baifeng Wang, Yiwei Lu, Zhe Wang, Peixin Ge, Guanjie Wang, Keyu Yao, Suyuan Peng, Yan Zhu
    Scientific Data.2025;[Epub]     CrossRef
  • Comparing ChatGPT and Bing, in response to the Home Blood Pressure Monitoring (HBPM) knowledge checklist
    Michaeel Motaghi Niko, Zahra Karbasi, Maryam Kazemi, Maryam Zahmatkeshan
    Hypertension Research.2024; 47(5): 1401.     CrossRef
  • The Utilization of ChatGPT in Reshaping Future Medical Education and Learning Perspectives: A Curse or a Blessing?
    Tessa Breeding, Brian Martinez, Heli Patel, Hazem Nasef, Hasan Arif, Don Nakayama, Adel Elkbuli
    The American Surgeon™.2024; 90(4): 560.     CrossRef
  • ChatGPT use by cancer patients and caregivers: A double‐edged sword?
    Gargi S. Sarode, Sachin C. Sarode
    Oral Surgery.2024; 17(1): 92.     CrossRef
  • Artificial Intelligence and Cerebrovascular Diseases: ChatGPT Model
    Erman Altunisik
    Cerebrovascular Diseases.2024; 53(3): 354.     CrossRef
  • Unveiling the ChatGPT phenomenon: Evaluating the consistency and accuracy of endodontic question answers
    Ana Suárez, Víctor Díaz‐Flores García, Juan Algar, Margarita Gómez Sánchez, María Llorente de Pedro, Yolanda Freire
    International Endodontic Journal.2024; 57(1): 108.     CrossRef
  • How ChatGPT performs in Oral Medicine: The case of oral potentially malignant disorders
    M. Diniz‐Freitas, B. Rivas‐Mundiña, J. R. García‐Iglesias, E. García‐Mato, P. Diz‐Dios
    Oral Diseases.2024; 30(4): 1912.     CrossRef
  • Evaluating the performance of ChatGPT in clinical pharmacy: A comparative study of ChatGPT and clinical pharmacists
    Xiaoru Huang, Dannya Estau, Xuening Liu, Yang Yu, Jiguang Qin, Zijian Li
    British Journal of Clinical Pharmacology.2024; 90(1): 232.     CrossRef
  • Large Language Models and Artificial Intelligence: A Primer for Plastic Surgeons on the Demonstrated and Potential Applications, Promises, and Limitations of ChatGPT
    Jad Abi-Rafeh, Hong Hao Xu, Roy Kazan, Ruth Tevlin, Heather Furnas
    Aesthetic Surgery Journal.2024; 44(3): 329.     CrossRef
  • Assessment of the Responses of the Artificial Intelligence–based Chatbot ChatGPT-4 to Frequently Asked Questions About Amblyopia and Childhood Myopia
    Mojgan Nikdel, Hadi Ghadimi, Mehdi Tavakoli, Donny W. Suh
    Journal of Pediatric Ophthalmology & Strabismus.2024; 61(2): 86.     CrossRef
  • The Genie Is Out of the Bottle
    Pedro Morales-Ramirez, Henry Mishek, Arhita Dasgupta
    Obstetrics & Gynecology.2024; 143(1): e1.     CrossRef
  • Assessing the performance of ChatGPT in bioethics: a large language model’s moral compass in medicine
    Jamie Chen, Angelo Cadiente, Lora J Kasselman, Bryan Pilkington
    Journal of Medical Ethics.2024; 50(2): 97.     CrossRef
  • Credibility of ChatGPT in the assessment of obesity in type 2 diabetes according to the guidelines
    Tugba Barlas, Alev Eroglu Altinova, Mujde Akturk, Fusun Balos Toruner
    International Journal of Obesity.2024; 48(2): 271.     CrossRef
  • Assessing ChatGPT’s ability to answer questions pertaining to erectile dysfunction: can our patients trust it?
    Shirin Razdan, Alexandra R. Siegal, Yukiko Brewer, Michaela Sljivich, Robert J. Valenzuela
    International Journal of Impotence Research.2024; 36(7): 734.     CrossRef
  • Assessing the potential of ChatGPT for psychodynamic formulations in psychiatry: An exploratory study
    Gyubeom Hwang, Dong Yun Lee, Soobeen Seol, Jaeoh Jung, Yeonkyu Choi, Eun Sil Her, Min Ho An, Rae Woong Park
    Psychiatry Research.2024; 331: 115655.     CrossRef
  • Appropriateness and Reliability of an Online Artificial Intelligence Platform’s Responses to Common Questions Regarding Distal Radius Fractures
    Michele Christy, Marie T. Morris, Charles A. Goldfarb, Christopher J. Dy
    The Journal of Hand Surgery.2024; 49(2): 91.     CrossRef
  • A Comprehensive Examination of ChatGPT's Contribution to the Healthcare Sector and Hepatology
    Kabita Kumari, Sharvan Kumar Pahuja, Sanjeev Kumar
    Digestive Diseases and Sciences.2024; 69(11): 4027.     CrossRef
  • Large language models in bariatric surgery patient support: A transformative approach to patient education and engagement
    Jamil S. Samaan, Nithya Rajeev, Nitin Srinivasan, Yee Hui Yeo, Kamran Samakar
    Clinical Obesity.2024;[Epub]     CrossRef
  • What Does ChatGPT Know About Dementia? A Comparative Analysis of Information Quality
    Jill A. Dosso, Jaya N. Kailley, Julie M. Robillard
    Journal of Alzheimer's Disease.2024; 97(2): 559.     CrossRef
  • The performance of large language models on fictional consult queries indicates favorable potential for AI-assisted vascular surgery consult handling
    Quang Le, Kedar S. Lavingia, Michael Amendola
    JVS-Vascular Insights.2024; 2: 100052.     CrossRef
  • Urological Cancers and ChatGPT: Assessing the Quality of Information and Possible Risks for Patients
    Faruk Ozgor, Ufuk Caglar, Ahmet Halis, Hakan Cakir, Ufuk Can Aksu, Ali Ayranci, Omer Sarilar
    Clinical Genitourinary Cancer.2024; 22(2): 454.     CrossRef
  • May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis
    Antonietta Gerarda Gravina, Raffaele Pellegrino, Marina Cipullo, Giovanna Palladino, Giuseppe Imperio, Andrea Ventura, Salvatore Auletta, Paola Ciamarra, Alessandro Federico
    World Journal of Gastroenterology.2024; 30(1): 17.     CrossRef
  • The Accuracy of ChatGPT-Generated Responses in Answering Commonly Asked Patient Questions About Labor Epidurals: A Survey-Based Study
    Allison A. Mootz, Brendan Carvalho, Pervez Sultan, Teresa P. Nguyen, Sharon C. Reale
    Anesthesia & Analgesia.2024; 138(5): 1142.     CrossRef
  • Evaluating the Accuracy of ChatGPT and Google BARD in Fielding Oculoplastic Patient Queries: A Comparative Study on Artificial versus Human Intelligence
    Eman M. Al-Sharif, Rafaella C. Penteado, Nahia Dib El Jalbout, Nicole J. Topilow, Marissa K. Shoji, Don O. Kikkawa, Catherine Y. Liu, Bobby S. Korn
    Ophthalmic Plastic & Reconstructive Surgery.2024; 40(3): 303.     CrossRef
  • Chatbot Performance in Defining and Differentiating Palliative Care, Supportive Care, Hospice Care
    Min Ji Kim, Sonal Admane, Yuchieh Kathryn Chang, Kao-swi Karina Shih, Akhila Reddy, Michael Tang, Maxine De La Cruz, Terry Pham Taylor, Eduardo Bruera, David Hui
    Journal of Pain and Symptom Management.2024; 67(5): e381.     CrossRef
  • Evaluating capabilities of large language models: Performance of GPT-4 on surgical knowledge assessments
    Brendin R. Beaulieu-Jones, Margaret T. Berrigan, Sahaj Shah, Jayson S. Marwaha, Shuo-Lun Lai, Gabriel A. Brat
    Surgery.2024; 175(4): 936.     CrossRef
  • AI-chatbots and oral oncology: A transformative frontier in patient support
    Amol S. Dhane, Sachin Sarode
    Oral Oncology.2024; 150: 106701.     CrossRef
  • Evaluation of ChatGPT-Generated Educational Patient Pamphlets for Common Interventional Radiology Procedures
    Soheil Kooraki, Melina Hosseiny, Mohamamd H. Jalili, Amir Ali Rahsepar, Amir Imanzadeh, Grace Hyun Kim, Cameron Hassani, Fereidoun Abtin, John M. Moriarty, Arash Bedayat
    Academic Radiology.2024; 31(11): 4548.     CrossRef
  • ChatGPT performance in prosthodontics: Assessment of accuracy and repeatability in answer generation
    Yolanda Freire, Andrea Santamaría Laorden, Jaime Orejas Pérez, Margarita Gómez Sánchez, Víctor Díaz-Flores García, Ana Suárez
    The Journal of Prosthetic Dentistry.2024; 131(4): 659.e1.     CrossRef
  • Comparing the quality of ChatGPT- and physician-generated responses to patients’ dermatology questions in the electronic medical record
    Kelly Reynolds, Daniel Nadelman, Joseph Durgin, Stephen Ansah-Addo, Daniel Cole, Rachel Fayne, Jane Harrell, Madison Ratycz, Mason Runge, Amanda Shepard-Hayes, Daniel Wenzel, Trilokraj Tejasvi
    Clinical and Experimental Dermatology.2024; 49(7): 715.     CrossRef
  • Evaluation of Informative Content on Cerebral Palsy in the Era of Artificial Intelligence: The Value of ChatGPT
    Ayşe Merve Ata, Berke Aras, Özlem Yılmaz Taşdelen, Canan Çelik, Canan Çulha
    Physical & Occupational Therapy In Pediatrics.2024; 44(5): 605.     CrossRef
  • Assessing Ability for ChatGPT to Answer Total Knee Arthroplasty-Related Questions
    Matthew L. Magruder, Ariel N. Rodriguez, Jason C.J. Wong, Orry Erez, Nicolas S. Piuzzi, Gil R. Scuderi, James D. Slover, Jason H. Oh, Ran Schwarzkopf, Antonia F. Chen, Richard Iorio, Stuart B. Goodman, Michael A. Mont
    The Journal of Arthroplasty.2024; 39(8): 2022.     CrossRef
  • Exploring the role of ChatGPT in clinical decision-making in otorhinolaryngology: a ChatGPT designed study
    Francisco Teixeira-Marques, Nuno Medeiros, Francisco Nazaré, Sandra Alves, Nuno Lima, Leandro Ribeiro, Rita Gama, Pedro Oliveira
    European Archives of Oto-Rhino-Laryngology.2024; 281(4): 2023.     CrossRef
  • Exploring the role of large language models in radiation emergency response
    Anirudh Chandra, Abinash Chakraborty
    Journal of Radiological Protection.2024; 44(1): 011510.     CrossRef
  • Artificial intelligence compared with human-derived patient educational materials on cirrhosis
    Faruq Pradhan, Alexandra Fiedler, Kaeli Samson, Marco Olivera-Martinez, Wuttiporn Manatsathit, Thoetchai Peeraphatdit
    Hepatology Communications.2024;[Epub]     CrossRef
  • Is ChatGPT a trusted source of information for total hip and knee arthroplasty patients?
    Benjamin M. Wright, Michael S. Bodnar, Andrew D. Moore, Meghan C. Maseda, Michael P. Kucharik, Connor C. Diaz, Christian M. Schmidt, Hassan R. Mir
    Bone & Joint Open.2024; 5(2): 139.     CrossRef
  • Perspective: Artificial intelligence and patient communication
    Gabriel Tse, Nicholas Kuzma, Alisa Khan
    Journal of Hospital Medicine.2024; 19(9): 845.     CrossRef
  • Performance of ChatGPT Compared to Clinical Practice Guidelines in Making Informed Decisions for Lumbosacral Radicular Pain: A Cross-sectional Study
    Silvia Gianola, Silvia Bargeri, Greta Castellini, Chad Cook, Alvisa Palese, Paolo Pillastrini, Silvia Salvalaggio, Andrea Turolla, Giacomo Rossettini
    Journal of Orthopaedic & Sports Physical Therapy.2024; 54(3): 222.     CrossRef
  • Applications of natural language processing tools in the surgical journey
    Khang Duy Ricky Le, Samuel Boon Ping Tay, Kay Tai Choy, Johan Verjans, Nicola Sasanelli, Joseph C. H. Kong
    Frontiers in Surgery.2024;[Epub]     CrossRef
  • ChatGPT as a Source of Patient Information for Lumbar Spinal Fusion and Laminectomy
    Patrick P. Nian, Jayson Saleet, Matthew Magruder, Ian J. Wellington, Jack Choueka, John K. Houten, Ahmed Saleh, Afshin E. Razi, Mitchell K. Ng
    Clinical Spine Surgery.2024; 37(10): E394.     CrossRef
  • “My kid has autism”: An interesting conversation with ChatGPT
    Yazan Hassona, Dua′a Alqaisi
    Special Care in Dentistry.2024; 44(4): 1296.     CrossRef
  • Harnessing ChatGPT dialogues to address claustrophobia in MRI - A radiographers' education perspective
    G.R. Bonfitto, A. Roletto, M. Savardi, S.V. Fasulo, D. Catania, A. Signoroni
    Radiography.2024; 30(3): 737.     CrossRef
  • Dr. Google to Dr. ChatGPT: assessing the content and quality of artificial intelligence-generated medical information on appendicitis
    Yazid K. Ghanem, Armaun D. Rouhi, Ammr Al-Houssan, Zena Saleh, Matthew C. Moccia, Hansa Joshi, Kristoffel R. Dumon, Young Hong, Francis Spitz, Amit R. Joshi, Michael Kwiatt
    Surgical Endoscopy.2024; 38(5): 2887.     CrossRef
  • Accuracy of Online Artificial Intelligence Models in Primary Care Settings
    Joseph Kassab, Abdel Hadi El Hajjar, Richard M. Wardrop, Andrei Brateanu
    American Journal of Preventive Medicine.2024; 66(6): 1054.     CrossRef
  • Assessing the Quality of ChatGPT Responses to Dementia Caregivers’ Questions: Qualitative Analysis
    Alyssa Aguirre, Robin Hilsabeck, Tawny Smith, Bo Xie, Daqing He, Zhendong Wang, Ning Zou
    JMIR Aging.2024; 7: e53019.     CrossRef
  • Large language models and bariatric surgery patient education: a comparative readability analysis of GPT-3.5, GPT-4, Bard, and online institutional resources
    Nitin Srinivasan, Jamil S. Samaan, Nithya D. Rajeev, Mmerobasi U. Kanu, Yee Hui Yeo, Kamran Samakar
    Surgical Endoscopy.2024; 38(5): 2522.     CrossRef
  • Conformity of ChatGPT recommendations with the AUA/SUFU guideline on postprostatectomy urinary incontinence
    Vicktor B. P. Pinto, Matheus F. de Azevedo, Marcelo L. Wroclawski, Guilherme Gentile, Vinicius L. M. Jesus, Jose de Bessa Junior, William C. Nahas, Carlos A. R. Sacomani, Jaspreet S. Sandhu, Cristiano M. Gomes
    Neurourology and Urodynamics.2024; 43(4): 935.     CrossRef
  • Enhanced Artificial Intelligence Strategies in Renal Oncology: Iterative Optimization and Comparative Analysis of GPT 3.5 Versus 4.0
    Rui Liang, Anguo Zhao, Lei Peng, Xiaojian Xu, Jianye Zhong, Fan Wu, Fulin Yi, Shaohua Zhang, Song Wu, Jianquan Hou
    Annals of Surgical Oncology.2024; 31(6): 3887.     CrossRef
  • Evaluating ChatGPT’s Capabilities on Orthopedic Training Examinations: An Analysis of New Image Processing Features
    Kevin M Posner, Cassandra Bakus, Grace Basralian, Grace Chester, Mallery Zeiman, Geoffrey R O'Malley, Gregg R Klein
    Cureus.2024;[Epub]     CrossRef
  • A Retrospective Comparison of Medication Recommendations Between a Cardiologist and ChatGPT-4 for Hypertension Patients in a Rural Clinic
    Ghaith Al Tibi, Melvin Alexander, Samuel Miller, Nicolas Chronos
    Cureus.2024;[Epub]     CrossRef
  • Accuracy and Readability of Kidney Stone Patient Information Materials Generated by a Large Language Model Compared to Official Urologic Organizations
    Abdulghafour Halawani, Alec Mitchell, Mohammadali Saffarzadeh, Victor Wong, Ben H. Chew, Connor M. Forbes
    Urology.2024; 186: 107.     CrossRef
  • The efficacy of artificial intelligence in urology: a detailed analysis of kidney stone-related queries
    Gökhan Cil, Kazim Dogan
    World Journal of Urology.2024;[Epub]     CrossRef
  • Charting new AI education in gastroenterology: Cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam
    Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, Andrea Ventura, Alessandro Federico
    Digestive and Liver Disease.2024; 56(8): 1304.     CrossRef
  • Deciphering Public Voices in the Digital Era
    Xinyu Fu, Thomas W. Sanchez, Chaosu Li, Juliana Reu Junqueira
    Journal of the American Planning Association.2024; 90(4): 728.     CrossRef
  • Prompt Engineering for Generative Artificial Intelligence in Gastroenterology and Hepatology
    Jin Ge, Irene Y. Chen, Mark J. Pletcher, Jennifer C. Lai
    American Journal of Gastroenterology.2024; 119(9): 1709.     CrossRef
  • Hepatocellular Carcinoma in the Era of Direct Antiviral Agents Against Hepatitis C Virus
    Alessio Aghemo, Davide Polverini, Massimo Colombo
    Current Hepatology Reports.2024; 23(3): 364.     CrossRef
  • The Research Interest in ChatGPT and Other Natural Language Processing Tools from a Public Health Perspective: A Bibliometric Analysis
    Giuliana Favara, Martina Barchitta, Andrea Maugeri, Roberta Magnano San Lio, Antonella Agodi
    Informatics.2024; 11(2): 13.     CrossRef
  • Exploring the Role of ChatGPT in Oncology: Providing Information and Support for Cancer Patients
    Maurizio Cè, Vittoria Chiarpenello, Alessandra Bubba, Paolo Florent Felisaz, Giancarlo Oliva, Giovanni Irmici, Michaela Cellina
    BioMedInformatics.2024; 4(2): 877.     CrossRef
  • The Role of Artificial Intelligence in Endocrine Management: Assessing ChatGPT’s Responses to Prolactinoma Queries
    Mustafa Can Şenoymak, Nuriye Hale Erbatur, İrem Şenoymak, Sevde Nur Fırat
    Journal of Personalized Medicine.2024; 14(4): 330.     CrossRef
  • Large Language Models in Oncology: Revolution or Cause for Concern?
    Aydin Caglayan, Wojciech Slusarczyk, Rukhshana Dina Rabbani, Aruni Ghose, Vasileios Papadopoulos, Stergios Boussios
    Current Oncology.2024; 31(4): 1817.     CrossRef
  • AI can help people feel heard, but an AI label diminishes this impact
    Yidan Yin, Nan Jia, Cheryl J. Wakslak
    Proceedings of the National Academy of Sciences.2024;[Epub]     CrossRef
  • Dr. Google vs. Dr. ChatGPT: Exploring the Use of Artificial Intelligence in Ophthalmology by Comparing the Accuracy, Safety, and Readability of Responses to Frequently Asked Patient Questions Regarding Cataracts and Cataract Surgery
    Samuel A. Cohen, Arthur Brant, Ann Caroline Fisher, Suzann Pershing, Diana Do, Carolyn Pan
    Seminars in Ophthalmology.2024; 39(6): 472.     CrossRef
  • Artificial intelligence performance in clinical neurology queries: the ChatGPT model
    Erman Altunisik, Yasemin Ekmekyapar Firat, Emine Kilicparlar Cengiz, Gulsum Bayana Comruk
    Neurological Research.2024; 46(5): 437.     CrossRef
  • Evaluation of the safety, accuracy, and helpfulness of the GPT-4.0 Large Language Model in neurosurgery
    Kevin T. Huang, Neel H. Mehta, Saksham Gupta, Alfred P. See, Omar Arnaout
    Journal of Clinical Neuroscience.2024; 123: 151.     CrossRef
  • Use of ChatGPT in Urology and its Relevance in Clinical Practice: Is it useful?
    Antonio Vitor Nascimento Martinelli Braga, Noel Charlles Nunes, Emanoel Nascimento Santos, Maria Luiza Veiga, Ana Aparecida Nascimento Martinelli Braga, Glicia Estevam de Abreu, José de Bessa Júnior, Luis Henrique Braga, Andrew J. Kirsch, Ubirajara Barros
    International braz j urol.2024; 50(2): 192.     CrossRef
  • ChatGPT for Educational Purposes: Investigating the Impact of Knowledge Management Factors on Student Satisfaction and Continuous Usage
    Thi Thuy An Ngo, Thanh Tu Tran, Gia Khuong An, Phuong Thy Nguyen
    IEEE Transactions on Learning Technologies.2024; 17: 1341.     CrossRef
  • Development of a liver disease–specific large language model chat interface using retrieval-augmented generation
    Jin Ge, Steve Sun, Joseph Owens, Victor Galvez, Oksana Gologorskaya, Jennifer C. Lai, Mark J. Pletcher, Ki Lai
    Hepatology.2024; 80(5): 1158.     CrossRef
  • Accuracy of Information given by ChatGPT for Patients with Inflammatory Bowel Disease in Relation to ECCO Guidelines
    Martina Sciberras, Yvette Farrugia, Hannah Gordon, Federica Furfaro, Mariangela Allocca, Joana Torres, Naila Arebi, Gionata Fiorino, Marietta Iacucci, Bram Verstockt, Fernando Magro, Kostas Katsanos, Josef Busuttil, Katya De Giovanni, Valerie Anne Fenech,
    Journal of Crohn's and Colitis.2024; 18(8): 1215.     CrossRef
  • Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignancies
    Itai Ghersin, Roni Weisshof, Eduard Koifman, Haggai Bar-Yoseph, Dana Ben Hur, Itay Maza, Erez Hasnis, Roni Nasser, Baruch Ovadia, Dikla Dror Zur, Matti Waterman, Yuri Gorelik
    Endoscopy.2024; 56(09): 706.     CrossRef
  • Geriatrics and artificial intelligence in Spain (Ger-IA project): talking to ChatGPT, a nationwide survey
    Daniel Rosselló-Jiménez, S. Docampo, Y. Collado, L. Cuadra-Llopart, F. Riba, M. Llonch-Masriera
    European Geriatric Medicine.2024; 15(4): 1129.     CrossRef
  • Understanding Health Care Students’ Perceptions, Beliefs, and Attitudes Toward AI-Powered Language Models: Cross-Sectional Study
    Ivan Cherrez-Ojeda, Juan C Gallardo-Bastidas, Karla Robles-Velasco, María F Osorio, Eleonor Maria Velez Leon, Manuel Leon Velastegui, Patrícia Pauletto, F C Aguilar-Díaz, Aldo Squassi, Susana Patricia González Eras, Erita Cordero Carrasco, Karol Leonor Ch
    JMIR Medical Education.2024; 10: e51757.     CrossRef
  • Performance of ChatGPT in Solving Questions From the Progress Test (Brazilian National Medical Exam): A Potential Artificial Intelligence Tool in Medical Practice
    Mateus Rodrigues Alessi, Heitor A Gomes, Matheus Lopes de Castro, Cristina Terumy Okamoto
    Cureus.2024;[Epub]     CrossRef
  • Large Language Models and User Trust: Consequence of Self-Referential Learning Loop and the Deskilling of Health Care Professionals
    Avishek Choudhury, Zaira Chaudhry
    Journal of Medical Internet Research.2024; 26: e56764.     CrossRef
  • How good is ChatGPT at answering patients’ questions related to early detection of oral (mouth) cancer?
    Yazan Hassona, Dua'a Alqaisi, Alaa AL-Haddad, Eleni A Georgakopoulou, Dimitris Malamos, Mohammad S Alrashdan, Faleh Sawair
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2024; 138(2): 269.     CrossRef
  • From Bytes to Best Practices: Tracing ChatGPT-3.5’s Evolution and Alignment With the National Comprehensive Cancer Network® Guidelines in Pancreatic Adenocarcinoma Management
    Tamir E. Bresler, Shivam Pandya, Ryan Meyer, Zin Htway, Manabu Fujita
    The American Surgeon™.2024; 90(10): 2543.     CrossRef
  • Evaluating the accuracy and reproducibility of ChatGPT-4 in answering patient questions related to small intestinal bacterial overgrowth
    Lauren Schlussel, Jamil S Samaan, Yin Chan, Bianca Chang, Yee Hui Yeo, Wee Han Ng, Ali Rezaie
    Artificial Intelligence in Gastroenterology.2024;[Epub]     CrossRef
  • Quantitative Comparison of Chatbots on Common Rhinology Pathologies
    Jeffrey R. Bellinger, Minhie W. Kwak, Gabriel A. Ramos, Jeffrey S. Mella, Jose L. Mattos
    The Laryngoscope.2024; 134(10): 4225.     CrossRef
  • Diagnosis in Bytes: Comparing the Diagnostic Accuracy of Google and ChatGPT 3.5 as an Educational Support Tool
    Guilherme R. Guimaraes, Ricardo G. Figueiredo, Caroline Santos Silva, Vanessa Arata, Jean Carlos Z. Contreras, Cristiano M. Gomes, Ricardo B. Tiraboschi, José Bessa Junior
    International Journal of Environmental Research and Public Health.2024; 21(5): 580.     CrossRef
  • Optimization of hepatological clinical guidelines interpretation by large language models: a retrieval augmented generation-based framework
    Simone Kresevic, Mauro Giuffrè, Milos Ajcevic, Agostino Accardo, Lory S. Crocè, Dennis L. Shung
    npj Digital Medicine.2024;[Epub]     CrossRef
  • Evaluating Chat Generative Pre-trained Transformer Responses to Common Pediatric In-toeing Questions
    Jason Zarahi Amaral, Rebecca J. Schultz, Benjamin M. Martin, Tristen Taylor, Basel Touban, Jessica McGraw-Heinrich, Scott D. McKay, Scott B. Rosenfeld, Brian G. Smith
    Journal of Pediatric Orthopaedics.2024; 44(7): e592.     CrossRef
  • Evaluation of large language models in breast cancer clinical scenarios: a comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2
    Linfang Deng, Tianyi Wang, Yangzhang, Zhenhua Zhai, Wei Tao, Jincheng Li, Yi Zhao, Shaoting Luo, Jinjiang Xu
    International Journal of Surgery.2024; 110(4): 1941.     CrossRef
  • Chatbots vs andrologists: Testing 25 clinical cases
    Ophélie Perrot, Aurelie Schirmann, Adrien Vidart, Cyrille Guillot-Tantay, Vincent Izard, Thierry Lebret, Bernard Boillot, Benoit Mesnard, Cedric Lebacle, François-Xavier Madec
    The French Journal of Urology.2024; 34(5): 102636.     CrossRef
  • A Multidisciplinary Assessment of ChatGPT’s Knowledge of Amyloidosis: Observational Study
    Ryan C King, Jamil S Samaan, Yee Hui Yeo, Yuxin Peng, David C Kunkel, Ali A Habib, Roxana Ghashghaei
    JMIR Cardio.2024; 8: e53421.     CrossRef
  • ChatGPT/GPT‐4 (large language models): Opportunities and challenges of perspective in bariatric healthcare professionals
    Saikam Law, Brian Oldfield, Wah Yang
    Obesity Reviews.2024;[Epub]     CrossRef
  • GPT (Generative Pre-Trained Transformer)— A Comprehensive Review on Enabling Technologies, Potential Applications, Emerging Challenges, and Future Directions
    Gokul Yenduri, M. Ramalingam, G. Chemmalar Selvi, Y. Supriya, Gautam Srivastava, Praveen Kumar Reddy Maddikunta, G. Deepti Raj, Rutvij H. Jhaveri, B. Prabadevi, Weizheng Wang, Athanasios V. Vasilakos, Thippa Reddy Gadekallu
    IEEE Access.2024; 12: 54608.     CrossRef
  • ChatGPT accurately performs genetic counseling for gynecologic cancers
    Jharna M. Patel, Catherine E. Hermann, Whitfield B. Growdon, Emeline Aviki, Marina Stasenko
    Gynecologic Oncology.2024; 183: 115.     CrossRef
  • ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner?
    Ughur Aghamaliyev, Javad Karimbayli, Clemens Giessen-Jung, Matthias Ilmer, Kristian Unger, Dorian Andrade, Felix O. Hofmann, Maximilian Weniger, Martin K. Angele, C. Benedikt Westphalen, Jens Werner, Bernhard W. Renz
    European Journal of Cancer.2024; 205: 114100.     CrossRef
  • Comparing generative and retrieval-based chatbots in answering patient questions regarding age-related macular degeneration and diabetic retinopathy
    Kai Xiong Cheong, Chenxi Zhang, Tien-En Tan, Beau J Fenner, Wendy Meihua Wong, Kelvin YC Teo, Ya Xing Wang, Sobha Sivaprasad, Pearse A Keane, Cecilia Sungmin Lee, Aaron Y Lee, Chui Ming Gemmy Cheung, Tien Yin Wong, Yun-Gyung Cheong, Su Jeong Song, Yih Chu
    British Journal of Ophthalmology.2024; 108(10): 1443.     CrossRef
  • Large language models illuminate a progressive pathway to artificial intelligent healthcare assistant
    Mingze Yuan, Peng Bao, Jiajia Yuan, Yunhao Shen, Zifan Chen, Yi Xie, Jie Zhao, Quanzheng Li, Yang Chen, Li Zhang, Lin Shen, Bin Dong
    Medicine Plus.2024; 1(2): 100030.     CrossRef
  • Assessing ChatGPT vs. Standard Medical Resources for Endoscopic Sleeve Gastroplasty Education: A Medical Professional Evaluation Study
    Razan Aburumman, Karim Al Annan, Rudy Mrad, Vitor O. Brunaldi, Khushboo Gala, Barham K. Abu Dayyeh
    Obesity Surgery.2024; 34(7): 2718.     CrossRef
  • Appropriateness of ChatGPT in Answering Heart Failure Related Questions
    Ryan C. King, Jamil S. Samaan, Yee Hui Yeo, Behram Mody, Dawn M. Lombardo, Roxana Ghashghaei
    Heart, Lung and Circulation.2024; 33(9): 1314.     CrossRef
  • Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology
    Estefania Roldan‐Vasquez, Samir Mitri, Shreya Bhasin, Tina Bharani, Kathryn Capasso, Michelle Haslinger, Ranjna Sharma, Ted A. James
    Journal of Surgical Oncology.2024; 130(2): 188.     CrossRef
  • Addressing 6 challenges in generative AI for digital health: A scoping review
    Tara Templin, Monika W. Perez, Sean Sylvia, Jeff Leek, Nasa Sinnott-Armstrong, Jennifer N. Avari Silva
    PLOS Digital Health.2024; 3(5): e0000503.     CrossRef
  • ChatGPT in medicine: prospects and challenges: a review article
    Songtao Tan, Xin Xin, Di Wu
    International Journal of Surgery.2024; 110(6): 3701.     CrossRef
  • Is ChatGPT knowledgeable of acute coronary syndromes and pertinent European Society of Cardiology Guidelines?
    Dogac C. GURBUZ, Eser VARIS
    Minerva Cardiology and Angiology.2024;[Epub]     CrossRef
  • Comparing Performances of Artificial Intelligence Chatbots to Patients’ Questions on Health Information: Comprehensiveness, Accuracy and Currency
    Mustafa Said Yıldız
    Journal of Consumer Health on the Internet.2024; 28(2): 115.     CrossRef
  • Utility of Large Language Models to Produce a Patient-Friendly Summary From Oncology Consultations
    Ryan G. Holstead
    JCO Oncology Practice.2024; 20(9): 1157.     CrossRef
  • Evaluating ChatGPT's Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
    Fan Ye, He Zhang, Xin Luo, Tong Wu, Qintai Yang, Zhaohui Shi
    Otolaryngology–Head and Neck Surgery.2024; 171(2): 571.     CrossRef
  • Optimizing large language models in digestive disease: strategies and challenges to improve clinical outcomes
    Mauro Giuffrè, Simone Kresevic, Nicola Pugliese, Kisung You, Dennis L. Shung
    Liver International.2024; 44(9): 2114.     CrossRef
  • PERFORMANCE ASSESSMENT OF AN ARTIFICIAL INTELLIGENCE CHATBOT IN CLINICAL VITREORETINAL SCENARIOS
    Michael J. Maywood, Ravi Parikh, Avnish Deobhakta, Tedi Begaj
    Retina.2024; 44(6): 954.     CrossRef
  • Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in SLE: results from the mixed methods international INSPIRE study
    Melanie Sloan, James A. Bourgeois, Guy Leschziner, Thomas A. Pollak, Mervi Pitkanen, Rupert Harwood, Michael Bosley, Alessandra Bortoluzzi, Laura Andreoli, Wendy Diment, James Brimicombe, Mandeep Ubhi, Colette Barrere, Felix Naughton, Caroline Gordon, Dav
    eClinicalMedicine.2024; 73: 102634.     CrossRef
  • The Use of Chatbots in Head and Neck Mucosal Malignancy Treatment Recommendations
    Caretia J. Washington, Marianne Abouyared, Shama Karanth, Dejana Braithwaite, Andrew Birkeland, Dustin A. Silverman, Si Chen
    Otolaryngology–Head and Neck Surgery.2024; 171(4): 1062.     CrossRef
  • Evaluating the accuracy and readability of ChatGPT in providing parental guidance for adenoidectomy, tonsillectomy, and ventilation tube insertion surgery
    Emre Polat, Yagmur Basak Polat, Erol Senturk, Remzi Dogan, Alper Yenigun, Selahattin Tugrul, Sabri Baki Eren, Fadlullah Aksoy, Orhan Ozturan
    International Journal of Pediatric Otorhinolaryngology.2024; 181: 111998.     CrossRef
  • Generative AI: A transformative force in advancing research and care in metabolic dysfunction-associated fatty liver disease
    Partha Pratim Ray
    Liver Research.2024; 8(2): 127.     CrossRef
  • The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach
    Dario Piazza, Federica Martorana, Annabella Curaba, Daniela Sambataro, Maria Rosaria Valerio, Alberto Firenze, Basilio Pecorino, Paolo Scollo, Vito Chiantera, Giuseppe Scibilia, Paolo Vigneri, Vittorio Gebbia, Giuseppa Scandurra
    Current Oncology.2024; 31(5): 2796.     CrossRef
  • ChatGPT and BCI-VR: a new integrated diagnostic and therapeutic perspective for the accurate diagnosis and personalized treatment of mild cognitive impairment
    Yiduo Yao, W. Z. W. Hasan, Wenlong Jiao, Xianling Dong, H. R. Ramli, N. M. H. Norsahperi, Dong Wen
    Frontiers in Human Neuroscience.2024;[Epub]     CrossRef
  • Systematic review: The use of large language models as medical chatbots in digestive diseases
    Mauro Giuffrè, Simone Kresevic, Kisung You, Johannes Dupont, Jack Huebner, Alyssa Ann Grimshaw, Dennis Legen Shung
    Alimentary Pharmacology & Therapeutics.2024; 60(2): 144.     CrossRef
  • Human vs machine: identifying ChatGPT-generated abstracts in Gynecology and Urogynecology
    Evelyn T. Pan, Maria Florian-Rodriguez
    American Journal of Obstetrics and Gynecology.2024; 231(2): 276.e1.     CrossRef
  • Communicative competence of generative artificial intelligence in responding to patient queries about colorectal cancer surgery
    Min Hyeong Jo, Min-Jun Kim, Heung-Kwon Oh, Mi Jeong Choi, Hye-Rim Shin, Tae-Gyun Lee, Hong-min Ahn, Duck-Woo Kim, Sung-Bum Kang
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Evaluation of large language models as a diagnostic aid for complex medical cases
    Alejandro Ríos-Hoyo, Naing Lin Shan, Anran Li, Alexander T. Pearson, Lajos Pusztai, Frederick M. Howard
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • The emerging role of generative artificial intelligence in transplant medicine
    Maya Deeb, Anirudh Gangadhar, Madhumitha Rabindranath, Khyathi Rao, Michael Brudno, Aman Sidhu, Bo Wang, Mamatha Bhat
    American Journal of Transplantation.2024; 24(10): 1724.     CrossRef
  • Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries
    Yongkang Lai, Foqiang Liao, Jiulong Zhao, Chunping Zhu, Yi Hu, Zhaoshen Li
    Helicobacter.2024;[Epub]     CrossRef
  • Medical Ethics of Large Language Models in Medicine
    Jasmine Chiat Ling Ong, Shelley Yin-Hsi Chang, Wasswa William, Atul J. Butte, Nigam H. Shah, Lita Sui Tjien Chew, Nan Liu, Finale Doshi-Velez, Wei Lu, Julian Savulescu, Daniel Shu Wei Ting
    NEJM AI.2024;[Epub]     CrossRef
  • An Analysis of ChatGPT4 to Respond to Glaucoma-Related Questions
    Suleyman G. Kerci, Berna Sahan
    Journal of Glaucoma.2024; 33(7): 486.     CrossRef
  • Assessing Generative Pretrained Transformers (GPT) in Clinical Decision-Making: Comparative Analysis of GPT-3.5 and GPT-4
    Adi Lahat, Kassem Sharif, Narmin Zoabi, Yonatan Shneor Patt, Yousra Sharif, Lior Fisher, Uria Shani, Mohamad Arow, Roni Levin, Eyal Klang
    Journal of Medical Internet Research.2024; 26: e54571.     CrossRef
  • Assessing the appropriateness and completeness of ChatGPT-4’s AI-generated responses for queries related to diabetic retinopathy
    Brughanya Subramanian, Ramachandran Rajalakshmi, Sobha Sivaprasad, Chetan Rao, Rajiv Raman
    Indian Journal of Ophthalmology.2024; 72(Suppl 4): S684.     CrossRef
  • Chatbots as Patient Education Resources for Aesthetic Facial Plastic Surgery: Evaluation of ChatGPT and Google Bard Responses
    Neha Garg, Daniel J. Campbell, Angela Yang, Adam McCann, Annie E. Moroco, Leonard E. Estephan, William J. Palmer, Howard Krein, Ryan Heffelfinger
    Facial Plastic Surgery & Aesthetic Medicine.2024; 26(6): 665.     CrossRef
  • Assessing ChatGPT as a Medical Consultation Assistant for Chronic Hepatitis B: Cross-Language Study of English and Chinese
    Yijie Wang, Yining Chen, Jifang Sheng
    JMIR Medical Informatics.2024; 12: e56426.     CrossRef
  • Examining the role of ChatGPT in the management of distal radius fractures: insights into its accuracy and consistency
    Christopha J Knee, Ryan J Campbell, David J Graham, Cameron Handford, Michael Symes, Brahman S Sivakumar
    ANZ Journal of Surgery.2024; 94(7-8): 1391.     CrossRef
  • ChatGPT Responses to Frequently Asked Questions on Ménière's Disease: A Comparison to Clinical Practice Guideline Answers
    Rebecca A. Ho, Ariana L. Shaari, Paul T. Cowan, Kenneth Yan
    OTO Open.2024;[Epub]     CrossRef
  • AI-Generated Content in Cancer Symptom Management: A Comparative Analysis Between ChatGPT and NCCN
    David Lazris, Yael Schenker, Teresa Hagan Thomas
    Journal of Pain and Symptom Management.2024; 68(4): e303.     CrossRef
  • Limitations of ChatGPT for Patient Education Regarding Frequently Searched Questions About Benign Prostatic Hyperplasia
    Paolo M. Muraira, Annie Chen, Lori B. Lerner, Steven A. Kaplan, Kevin T. McVary, Franco M. Muraira, Ricardo R. Gonzalez
    JU Open Plus.2024;[Epub]     CrossRef
  • Evaluation of the quality and quantity of artificial intelligence-generated responses about anesthesia and surgery: using ChatGPT 3.5 and 4.0
    Jisun Choi, Ah Ran Oh, Jungchan Park, Ryung A. Kang, Seung Yeon Yoo, Dong Jae Lee, Kwangmo Yang
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Large language models’ responses to liver cancer surveillance, diagnosis, and management questions: accuracy, reliability, readability
    Jennie J. Cao, Daniel H. Kwon, Tara T. Ghaziani, Paul Kwo, Gary Tse, Andrew Kesselman, Aya Kamaya, Justin R. Tse
    Abdominal Radiology.2024; 49(12): 4286.     CrossRef
  • Large Language Model–Based Responses to Patients’ In-Basket Messages
    William R. Small, Batia Wiesenfeld, Beatrix Brandfield-Harvey, Zoe Jonassen, Soumik Mandal, Elizabeth R. Stevens, Vincent J. Major, Erin Lostraglio, Adam Szerencsy, Simon Jones, Yindalon Aphinyanaphongs, Stephen B. Johnson, Oded Nov, Devin Mann
    JAMA Network Open.2024; 7(7): e2422399.     CrossRef
  • Artificial intelligence methods available for cancer research
    Ankita Murmu, Balázs Győrffy
    Frontiers of Medicine.2024; 18(5): 778.     CrossRef
  • Readability and Information Quality in Cancer Information From a Free vs Paid Chatbot
    David Musheyev, Alexander Pan, Preston Gross, Daniel Kamyab, Peter Kaplinsky, Mark Spivak, Marie A. Bragg, Stacy Loeb, Abdo E. Kabarriti
    JAMA Network Open.2024; 7(7): e2422275.     CrossRef
  • Clinical application potential of large language model: a study based on thyroid nodules
    Shujun Xia, Qing Hua, Zihan Mei, Wenwen Xu, Limei Lai, Minyan Wei, Yu Qin, Lin Luo, Changhua Wang, ShengNan Huo, Lijun Fu, Feidu Zhou, Jiang Wu, Li Zhang, De Lv, Jianxin Li, Xin Wang, Ning Li, Yanyan Song, Jianqiao Zhou
    Endocrine.2024; 87(1): 206.     CrossRef
  • ChatGPT and Health Communication
    Min Li, Amily W. Guenier
    International Journal of E-Health and Medical Communications.2024; 15(1): 1.     CrossRef
  • Evaluating the Accuracy of ChatGPT in Common Patient Questions Regarding HPV+ Oropharyngeal Carcinoma
    Nikhil Bellamkonda, Janice L. Farlow, Catherine T. Haring, Michael W. Sim, Nolan B. Seim, Richard B. Cannon, Marcus M. Monroe, Amit Agrawal, James W. Rocco, Hilary C. McCrary
    Annals of Otology, Rhinology & Laryngology.2024; 133(9): 814.     CrossRef
  • Assessment of ChatGPT generated educational material for head and neck surgery counseling
    Lana Mnajjed, Rusha J. Patel
    American Journal of Otolaryngology.2024; 45(5): 104410.     CrossRef
  • ChatGPT-3.5 Versus Google Bard: Which Large Language Model Responds Best to Commonly Asked Pregnancy Questions?
    Keren Khromchenko, Sameeha Shaikh, Meghana Singh, Gregory Vurture, Rima A Rana, Jonathan D Baum
    Cureus.2024;[Epub]     CrossRef
  • ChatGPT in medicine: A cross-disciplinary systematic review of ChatGPT’s (artificial intelligence) role in research, clinical practice, education, and patient interaction
    Afia Fatima, Muhammad Ashir Shafique, Khadija Alam, Tagwa Kalool Fadlalla Ahmed, Muhammad Saqlain Mustafa
    Medicine.2024; 103(32): e39250.     CrossRef
  • Evaluating accuracy and reproducibility of ChatGPT responses to patient-based questions in Ophthalmology: An observational study
    Asem A. Alqudah, Abdelwahab J. Aleshawi, Mohammed Baker, Zaina Alnajjar, Ibrahim Ayasrah, Yaqoot Ta’ani, Mohammad Al Salkhadi, Shaima’a Aljawarneh
    Medicine.2024; 103(32): e39120.     CrossRef
  • ChatGPT efficacy for answering musculoskeletal anatomy questions: a study evaluating quality and consistency between raters and timepoints
    Nikolaos Mantzou, Vasileios Ediaroglou, Elena Drakonaki, Spyros A. Syggelos, Filippos F. Karageorgos, Trifon Totlis
    Surgical and Radiologic Anatomy.2024; 46(11): 1885.     CrossRef
  • Exploring the ability of ChatGPT to create quality patient education resources about kidney transplant
    Jacqueline Tian Tran, Ashley Burghall, Tom Blydt-Hansen, Allison Cammer, Aviva Goldberg, Lorraine Hamiwka, Corinne Johnson, Conner Kehler, Véronique Phan, Nicola Rosaasen, Michelle Ruhl, Julie Strong, Chia Wei Teoh, Jenny Wichart, Holly Mansell
    Patient Education and Counseling.2024; 129: 108400.     CrossRef
  • Evaluation of Generative Language Models in Personalizing Medical Information: Instrument Validation Study
    Aidin Spina, Saman Andalib, Daniel Flores, Rishi Vermani, Faris F Halaseh, Ariana M Nelson
    JMIR AI.2024; 3: e54371.     CrossRef
  • Practical Evaluation of ChatGPT Performance for Radiology Report Generation
    Mohsen Soleimani, Navisa Seyyedi, Seyed Mohammad Ayyoubzadeh, Sharareh Rostam Niakan Kalhori, Hamidreza Keshavarz
    Academic Radiology.2024; 31(12): 4823.     CrossRef
  • Evaluation of the Quality of ChatGPT’s Responses to Top 20 Questions about Robotic Hip and Knee Arthroplasty: Findings, Perspectives and Critical Remarks on Healthcare Education
    Michele Venosa, Vittorio Calvisi, Giulio Iademarco, Emilio Romanini, Enrico Ciminello, Simone Cerciello, Giandomenico Logroscino
    Prosthesis.2024; 6(4): 913.     CrossRef
  • Assessing the accuracy and reliability of ChatGPT’s medical responses about thyroid cancer
    Burcak Cavnar Helvaci, Sema Hepsen, Burcu Candemir, Ogulcan Boz, Halil Durantas, Mehdi Houssein, Erman Cakal
    International Journal of Medical Informatics.2024; 191: 105593.     CrossRef
  • ChatGPT as an Information Source for Patients with Migraines: A Qualitative Case Study
    Pascal Schütz, Sina Lob, Hiba Chahed, Lisa Dathe, Maren Löwer, Hannah Reiß, Alina Weigel, Joanna Albrecht, Pinar Tokgöz, Christoph Dockweiler
    Healthcare.2024; 12(16): 1594.     CrossRef
  • Response to Pingping Yang et al.
    Yongkang Lai, Yi Hu, Zhaoshen Li
    Helicobacter.2024;[Epub]     CrossRef
  • The applications and prospects of big data in perioperative anesthetic management
    Yiziting Zhu, Xiang Liu, Yujie Li, Bin Yi
    Anesthesiology and Perioperative Science.2024;[Epub]     CrossRef
  • Performance of ChatGPT 3.5 and 4 as a tool for patient support before and after DBS surgery for Parkinson’s disease
    Ana Lúcia Oliveira, Miguel Coelho, Leonor Correia Guedes, Maria Begoña Cattoni, Herculano Carvalho, Pedro Duarte-Batista
    Neurological Sciences.2024; 45(12): 5757.     CrossRef
  • NeuroGPT, evaluando ChatGPT: Diagnóstico y tratamiento de 72 pacientes neurológicos
    Alejandro Fernández Cabrera, Jesús García de Soto, Paula Santamaría Montero, Héctor Chinea García, Robustiano Pego Reigosa
    Neurología Argentina.2024; 16(3): 136.     CrossRef
  • The practical use of artificial intelligence in Transfusion Medicine and Apheresis
    Celine Anstey, David Ullman, Leon Su, Chuying Su, Chad Siniard, Sierra Simmons, Jesse Edberg, Lance A. Williams
    Transfusion and Apheresis Science.2024; 63(6): 104001.     CrossRef
  • Trustworthiness, Value, Danger, and Readability of ChatGPT-Generated Responses to Health Questions Related to Pulmonary Arterial Hypertension
    Murat Kerkütlüoğlu, Erhan Kaya, Rasim Gökmen
    Cureus.2024;[Epub]     CrossRef
  • Accuracy of Prospective Assessments of 4 Large Language Model Chatbot Responses to Patient Questions About Emergency Care: Experimental Comparative Study
    Jonathan Yi-Shin Yau, Soheil Saadat, Edmund Hsu, Linda Suk-Ling Murphy, Jennifer S Roh, Jeffrey Suchard, Antonio Tapia, Warren Wiechmann, Mark I Langdorf
    Journal of Medical Internet Research.2024; 26: e60291.     CrossRef
  • The rise of ChatGPT-4: exploring its efficacy as a decision support tool in esophageal surgery – a research letter
    Jianfeng Zhou, Yixin Liu, Yushang Yang, Pinhao Fang, Longqi Chen, Yong Yuan
    International Journal of Surgery.2024; 110(9): 5928.     CrossRef
  • Based on Medicine, The Now and Future of Large Language Models
    Ziqing Su, Guozhang Tang, Rui Huang, Yang Qiao, Zheng Zhang, Xingliang Dai
    Cellular and Molecular Bioengineering.2024; 17(4): 263.     CrossRef
  • ChatGPT vs. sleep disorder specialist responses to common sleep queries: Ratings by experts and laypeople
    Jiyoung Kim, Seo-Young Lee, Jee Hyun Kim, Dong-Hyeon Shin, Eun Hye Oh, Jin A Kim, Jae Wook Cho
    Sleep Health.2024; 10(6): 665.     CrossRef
  • eHealth Assistant AI Chatbot Using a Large Language Model to Provide Personalized Answers through Secure Decentralized Communication
    Iuliu Alexandru Pap, Stefan Oniga
    Sensors.2024; 24(18): 6140.     CrossRef
  • The Application of Large Language Models in Gastroenterology: A Review of the Literature
    Marcello Maida, Ciro Celsa, Louis H. S. Lau, Dario Ligresti, Stefano Baraldo, Daryl Ramai, Gabriele Di Maria, Marco Cannemi, Antonio Facciorusso, Calogero Cammà
    Cancers.2024; 16(19): 3328.     CrossRef
  • “Doctor ChatGPT, Can You Help Me?” The Patient’s Perspective: Cross-Sectional Study
    Jonas Armbruster, Florian Bussmann, Catharina Rothhaas, Nadine Titze, Paul Alfred Grützner, Holger Freischmidt
    Journal of Medical Internet Research.2024; 26: e58831.     CrossRef
  • Assessing the performance of large language models (LLMs) in answering medical questions regarding breast cancer in the Chinese context
    Ying Piao, Hongtao Chen, Shihai Wu, Xianming Li, Zihuang Li, Dong Yang
    DIGITAL HEALTH.2024;[Epub]     CrossRef
  • Applications and Concerns of ChatGPT and Other Conversational Large Language Models in Health Care: Systematic Review
    Leyao Wang, Zhiyu Wan, Congning Ni, Qingyuan Song, Yang Li, Ellen Clayton, Bradley Malin, Zhijun Yin
    Journal of Medical Internet Research.2024; 26: e22769.     CrossRef
  • Evaluating the comprehension and accuracy of ChatGPT's responses to diabetes-related questions in Urdu compared to English
    Seyreen Faisal, Tafiya Erum Kamran, Rimsha Khalid, Zaira Haider, Yusra Siddiqui, Nadia Saeed, Sunaina Imran, Romaan Faisal, Misbah Jabeen
    DIGITAL HEALTH.2024;[Epub]     CrossRef
  • Digesting Digital Health: A Study of Appropriateness and Readability of ChatGPT-Generated Gastroenterological Information
    Avi Toiv, Zachary Saleh, Angela Ishak, Eva Alsheik, Deepak Venkat, Neilanjan Nandi, Tobias E. Zuchelli
    Clinical and Translational Gastroenterology.2024; 15(11): e00765.     CrossRef
  • Application of large language model combined with retrieval enhanced generation technology in digestive endoscopic nursing
    Zhaoli Fu, Siyuan Fu, Yuan Huang, Wenfang He, Zhuodan Zhong, Yan Guo, Yanfeng Lin
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • The performance of large language model-powered chatbots compared to oncology physicians on colorectal cancer queries
    Shan Zhou, Xiao Luo, Chan Chen, Hong Jiang, Chun Yang, Guanghui Ran, Juan Yu, Chengliang Yin
    International Journal of Surgery.2024; 110(10): 6509.     CrossRef
  • Amplifying Chinese physicians’ emphasis on patients’ psychological states beyond urologic diagnoses with ChatGPT – a multicenter cross-sectional study
    Lei Peng, Rui Liang, Anguo Zhao, Ruonan Sun, Fulin Yi, Jianye Zhong, Rongkang Li, Shimao Zhu, Shaohua Zhang, Song Wu
    International Journal of Surgery.2024; 110(10): 6501.     CrossRef
  • Large Language Models and Empathy: Systematic Review
    Vera Sorin, Dana Brin, Yiftach Barash, Eli Konen, Alexander Charney, Girish Nadkarni, Eyal Klang
    Journal of Medical Internet Research.2024; 26: e52597.     CrossRef
  • Large language model use in clinical oncology
    Nicolas Carl, Franziska Schramm, Sarah Haggenmüller, Jakob Nikolas Kather, Martin J. Hetz, Christoph Wies, Maurice Stephan Michel, Frederik Wessels, Titus J. Brinker
    npj Precision Oncology.2024;[Epub]     CrossRef
  • Large language models in patient education: a scoping review of applications in medicine
    Serhat Aydin, Mert Karabacak, Victoria Vlachos, Konstantinos Margetis
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Battle of the bots: a comparative analysis of ChatGPT and bing AI for kidney stone-related questions
    Amber K. McMahon, Russell S. Terry, Willian E. Ito, Wilson R. Molina, Bristol B. Whiles
    World Journal of Urology.2024;[Epub]     CrossRef
  • Patients Facing Large Language Models in Oncology: A Narrative Review
    Charles Raynaud, David Wu, Jarod Levy, Matteo Marengo, Jean-Emmanuel Bibault
    JCO Clinical Cancer Informatics.2024;[Epub]     CrossRef
  • The Feasibility and Usability of an Artificial Intelligence-Enabled Conversational Agent in Virtual Reality for Patients with Alcohol-Associated Cirrhosis: A Multi-Methods Study
    Yee Hui Yeo, Allistair Clark, Muskaan Mehra, Itai Danovitch, Karen Osilla, Ju Dong Yang, Alexander Kuo, Hyun-Seok Kim, Aarshi Vipani, Yun Wang, Walid Ayoub, Hirsh Trivedi, Jamil S. Samaan, Tiffany Wu, Vijay H. Shah, Omer Liran, Brennan Spiegel
    Journal of Medical Extended Reality.2024; 1(1): 257.     CrossRef
  • Assessing the accuracy and readability of ChatGPT-4 and Gemini in answering oral cancer queries—an exploratory study
    Márcio Diniz-Freitas, Rosa María López-Pintor, Alan Roger Santos-Silva, Saman Warnakulasuriya, Pedro Diz-Dios
    Exploration of Digital Health Technologies.2024; : 334.     CrossRef
  • Assessing the accuracy and consistency of answers by ChatGPT to questions regarding carbon monoxide poisoning
    Jun Qiu, Youlian Zhou, Mostafa Ghafouri Moghaddam
    PLOS ONE.2024; 19(11): e0311937.     CrossRef
  • ChatGPT utilization within the building blocks of the healthcare services: A mixed-methods study
    Payam Shojaei, Mohsen Khosravi, Yalda Jafari, Amir Hossein Mahmoudi, Hadis Hassanipourmahani
    DIGITAL HEALTH.2024;[Epub]     CrossRef
  • Performance of ChatGPT and Bard on the medical licensing examinations varies across different cultures: a comparison study
    Yikai Chen, Xiujie Huang, Fangjie Yang, Haiming Lin, Haoyu Lin, Zhuoqun Zheng, Qifeng Liang, Jinhai Zhang, Xinxin Li
    BMC Medical Education.2024;[Epub]     CrossRef
  • Qualitative metrics from the biomedical literature for evaluating large language models in clinical decision-making: a narrative review
    Cindy N. Ho, Tiffany Tian, Alessandra T. Ayers, Rachel E. Aaron, Vidith Phillips, Risa M. Wolf, Nestoras Mathioudakis, Tinglong Dai, David C. Klonoff
    BMC Medical Informatics and Decision Making.2024;[Epub]     CrossRef
  • Exploring ChatGPT in clinical inquiry: a scoping review of characteristics, applications, challenges, and evaluation
    Shahabeddin Abhari, Yasna Afshari, Farhad Fatehi, Hosna Salmani, Ali Garavand, Dmytro Chumachenko, Somayyeh Zakerabasali, Plinio P. Morita
    Annals of Medicine & Surgery.2024; 86(12): 7094.     CrossRef
  • Comparing the Accuracy of Two Generated Large Language Models in Identifying Health-Related Rumors or Misconceptions and the Applicability in Health Science Popularization: Proof-of-Concept Study
    Yuan Luo, Yiqun Miao, Yuhan Zhao, Jiawei Li, Yuling Chen, Yuexue Yue, Ying Wu
    JMIR Formative Research.2024; 8: e63188.     CrossRef
  • ChatGPT: Transforming Healthcare with AI
    Fnu Neha, Deepshikha Bhati, Deepak Kumar Shukla, Md Amiruzzaman
    AI.2024; 5(4): 2618.     CrossRef
  • Assessing the role of AI in advancing construction sector industrial symbiosis research: a comparative study of leading digital assistants
    Olcay Genc
    Environment, Development and Sustainability.2024; 27(10): 23615.     CrossRef
  • Effectiveness of a large language model for clinical information retrieval regarding shoulder arthroplasty
    Jacob F. Oeding, Amy Z. Lu, Michael Mazzucco, Michael C. Fu, David M. Dines, Russell F. Warren, Lawrence V. Gulotta, Joshua S. Dines, Kyle N. Kunze
    Journal of Experimental Orthopaedics.2024;[Epub]     CrossRef
  • Comparing ChatGPT-3.5 and ChatGPT-4’s alignments with the German evidence-based S3 guideline for adult soft tissue sarcoma
    Cheng-Peng Li, Jens Jakob, Franka Menge, Christoph Reißfelder, Peter Hohenberger, Cui Yang
    iScience.2024; 27(12): 111493.     CrossRef
  • Applications and Future Prospects of Medical LLMs: A Survey Based on the M-KAT Conceptual Framework
    Ying Chang, Jian-ming Yin, Jian-min Li, Chang Liu, Ling-yong Cao, Shu-yuan Lin
    Journal of Medical Systems.2024;[Epub]     CrossRef
  • AI-Enhanced Healthcare: Integrating ChatGPT-4 in ePROs for Improved Oncology Care and Decision-Making: A Pilot Evaluation
    Chihying Liao, Chinnan Chu, Mingyu Lien, Yaochung Wu, Tihao Wang
    Current Oncology.2024; 32(1): 7.     CrossRef
  • Patient Support in Obstructive Sleep Apnoea by a Large Language Model – ChatGPT 4o on Answering Frequently Asked Questions on First Line Positive Airway Pressure and Second Line Hypoglossal Nerve Stimulation Therapy: A Pilot Study
    Johannes Pordzik, Katharina Bahr-Hamm, Tilman Huppertz, Haralampos Gouveris, Christopher Seifen, Andrew Blaikie, Christoph Matthias, Sebastian Kuhn, Jonas Eckrich, Christoph R Buhr
    Nature and Science of Sleep.2024; Volume 16: 2269.     CrossRef
  • CHATGPT DALAM PRAKTIK KEPERAWATAN: REVIEW LITERATUR LENGKAP
    Idauli Simbolon, Albinur Limbong
    JURNAL KEPERAWATAN TROPIS PAPUA.2024; 7(2): 85.     CrossRef
  • Quantitative evaluation of GPT-4’s performance on US and Chinese osteoarthritis treatment guideline interpretation and orthopaedic case consultation
    Juntan Li, Xiang Gao, Tianxu Dou, Yuyang Gao, Xu Li, Wannan Zhu
    BMJ Open.2024; 14(12): e082344.     CrossRef
  • In Patients Evaluated In The Emergency Room With Suspected Community-Acquired Pneumonia, ChatGPT 3.5 May Help Physicians With Assessments And Plans.
    Alejandro Chirino, Guillermo Cabral, Rodrigo Cavallazzi, Josue Prado, Thomas Chandler, Stephen Furmanek, William Mattingly, Timothy Wiemken, Ruth Carrico, Matthew Song, Kirsten Trudeau, Alex Glynn, Julio A. Ramirez
    Norton Healthcare Medical Journal.2024;[Epub]     CrossRef
  • Examining the Accuracy and Reproducibility of Responses to Nutrition Questions Related to Inflammatory Bowel Disease by Generative Pre-trained Transformer-4
    Jamil S Samaan, Kelly Issokson, Erin Feldman, Christina Fasulo, Nithya Rajeev, Wee Han Ng, Barbara Hollander, Yee Hui Yeo, Eric Vasiliauskas
    Crohn's & Colitis 360.2024;[Epub]     CrossRef
  • Global Healthcare Professionals’ Perceptions of Large Language Model Use In Practice (Preprint)
    Ecem Ozkan, Aysun Tekin, Mahmut Can Ozkan, Daniel Cabrera, Alexander Niven, Yue Dong
    JMIR Medical Education.2024;[Epub]     CrossRef
  • Comparison of Ophthalmologist and Large Language Model Chatbot Responses to Online Patient Eye Care Questions
    Isaac A. Bernstein, Youchen (Victor) Zhang, Devendra Govil, Iyad Majid, Robert T. Chang, Yang Sun, Ann Shue, Jonathan C. Chou, Emily Schehlein, Karen L. Christopher, Sylvia L. Groth, Cassie Ludwig, Sophia Y. Wang
    JAMA Network Open.2023; 6(8): e2330320.     CrossRef
  • Assessing the Accuracy of Responses by the Language Model ChatGPT to Questions Regarding Bariatric Surgery
    Jamil S. Samaan, Yee Hui Yeo, Nithya Rajeev, Lauren Hawley, Stuart Abel, Wee Han Ng, Nitin Srinivasan, Justin Park, Miguel Burch, Rabindra Watson, Omer Liran, Kamran Samakar
    Obesity Surgery.2023; 33(6): 1790.     CrossRef
  • Proof of Concept: Using ChatGPT to Teach Emergency Physicians How to Break Bad News
    Jeremy J Webb
    Cureus.2023;[Epub]     CrossRef
  • Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
    Harold Edward Bays, Angela Fitch, Suzanne Cuda, Sylvia Gonsahn-Bollie, Elario Rickey, Joan Hablutzel, Rachel Coy, Marisa Censani
    Obesity Pillars.2023; 6: 100065.     CrossRef
  • Can ChatGPT-4 Diagnose in Turkish: A Comparison of ChatGPT Responses to Health-related Questions in English and Turkish
    Mustafa Said Yıldız, Ayfer Alper
    SSRN Electronic Journal.2023;[Epub]     CrossRef
  • Evaluating the Utility of a Large Language Model in Answering Common Patients’ Gastrointestinal Health-Related Questions: Are We There Yet?
    Adi Lahat, Eyal Shachar, Benjamin Avidan, Benjamin Glicksberg, Eyal Klang
    Diagnostics.2023; 13(11): 1950.     CrossRef
  • Appropriateness and Readability of ChatGPT-4 generated Responses for Surgical Treatment of Retinal Diseases
    Bita Momenaei, Taku Wakabayashi, Abtin Shahlaee, Asad F. Durrani, Saagar A. Pandit, Kristine Wang, Hana A. Mansour, Robert M. Abishek, David Xu, Jayanth Sridhar, Yoshihiro Yonekawa, Ajay E. Kuriyan
    Ophthalmology Retina.2023;[Epub]     CrossRef
  • Reply to “Assessing the Accuracy of Responses by the Language Model ChatGPT to Questions Regarding Bariatric Surgery: a Critical Appraisal”
    Jamil S. Samaan, Yee Hui Yeo, Nithya Rajeev, Wee Han Ng, Nitin Srinivasan, Kamran Samakar
    Obesity Surgery.2023; 33(8): 2590.     CrossRef
  • Snakebite Advice and Counseling From Artificial Intelligence: An Acute Venomous Snakebite Consultation With ChatGPT
    Ibraheem Altamimi, Abdullah Altamimi, Abdullah S Alhumimidi, Abdulaziz Altamimi, Mohamad-Hani Temsah
    Cureus.2023;[Epub]     CrossRef
  • Generative Pre‐Trained Transformer 4 in healthcare: Challenges, opportunities, and recommendations
    Hassam Ali
    Medicine Advances.2023; 1(2): 163.     CrossRef
  • Utility of ChatGPT in Clinical Practice
    Jialin Liu, Changyu Wang, Siru Liu
    Journal of Medical Internet Research.2023; 25: e48568.     CrossRef
  • Role of chatbots on gastroenterology: Let's chat about the future
    Lianyong Li
    Gastroenterology & Endoscopy.2023;[Epub]     CrossRef
  • Chat Generative Pre-Trained Transformer (ChatGPT) usage in healthcare
    Yanhui Zhang, Haolong Pei, Shihan Zhen, Qian Li, Fengchao Liang
    Gastroenterology & Endoscopy.2023;[Epub]     CrossRef
  • Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
    Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng
    Clinical and Molecular Hepatology.2023; 29(3): 823.     CrossRef
  • Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
    Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng
    Clinical and Molecular Hepatology.2023; 29(3): 821.     CrossRef
  • ChatGPT and Artificial Intelligence in Transplantation Research: Is It Always Correct?
    Badi Rawashdeh, Joohyun Kim, Saif Aldeen AlRyalat, Raj Prasad, Matthew Cooper
    Cureus.2023;[Epub]     CrossRef
  • Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
    Hassam Ali
    Clinical and Molecular Hepatology.2023; 29(3): 813.     CrossRef
  • Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
    Amnuay Kleebayoon, Viroj Wiwanitkit
    Clinical and Molecular Hepatology.2023; 29(3): 815.     CrossRef
  • Exploring the potential of ChatGPT as a supplementary tool for providing orthopaedic information
    Janina Kaarre, Robert Feldt, Laura E. Keeling, Sahil Dadoo, Bálint Zsidai, Jonathan D. Hughes, Kristian Samuelsson, Volker Musahl
    Knee Surgery, Sports Traumatology, Arthroscopy.2023; 31(11): 5190.     CrossRef
  • A regulatory challenge for natural language processing (NLP)‐based tools such as ChatGPT to be legally used for healthcare decisions. Where are we now?
    Christian Baumgartner, Daniela Baumgartner
    Clinical and Translational Medicine.2023;[Epub]     CrossRef
  • Limitations of large language models in medical applications
    Jiawen Deng, Areeba Zubair, Ye-Jean Park
    Postgraduate Medical Journal.2023; 99(1178): 1298.     CrossRef
  • Can ChatGPT-4 Diagnose in Turkish: A Comparison of ChatGPT Responses to Health-Related Questions in English and Turkish
    Mustafa Said Yıldız, Ayfer Alper
    Journal of Consumer Health on the Internet.2023; 27(3): 294.     CrossRef
  • Applications of large language models in cancer care: current evidence and future perspectives
    Giovanni Maria Iannantuono, Dara Bracken-Clarke, Charalampos S. Floudas, Mario Roselli, James L. Gulley, Fatima Karzai
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Evaluating the performance of ChatGPT in answering questions related to urolithiasis
    Hakan Cakir, Ufuk Caglar, Oguzhan Yildiz, Arda Meric, Ali Ayranci, Faruk Ozgor
    International Urology and Nephrology.2023; 56(1): 17.     CrossRef
  • AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends
    He S Yang, Fei Wang, Matthew B Greenblatt, Sharon X Huang, Yi Zhang
    Clinical Chemistry.2023; 69(11): 1238.     CrossRef
  • Expanding horizons and navigating challenges for enhanced clinical workflows: ChatGPT in urology
    Ali Talyshinskii, Nithesh Naik, B. M Zeeshan Hameed, Ulanbek Zhanbyrbekuly, Gafur Khairli, Bakhman Guliev, Patrick Juilebø-Jones, Lazaros Tzelves, Bhaskar Kumar Somani
    Frontiers in Surgery.2023;[Epub]     CrossRef
  • Breaking barriers: can ChatGPT compete with a shoulder and elbow specialist in diagnosis and management?
    Mohammad Daher, Jonathan Koa, Peter Boufadel, Jaspal Singh, Mohamad Y. Fares, Joseph A. Abboud
    JSES International.2023; 7(6): 2534.     CrossRef
  • ChatGPT: promise and challenges for deployment in low- and middle-income countries
    Xiaofei Wang, Hayley M. Sanders, Yuchen Liu, Kennarey Seang, Bach Xuan Tran, Atanas G. Atanasov, Yue Qiu, Shenglan Tang, Josip Car, Ya Xing Wang, Tien Yin Wong, Yih-Chung Tham, Kevin C. Chung
    The Lancet Regional Health - Western Pacific.2023; 41: 100905.     CrossRef
  • ChatGPT’s ability to comprehend and answer cirrhosis related questions in Arabic
    Jamil S. Samaan, Yee Hui Yeo, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo, Walid S. Ayoub
    Arab Journal of Gastroenterology.2023; 24(3): 145.     CrossRef
  • Performance of artificial intelligence chatbot as a source of patient information on anti-rheumatic drug use in pregnancy
    Nurdan Oruçoğlu, Elif Altunel Kılınç
    Journal of Surgery and Medicine.2023; 7(10): 651.     CrossRef
  • Assessing ChatGPT’s Ability to Reply to Queries Regarding Colon Cancer Screening Based on Multisociety Guidelines
    S. Mukherjee, C. Durkin, A.M. PeBenito, N.D. Ferrante, I.C. Umana, M.L. Kochman
    Gastro Hep Advances.2023; 2(8): 1040.     CrossRef
  • A SWOT (Strengths, Weaknesses, Opportunities, and Threats) Analysis of ChatGPT in the Medical Literature: Concise Review
    Daniel Gödde, Sophia Nöhl, Carina Wolf, Yannick Rupert, Lukas Rimkus, Jan Ehlers, Frank Breuckmann, Timur Sellmann
    Journal of Medical Internet Research.2023; 25: e49368.     CrossRef
  • Overview of Chatbots with special emphasis on artificial intelligence-enabled ChatGPT in medical science
    Chiranjib Chakraborty, Soumen Pal, Manojit Bhattacharya, Snehasish Dash, Sang-Soo Lee
    Frontiers in Artificial Intelligence.2023;[Epub]     CrossRef
  • Assessing the Accuracy and Comprehensiveness of ChatGPT in Offering Clinical Guidance for Atopic Dermatitis and Acne Vulgaris
    Nehal Lakdawala, Leelakrishna Channa, Christian Gronbeck, Nikita Lakdawala, Gillian Weston, Brett Sloan, Hao Feng
    JMIR Dermatology.2023; 6: e50409.     CrossRef
  • ChatGPT and mycosis– a new weapon in the knowledge battlefield
    Yi Jin, Hua Liu, Bin Zhao, Weihua Pan
    BMC Infectious Diseases.2023;[Epub]     CrossRef
  • Potential Use of ChatGPT for Patient Information in Periodontology: A Descriptive Pilot Study
    Osman Babayiğit, Zeynep Tastan Eroglu, Dilek Ozkan Sen, Fatma Ucan Yarkac
    Cureus.2023;[Epub]     CrossRef
  • The Role of ChatGPT in the Advancement of Diagnosis, Management, and Prognosis of Cardiovascular and Cerebrovascular Disease
    David-Dimitris Chlorogiannis, Anastasios Apostolos, Anargyros Chlorogiannis, Leonidas Palaiodimos, George Giannakoulas, Sumant Pargaonkar, Sofia Xesfingi, Damianos G. Kokkinidis
    Healthcare.2023; 11(21): 2906.     CrossRef
  • AI (Artificial Intelligence) as an IA (Intelligent Assistant): ChatGPT for Surveillance Colonoscopy Questions
    Passisd Laoveeravat, Douglas A. Simonetto
    Gastro Hep Advances.2023; 2(8): 1138.     CrossRef
  • Editorial Commentary: Recognizing and Avoiding Medical Misinformation Across Digital Platforms: Smoke, Mirrors (and Streaming)
    Kyle N. Kunze
    Arthroscopy.2023; 39(12): 2454.     CrossRef
  • Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment
    Chaoyi Zhang, Jin Xu, Rong Tang, Jianhui Yang, Wei Wang, Xianjun Yu, Si Shi
    Journal of Hematology & Oncology.2023;[Epub]     CrossRef
  • Let's chat about cervical cancer: Assessing the accuracy of ChatGPT responses to cervical cancer questions
    Catherine E. Hermann, Jharna M. Patel, Leslie Boyd, Whitfield B. Growdon, Emeline Aviki, Marina Stasenko
    Gynecologic Oncology.2023; 179: 164.     CrossRef
  • Evaluating the Performance of Different Large Language Models on Health Consultation and Patient Education in Urolithiasis
    Haifeng Song, Yi Xia, Zhichao Luo, Hui Liu, Yan Song, Xue Zeng, Tianjie Li, Guangxin Zhong, Jianxing Li, Ming Chen, Guangyuan Zhang, Bo Xiao
    Journal of Medical Systems.2023;[Epub]     CrossRef
  • Generative Artificial Intelligence for Gastroenterology: Neither Friend nor Foe
    Frances Dang, Jason B. Samarasena
    American Journal of Gastroenterology.2023; 118(12): 2146.     CrossRef
  • Innovating Personalized Nephrology Care: Exploring the Potential Utilization of ChatGPT
    Jing Miao, Charat Thongprayoon, Supawadee Suppadungsuk, Oscar A. Garcia Valencia, Fawad Qureshi, Wisit Cheungpasitporn
    Journal of Personalized Medicine.2023; 13(12): 1681.     CrossRef
  • Evaluating the performance of ChatGPT in responding to questions about endoscopic procedures for patients
    Hassam Ali, Pratik Patel, Itegbemie Obaitan, Babu P. Mohan, Amir Humza Sohail, Lucia Smith-Martinez, Karrisa Lambert, Manesh Kumar Gangwani, Jeffrey J. Easler, Douglas G. Adler
    iGIE.2023; 2(4): 553.     CrossRef
  • Harnessing ChatGPT and GPT-4 for evaluating the rheumatology questions of the Spanish access exam to specialized medical training
    Alfredo Madrid-García, Zulema Rosales-Rosado, Dalifer Freites-Nuñez, Inés Pérez-Sancristóbal, Esperanza Pato-Cour, Chamaida Plasencia-Rodríguez, Luis Cabeza-Osorio, Lydia Abasolo-Alcázar, Leticia León-Mateos, Benjamín Fernández-Gutiérrez, Luis Rodríguez-R
    Scientific Reports.2023;[Epub]     CrossRef
  • Auxiliary use of ChatGPT in surgical diagnosis and treatment
    Kahei Au, Wah Yang
    International Journal of Surgery.2023; 109(12): 3940.     CrossRef
  • Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
    Hinpetch Daungsupawong, Viroj Wiwanitkit
    Clinical and Molecular Hepatology.2023; 30(1): 111.     CrossRef
  • Evaluating the performance of ChatGPT in answering questions related to benign prostate hyperplasia and prostate cancer
    Ufuk CAGLAR, Oguzhan YILDIZ, Arda MERIC, Ali AYRANCI, Resit YUSUF, Omer SARILAR, Faruk OZGOR
    Minerva Urology and Nephrology.2023;[Epub]     CrossRef
  • How Well Did ChatGPT Perform in Answering Questions on Different Topics in Gross Anatomy?
    Olena Bolgova, Inna Shypilova, Larysa Sankova, Volodymyr Mavrych
    European Journal of Medical and Health Sciences.2023; 5(6): 94.     CrossRef
  • 56,678 View
  • 1,820 Download
  • 497 Web of Science
  • Crossref

Reviews

Steatotic liver disease

Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg Semmler, Christian Datz, Michael Trauner
Clin Mol Hepatol 2023;29(Suppl):S244-S260.
Published online December 14, 2022
DOI: https://doi.org/10.3350/cmh.2022.0364
Nutrition and dietary interventions are a central component in the pathophysiology, but also a cornerstone in the management of patients with non-alcoholic fatty liver disease (NAFLD). Summarizing our rapidly advancing understanding of how our diet influences our metabolism and focusing on specific effects on the liver, we provide a comprehensive overview of dietary concepts to counteract the increasing burden of NAFLD. Specifically, we emphasize the importance of dietary calorie restriction independently of the macronutrient composition together with adherence to a Mediterranean diet low in added fructose and processed meat that seems to exert favorable effects beyond calorie restriction. Also, we discuss intermittent fasting as a type of diet specifically tailored to decrease liver fat content and increase ketogenesis, awaiting future study results in NAFLD. Finally, personalized dietary recommendations could be powerful tools to increase the effectiveness of dietary interventions in patients with NAFLD considering the genetic background and the microbiome, among others.

Citations

Citations to this article as recorded by  Crossref logo
  • Association between dietary amino acid intake and the risk of metabolic dysfunction-associated steatotic liver disease
    Ruoqi Zhou, Xinrong Zhang, Xinxin Liu, Rui Huang, Yuwei Wang, Dajing Xia, Xue Li, Yihua Wu, Yu Shi
    Journal of Advanced Research.2026; 80: 893.     CrossRef
  • Ultrafiltered mulberry leaf glutelin mitigates non-alcoholic fatty liver disease through modulation of lipid metabolism, inflammation, and serum metabolomics
    Mingxi Li, Hongyan Li, Jia Zou, Renqin Li, Haoqi Zhang, Wenhan Yang, Xiyang Wu, Chongzhen Sun
    Food & Function.2026; 17(2): 819.     CrossRef
  • Long-Term Fructose Intake Induces Moderate Liver Inflammation but Does not Overlap with the Detrimental Effects of the Ketogenic Diet on Hepatic Steatosis in Rats
    Júlia Galbiati de Souza, Glaucivan Gomes Gurgel, Fernanda Marques Rodrigues, Ribanna Aparecida Marques Braga, Rosana Aparecida Manólio Soares, Luís Alberto de Pádua Covas Lage, Iberê Cauduro Soares, Débora Levy, Nágila Raquel Teixeira Damasceno
    Inflammation.2026;[Epub]     CrossRef
  • Effects of Intermittent Calorie Restriction in Nondiabetic Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Han Ah Lee, Hyeyoung Moon, Yuri Kim, Jeong Kyong Lee, Hye Ah Lee, Hwi Young Kim
    Clinical Gastroenterology and Hepatology.2025; 23(1): 114.     CrossRef
  • Total choline intake, liver fibrosis and the progression of metabolic dysfunction-associated steatotic liver disease: Results from 2017 to 2020 NHANES
    Siraphat Taesuwan, Matina Kouvari, Andrew J. McKune, Demosthenes B. Panagiotakos, Julaluk Khemacheewakul, Noppol Leksawasdi, Pornchai Rachtanapun, Nenad Naumovski
    Maturitas.2025; 191: 108150.     CrossRef
  • Treating Metabolic Dysregulation and Senescence by Caloric Restriction: Killing Two Birds with One Stone?
    Lara Russo, Serena Babboni, Maria Grazia Andreassi, Jalil Daher, Paola Canale, Serena Del Turco, Giuseppina Basta
    Antioxidants.2025; 14(1): 99.     CrossRef
  • Monascus pilosus SWM-008 red mold rice and its components, monascinol and monascin, reduce obesity in a high-fat diet-induced rat model through synergistic modulation of gut microbiota and anti-lipogenesis
    Chin-Feng Liu, Hui-Tzu Chuang, Chia-Shu Wang, Ya-Wen Hsu, Tzu-Ming Pan, Chun-Lin Lee
    Food & Function.2025; 16(3): 966.     CrossRef
  • Dietary and lifestyle indices for hyperinsulinemia and odds of MAFLD in overweight and obese children and adolescents
    Ali Nikparast, Maryam Razavi, Parmis Mirzaei, Pooneh Dehghan, Mahdi Amani Farani, Golaleh Asghari
    Scientific Reports.2025;[Epub]     CrossRef
  • YouTube as a Source of Information for Dietary Guidance and Advisory Content in the Management of Non-Alcoholic Fatty Liver Disease
    Kagan Tur
    Healthcare.2025; 13(4): 351.     CrossRef
  • Sex-Specific Biochemical and Histopathological Effects of Chronic Meat-Based vs. Plant-Based Burger Consumption in a Rodent Model
    Cristina Filip, Ruxandra Ștefănescu, Bianca-Eugenia Ősz, Amalia Pușcaș, Corneliu Tanase, Adela Nechifor-Boilă, Amelia Tero-Vescan
    Foods.2025; 14(5): 888.     CrossRef
  • Non-alcoholic fatty liver disease: diet therapy and pharmacotherapy
    M. L. Maksimov, V. A. Dudareva, V. O. Vovk, V. I. Sklyarova, S. O. Ivashchenko, A. A. Shikaleva
    Terapevt (General Physician).2025; (3): 37.     CrossRef
  • Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
    Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
    Clinical and Molecular Hepatology.2025; 31(2): e186.     CrossRef
  • An umbrella review of the association between dietary factors and hepatocellular carcinoma risk
    Han Li, Qi-Hang Cao, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Han-Chao Wang, Rui Dong, Bao-Wen Tian, Cheng-Long Han, Zhao-Ru Dong, Long-Shan Yang, Xin-Cheng Mao, Yu-Chuan Yan, Dong-Xu Wang, Tao Li
    Food & Function.2025; 16(10): 3879.     CrossRef
  • ASS1 is a hub gene and possible therapeutic target for regulating metabolic dysfunction-associated steatotic liver disease modulated by a carbohydrate-restricted diet
    Shaojun Chen, Yanhua Bi, Lihua Zhang
    Molecular Diversity.2025; 29(4): 3717.     CrossRef
  • 2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation
    Chien-Yun Hsiang, Kuang-Ting Hsu, Hsin-Yi Lo, Yun-Jhu Hou, Tin-Yun Ho
    Nutrients.2025; 17(11): 1835.     CrossRef
  • Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review
    Erdenetsogt Dungubat, Kohei Fujikura, Masahiko Kuroda, Toshio Fukusato, Yoshihisa Takahashi
    Nutrients.2025; 17(13): 2211.     CrossRef
  • Amaranthus graecizans L. Mitigates Hyperlipidemia-Induced Nonalcoholic Fatty Liver Disease in Experimental Rats: Future Pharmaceuticals
    Nadiah S. Alzahrani, Bayan Aljahdali, Aeshah Alhosain, Abeer Abdullah Alasmari, Touseef Amna, Soha Mohamed Yousef
    Pharmaceuticals.2025; 18(8): 1196.     CrossRef
  • Higher Food Inflammation Index Is Linearly Associated With Higher Risk of MASLD: A Cross‐Sectional Study Based on the NHANES (1999–2020)
    Qingwan Yang, Xin Cai, Zhenghua Xiao
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • Comparative efficacy of different diet modalities on metabolic profiles and liver functions in metabolic dysfunction-associated fatty liver disease: a network meta-analysis
    Jiahui Zou, Fei Tian, Shuqing Cui, Jing Hou, Zhenhua Li, Yaochen Wei, Haozhe Cui, Yunpeng Li, Shuanghao Zhou, Zechao He, Xiangming Ma
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Ramadan fasting model exerts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats
    Abeer A. Alasmari, Abdulrahman S. Al-Khalifah, Ahmed S. BaHammam, Noura M. S. Alshiban, Ahmad T. Almnaizel, Hesham S. Alodah, Maha H. Alhussain
    Saudi Journal of Gastroenterology.2024; 30(1): 53.     CrossRef
  • Decrease in Leptin Expression in the Liver after Prolonged Every-Other-Day Feeding in C57Bl/6 Male Mice
    Katarzyna Piotrowska, Maciej Tarnowski, Patrycja Tomasiak, Michał Czerewaty, Katarzyna Zgutka, Andrzej Pawlik
    Physiologia.2024; 4(1): 100.     CrossRef
  • Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
    Qingxuan Deng, Ruyue Lv, Haoqi Zou, Tangbin Zou
    Egyptian Liver Journal.2024;[Epub]     CrossRef
  • Metformin: Beyond Type 2 Diabetes Mellitus
    Rahnuma Ahmad, Mainul Haque
    Cureus.2024;[Epub]     CrossRef
  • Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression
    Tomas Hrncir, Eva Trckova, Lucia Hrncirova
    Nutrients.2024; 16(21): 3722.     CrossRef
  • The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial
    Oliwia Gawlik-Kotelnicka, Jakub Rogalski, Karolina H. Czarnecka-Chrebelska, Jacek Burzyński, Paulina Jakubowska, Anna Skowrońska, Dominik Strzelecki
    Nutrients.2024; 16(23): 4024.     CrossRef
  • Prevalence of Liver Steatosis Among Workers in Ouagadougou and Associated Factors: A Cross‐Sectional Study
    Delphine Napon‐Zongo, Jeoffray Diendere, Armel M. Sanou, Abou Coulibaly, Abdoulaye Dera, Nina G. M. Ouattara, Augustin N. Zeba, Seni Kouanda
    JGH Open.2024;[Epub]     CrossRef
  • Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury
    Han Pan, Delei Song, Zhiyi Wang, Xin Yang, Pei Luo, Wei Li, Yan Li, Mengxue Gong, Chenhong Zhang
    Gut Microbes.2024;[Epub]     CrossRef
  • Non-alcoholic fatty liver disease in people with normal body weight
    S. V. Turkina, I. A. Tyshchenko, M. N. Titarenko
    Experimental and Clinical Gastroenterology.2024; (10): 36.     CrossRef
  • Optimal choice of diet and food for NAFLD
    G. V. Shavkuta, L. B. Lazebnik
    Experimental and Clinical Gastroenterology.2024; (10): 98.     CrossRef
  • Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Ling Pan, Jing Sui, Ying Xu, Qun Zhao
    Nutrients.2023; 15(10): 2394.     CrossRef
  • Synergistic Effect of Diet and Physical Activity on a NAFLD Cohort: Metabolomics Profile and Clinical Variable Evaluation
    Francesco Maria Calabrese, Giuseppe Celano, Caterina Bonfiglio, Angelo Campanella, Isabella Franco, Alessandro Annunziato, Gianluigi Giannelli, Alberto Ruben Osella, Maria De Angelis
    Nutrients.2023; 15(11): 2457.     CrossRef
  • Diet and non-alcoholic fatty liver disease, a short narrative review
    W.J. Kwanten
    Acta Gastro Enterologica Belgica.2023; 86(2): 306.     CrossRef
  • β-hydroxybutyrate: A crucial therapeutic target for diverse liver diseases
    Ke Li, Wen-hong Wang, Jia-bin Wu, Wei-hua Xiao
    Biomedicine & Pharmacotherapy.2023; 165: 115191.     CrossRef
  • Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
    Eileen L. Yoon, Dae Won Jun
    Clinical and Molecular Hepatology.2023; 29(4): 1050.     CrossRef
  • 18,164 View
  • 417 Download
  • 31 Web of Science
  • Crossref
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
Sung Hak Lee, Hyun-Jong Jang
Clin Mol Hepatol 2022;28(4):754-772.
Published online April 21, 2022
DOI: https://doi.org/10.3350/cmh.2021.0394
Molecular tests are necessary to stratify cancer patients for targeted therapy. However, high cost and technical barriers limit the application of these tests, hindering optimal treatment. Recently, deep learning (DL) has been applied to predict molecular test results from digitized images of tissue slides. Furthermore, treatment response and prognosis can be predicted from tissue slides using DL. In this review, we summarized DL-based studies regarding the prediction of genetic mutation, microsatellite instability, tumor mutational burden, molecular subtypes, gene expression, treatment response, and prognosis directly from hematoxylin- and eosin-stained tissue slides. Although performance needs to be improved, these studies clearly demonstrated the feasibility of DL-based prediction of key molecular features in cancer tissues. With the accumulation of data and technical advances, the performance of the DL system could be improved in the near future. Therefore, we expect that DL could provide cost- and time-effective alternative tools for patient stratification in the era of precision oncology.

Citations

Citations to this article as recorded by  Crossref logo
  • Deep learning-driven morphological analysis for assessing EMT state and drug sensitivity of single tumor cell
    Yiyao Yang, Yuxin Guo, Zhaoliang Wang, Yifan Weng, Tingting Hao, Qingqing Zhang, Shuihua Wang, Zhiyong Guo
    Biosensors and Bioelectronics.2026; 291: 118051.     CrossRef
  • Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases
    Huiting Che, Yidan Gao, Yonghu Xu, Hui Xu, Roland Eils, Mei Tian
    Signal Transduction and Targeted Therapy.2026;[Epub]     CrossRef
  • What if Every Patient’s Immune System Could be Guided by the World’s Most Powerful Computers to Fight Cancer? The UK Cancer Vaccines AI and Supercompute Project
    Michael E. Bryan, Joseph Conway, Gareth Bloomfield, Aska Matsunaga, David Narganes-Carlon, Ian Lowenhoff, Nick K. Davis, Justin K.H. Liu, Qamar Ghafoor, Michael Tilby, Michael Rowe, Isabella Watts, Sam Khan, Rene Roux, Kristen Dahlgren, Matt Hancock, Elis
    EMJ Innovation.2026;[Epub]     CrossRef
  • Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment
    Ina Bergheim, Jean Francois Cadranel, Jianguo Chen, Wenxing Ding, Robert Eferl, Carmen Garcia-Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann, Nahum Méndez-Sánchez, Camelia Mokhtari, Han Moshage, Chiara Raggi, Pavel Strnad, Oren
    Exploration of Digestive Diseases.2026;[Epub]     CrossRef
  • PH2ST: Prompt-guided hypergraph learning for spatial transcriptomics prediction in whole slide images
    Yi Niu, Jiashuai Liu, Yingkang Zhan, Jiangbo Shi, Di Zhang, Marika Reinius, Ines Machado, Mireia Crispin-Ortuzar, Jialun Wu, Chen Li, Zeyu Gao
    Medical Image Analysis.2026; 110: 104008.     CrossRef
  • Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features
    Xin Pan, Linwen Lv, Jiayi Wang, Haojun Liang, Jiaxin Wan, Junhui Zhang, Ruyu Yan, Juan Li, Ya-nan Chang, Xue Bai, Lu Zhang, Gengmei Xing, Kui Chen
    ACS Nano.2026; 20(14): 11409.     CrossRef
  • Advancements in artificial intelligence for cancer diagnosis and prognosis prediction: current applications and emerging opportunities
    Qingmiao Shi, Na Lou, Chen Xue
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
  • Explainable deep learning approaches and clinical insights for cancer biomarker identification
    Kshitij Srivastava, Ruby Srivastava
    Frontiers in Oncology.2026;[Epub]     CrossRef
  • Comparative Analysis of Deep Learning Approaches for Histopathology-Based Survival Prediction in Hepatocellular Carcinoma
    Sung Hak Lee, Kwangil Yim, Hyun-Jong Jang
    Cancers.2026; 18(10): 1534.     CrossRef
  • Deep Learning-Based Diagnosis of Epithelial Ovarian Cancer from Whole-Slide Histopathology Images
    Jihyun Chun, Haeyoun Kang, Heewon Chung, Jae-Myung Jang, Jangwon Seo, Taegyu Kim, Woohyun Lee, Cheolhong Park, Mingi Hong, Han-Mac Brian Kim, Messi H. J. Lee, Kyongseok Jang, Chan Kwon Jung, Sang Wun Kim, Ahwon Lee
    Diagnostics.2026; 16(10): 1470.     CrossRef
  • Profiling of extracellular vesicles from primary hepatocytes, organoids, and mash patients identifies cell injury-specific signatures
    Aleksandra Leszczynska, Benedikt Kaufmann, Hana Sung, Christian Stoess, Agustina Reca, Andrea Kim, Yeon-Kyung Choi, Chelsea Tran, Sung-Eun Kim, Davide Povero, Bruce Wolfe, Trevor Crafts, Akiko Eguchi, Ariel E. Feldstein
    Scientific Reports.2026;[Epub]     CrossRef
  • Deep learning-based image analysis in muscle histopathology using photo-realistic synthetic data
    Leonid Mill, Oliver Aust, Jochen A. Ackermann, Philipp Burger, Monica Pascual, Katrin Palumbo-Zerr, Gerhard Krönke, Stefan Uderhardt, Georg Schett, Christoph S. Clemen, Christian Holtzhausen, Samir Jabari, Rolf Schröder, Andreas Maier, Anika Grüneboom
    Communications Medicine.2025;[Epub]     CrossRef
  • Deep Learning–Powered Whole Slide Image Analysis in Cancer Pathology
    Chengrun Dang, Zhuang Qi, Tao Xu, Mingkai Gu, Jiajia Chen, Jie Wu, Yuxin Lin, Xin Qi
    Laboratory Investigation.2025; 105(7): 104186.     CrossRef
  • Recent advances and challenges in colorectal cancer: From molecular research to treatment
    Gao-Xiu Qi, Rui-Xia Zhao, Chen Gao, Zeng-Yan Ma, Shang Wang, Jing Xu
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Deep Learning Model-Based Architectures for Lung Tumor Mutation Profiling: A Systematic Review
    Samanta Ortuño-Miquel, Reyes Roca, Cristina Alenda, Francisco Aranda, Natividad Martínez-Banaclocha, Sandra Amador, David Gil
    Cancers.2025; 17(22): 3619.     CrossRef
  • AI-Driven Digital Pathology: Deep Learning and Multimodal Integration for Precision Oncology
    Hyun-Jong Jang, Sung Hak Lee
    International Journal of Molecular Sciences.2025; 27(1): 379.     CrossRef
  • Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy
    Abu Bakr Azam, Felicia Wee, Juha P. Väyrynen, Willa Wen-You Yim, Yue Zhen Xue, Bok Leong Chua, Jeffrey Chun Tatt Lim, Aditya Chidambaram Somasundaram, Daniel Shao Weng Tan, Angela Takano, Chun Yuen Chow, Li Yan Khor, Tony Kiat Hon Lim, Joe Yeong, Mai Chan
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
    Su Bin Lim, Hyo Jung Cho
    Clinical and Molecular Hepatology.2024; 30(4): 1009.     CrossRef
  • Integrating transcriptomic data and digital pathology for NRG-based prediction of prognosis and therapy response in gastric cancer
    Qiuyan Sun, Tan Li, Zheng Wei, Zhiyi Ye, Xu Zhao, Jingjing Jing
    Annals of Medicine.2024;[Epub]     CrossRef
  • Development and validation of a prognostic nomogram including inflammatory indicators for overall survival in hepatocellular carcinoma patients treated primarily with surgery or loco-regional therapy: A single-center retrospective study
    Xin Wang, Jing Xu, Zhenya Jia, Guoping Sun
    Medicine.2024; 103(50): e40889.     CrossRef
  • Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer
    Sung Hak Lee, Yujin Lee, Hyun‐Jong Jang
    International Journal of Cancer.2023; 152(2): 298.     CrossRef
  • A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
    Chih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, Cheng-Hung Chien, Li-Wei Chen, Rong-Nan Chien, Yang-Hsiang Lin, Chau-Ting Yeh
    International Journal of Molecular Sciences.2023; 24(2): 1681.     CrossRef
  • Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
    Violetta Rosiek, Ksenia Janas, Beata Kos-Kudła
    Biomedicines.2023; 11(3): 842.     CrossRef
  • Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
    Wang Yao, Ran Wei, Jia Jia, Wang Li, Mengxuan Zuo, Shuqing Zhuo, Ge Shi, Peihong Wu, Chao An
    Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
  • High-content microscopy reveals a morphological signature of bortezomib resistance
    Megan E Kelley, Adi Y Berman, David R Stirling, Beth A Cimini, Yu Han, Shantanu Singh, Anne E Carpenter, Tarun M Kapoor, Gregory P Way
    eLife.2023;[Epub]     CrossRef
  • Deep Learning-Based Classification of Uterine Cervical and Endometrial Cancer Subtypes from Whole-Slide Histopathology Images
    JaeYen Song, Soyoung Im, Sung Hak Lee, Hyun-Jong Jang
    Diagnostics.2022; 12(11): 2623.     CrossRef
  • Deep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical Review
    Heather D. Couture
    Journal of Personalized Medicine.2022; 12(12): 2022.     CrossRef
  • 11,455 View
  • 277 Download
  • 26 Web of Science
  • Crossref

Steatotic liver disease

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol 2020;26(4):461-475.
Published online September 10, 2020
DOI: https://doi.org/10.3350/cmh.2020.0136
Despite more than two decades of extensive research focusing on nonalcoholic fatty liver disease (NAFLD), no approved therapy for steatohepatitis—the severe histological form of the disease—presently exists. More importantly, new drugs and small molecules with diverse molecular targets on the pathways of hepatocyte injury, inflammation, and fibrosis cannot achieve the primary efficacy endpoints. Precision medicine can potentially overcome this issue, as it is founded on extensive knowledge of the druggable genome/proteome. Hence, this review summarizes significant trends and developments in precision medicine with a particular focus on new potential therapeutic discoveries modeled via systems biology approaches. In addition, we computed and simulated the potential utility of the NAFLD polygenic risk score, which could be conceptually very advantageous not only for early disease detection but also for implementing actionable measures. Incomplete knowledge of the druggable NAFLD genome severely impedes the drug discovery process and limits the likelihood of identifying robust and safe drug candidates. Thus, we close this article with some insights into emerging disciplines, such as chemical genetics, that may accelerate accurate identification of the druggable NAFLD genome/proteome.

Citations

Citations to this article as recorded by  Crossref logo
  • Personalized Medicine Approaches in Metabolically Associated Fatty Liver Disease: A Comprehensive Review
    Vaibhavkumar Patel, Archana Navale, Pratichi Singh
    SN Comprehensive Clinical Medicine.2026;[Epub]     CrossRef
  • Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
    Mary E. Rinella, Silvia Sookoian
    Nature Reviews Gastroenterology & Hepatology.2026; 23(6): 460.     CrossRef
  • Methotrexate-induced hepatotoxicity-mechanism, clinical cases and treatment approaches
    Anand Kumar Shah, Souvik Banerjee, Shareen Singh, Vetriselvan Subramaniyan, Thakur Gurjeet Singh
    Toxicological Research.2026;[Epub]     CrossRef
  • NAFLD No More: A Review of Current Guidelines in the Diagnosis and Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Kerim B. Kaylan, Sonali Paul
    Current Diabetes Reports.2025;[Epub]     CrossRef
  • The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions
    Carlos José Pirola, Tomas Fernández Gianotti, Silvia Sookoian
    Alimentary Pharmacology & Therapeutics.2025; 61(4): 614.     CrossRef
  • Statins as a Potential Treatment for Non-alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis
    Ali Mahmoudi, Alexandra E. Butler, Alexander N. Orekhov, Tannaz Jamialahmadi, Amirhossein Sahebkar
    Current Medicinal Chemistry.2025; 32(7): 1355.     CrossRef
  • Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease
    Andrea Caddeo, Stefano Romeo
    Clinical and Molecular Hepatology.2025; 31(Suppl): S76.     CrossRef
  • An association study of SERPINA1 gene polymorphisms with the risk of metabolic dysfunction-associated steatotic liver disease In an Iranian population: A preliminary case-control study
    Samira Abdollahi, Abbas Sahebghadam Lotfi, Ramin Saravani, Hamed Taheri
    Biochemistry and Biophysics Reports.2025; 42: 101974.     CrossRef
  • Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health
    Sharon Olabisoye Oladipupo, Emmanuel Henry Ezenabor, Adebola Busola Ojo, Akingbolabo Daniel Ogunlakin, Oluwafemi Adeleke Ojo
    Obesity Medicine.2025; 55: 100613.     CrossRef
  • Cell and gene therapeutic approaches in non-alcoholic fatty liver disease
    Mohadeseh Poudineh, Fatemeh Mohammadyari, Negin Parsamanesh, Tananz Jamialahmadi, Prashant Kesharwani, Amirhossein Sahebkar
    Gene.2025; 956: 149466.     CrossRef
  • Repurposing daclatasvir for MASLD Therapy—A promising step forward with challenges ahead
    Carlos Jose Pirola
    Journal of Lipid Research.2025; 66(8): 100857.     CrossRef
  • Development of a diagnostic model for MASLD and identification of daidzein as the potential drug using bioinformatics analysis and experiments
    Tao Wang, Hao Zhang, Kaixia Wang, Chunxue Liu, Nan Kong, Luocheng Zhou, Lihong Qu
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • NOVEL APPROACHES IN OBESITY TREATMENT: THE PROMISE OF GENE THERAPIES
    Karolina Błądzińska, Anna Opalińska, Cezary Lubas, Paula Folta, Kacper Szeląg, Joanna Kłosowska, Maciej Błądziński, Małgorzata Zach, Piotr Świerczek, Antoni Kujawski
    International Journal of Innovative Technologies in Social Science.2025;[Epub]     CrossRef
  • The sulfur microbial diet and risk of nonalcoholic fatty liver disease: a prospective gene–diet study from the UK Biobank
    Zhening Liu, Hangkai Huang, Jiaqi Ruan, Zejun Wang, Chengfu Xu
    The American Journal of Clinical Nutrition.2024; 119(2): 417.     CrossRef
  • Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets
    Ali Mahmoudi, Amin Jalili, Alexandra E. Butler, Seyed H. Aghaee-Bakhtiari, Tannaz Jamialahmadi, Amirhossein Sahebkar
    Journal of Clinical and Experimental Hepatology.2024; 14(4): 101365.     CrossRef
  • siRNA-mediated gene silencing for non-alcoholic fatty liver disease: A comprehensive review of molecular targets
    Ali Mahmoudi, Mehdi Rostami, Mohammad Mahdi Hajihasani, Vasily N. Sukhorukov, Prashant Kesharwani, Amirhossein Sahebkar
    European Polymer Journal.2024; 208: 112866.     CrossRef
  • PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children
    Kyung Jae Lee, Jin Soo Moon, Jin Gyu Lim, Homin Huh, Jeong Eun Ahn, Lia Kim, Nan Young Kim, Jae Sung Ko
    Journal of Gastroenterology and Hepatology.2024; 39(6): 1172.     CrossRef
  • Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease
    Ali Mahmoudi, Amin Jalili, Seyed Hamid Aghaee-Bakhtiari, Reza Kazemi Oskuee, Alexandra E. Butler, Manfredi Rizzo, Amirhossein Sahebkar
    Journal of Diabetes and its Complications.2024; 38(4): 108722.     CrossRef
  • Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
    Seyedeh Kosar Mahmoudi, Shadi Tarzemani, Taha Aghajanzadeh, Mohammadreza Kasravi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei
    European Journal of Medical Research.2024;[Epub]     CrossRef
  • Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation
    Sophie Reichelt, Uta Merle, Miriam Klauss, Christoph Kahlert, Georg Lurje, Arianeb Mehrabi, Zoltan Czigany
    Liver International.2024; 44(7): 1483.     CrossRef
  • A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD
    Nimish Thakral, Hailemichael Desalegn, Luis Antonio Diaz, Daniel Cabrera, Rohit Loomba, Marco Arrese, Juan Pablo Arab
    Seminars in Liver Disease.2024; 44(03): 273.     CrossRef
  • Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine
    Jake B. Hermanson, Samar A. Tolba, Evan A. Chrisler, Vanessa A. Leone
    The Journal of Nutritional Biochemistry.2024; 133: 109704.     CrossRef
  • Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update
    Silvia Sookoian, Yaron Rotman, Luca Valenti
    Clinical Gastroenterology and Hepatology.2024; 22(11): 2177.     CrossRef
  • Multiple Machine Learning Identifies Key Gene PHLDA1 Suppressing NAFLD Progression
    Zhenwei Yang, Zhiqin Chen, Jingchao Wang, Yizhang Li, Hailin Zhang, Yu Xiang, Yuwei Zhang, Zhaozhao Shao, Pei Wu, Ding Lu, Huajiang Lin, Zhaowei Tong, Jiang Liu, Quan Dong
    Inflammation.2024; 48(4): 1912.     CrossRef
  • Non-alcoholic fatty liver disease: the pathologist’s perspective
    Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
    Clinical and Molecular Hepatology.2023; 29(Suppl): S302.     CrossRef
  • Non-alcoholic fatty liver disease: Definition and subtypes
    Seul Ki Han, Soon Koo Baik, Moon Young Kim
    Clinical and Molecular Hepatology.2023; 29(Suppl): S5.     CrossRef
  • Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
    Silvia Sookoian, Carlos J. Pirola
    Clinical and Molecular Hepatology.2023; 29(Suppl): S184.     CrossRef
  • Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
    Georg Semmler, Christian Datz, Michael Trauner
    Clinical and Molecular Hepatology.2023; 29(Suppl): S244.     CrossRef
  • Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making
    Carlos J Pirola, Silvia Sookoian
    Expert Review of Gastroenterology & Hepatology.2023; 17(4): 317.     CrossRef
  • Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease
    Hua Ye, Mengxia Sun, Mingli Su, Dahua Chen, Huiwei Liu, Yanyan Ma, Wenjing Luo, Hong Li, Feng Xu
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Examining genetic associations with hepatic steatosis in Mexican-origin adults
    Mario Jesus Trejo, Kristin E. Morrill, Yann C. Klimentidis, David O. Garcia
    Annals of Hepatology.2023; 28(5): 101120.     CrossRef
  • Exploring the Role of Enhancer-Mediated Transcriptional Regulation in Precision Biology
    Xueyan Wang, Danli Liu, Jing Luo, Dashuai Kong, Yubo Zhang
    International Journal of Molecular Sciences.2023; 24(13): 10843.     CrossRef
  • Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke
    Shen Chen, Hongliang Xue, Rong Huang, Ke Chen, Haoyang Zhang, Xu Chen
    Diabetes & Metabolism.2023; 49(5): 101468.     CrossRef
  • Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD
    Charalambos Fotakis, Ioanna-Panagiota Kalafati, Athina I. Amanatidou, Vasiliki Andreou, Manolis Matzapetakis, Maria Kafyra, Iraklis Varlamis, Maria Zervou, George V. Dedoussis
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
    Chander K. Negi, Pavel Babica, Lola Bajard, Julie Bienertova-Vasku, Giovanni Tarantino
    Metabolism.2022; 126: 154925.     CrossRef
  • Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non‐alcoholic fatty liver disease in children
    Kyung Jae Lee, Jin Soo Moon, Nan Young Kim, Jae Sung Ko
    Pediatric Obesity.2022;[Epub]     CrossRef
  • Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications
    Carlos J. Pirola, Silvia Sookoian
    Current Opinion in Lipidology.2022; 33(2): 95.     CrossRef
  • Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis
    Ali Mahmoudi, Alexandra E. Butler, Muhammed Majeed, Maciej Banach, Amirhossein Sahebkar
    Nutrients.2022; 14(7): 1331.     CrossRef
  • TissueSpace: a web tool for rank-based transcriptome representation and its applications in molecular medicine
    Yiruo He, Wei Liu
    Genes & Genomics.2022; 44(7): 793.     CrossRef
  • Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy
    Pil Soo Sung, Dong Jun Park, Pu Reun Roh, Kyoung Do Mun, Sung Woo Cho, Gil Won Lee, Eun Sun Jung, Sung Hak Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Jonghwan Choi, Jaegyoon Ahn, Seung Kew Yoon
    Journal for ImmunoTherapy of Cancer.2022; 10(5): e003618.     CrossRef
  • Precision medicine in nonalcoholic fatty liver disease
    Amedeo Lonardo
    Journal of Gastroenterology and Hepatology.2022; 37(7): 1175.     CrossRef
  • Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update
    Nicholas W. S. Chew, Cheng Han Ng, Emily Truong, Mazen Noureddin, Kris V. Kowdley
    Seminars in Liver Disease.2022; 42(03): 379.     CrossRef
  • Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
    Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Tuo Lin, Xin M. Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi N
    Journal of Hepatology.2022; 77(6): 1482.     CrossRef
  • Personalized medicine in nonalcoholic fatty liver disease
    Carlos J. Pirola, Silvia Sookoian
    Clinical and Molecular Hepatology.2022; 28(4): 935.     CrossRef
  • Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
    Carlos Jose Pirola, Adrian Salatino, Silvia Sookoian
    World Journal of Gastroenterology.2021; 27(4): 305.     CrossRef
  • The lipidome in nonalcoholic fatty liver disease: actionable targets
    Carlos J. Pirola, Silvia Sookoian
    Journal of Lipid Research.2021; 62: 100073.     CrossRef
  • Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
    Marco Arrese, Juan P. Arab, Francisco Barrera, Benedikt Kaufmann, Luca Valenti, Ariel E. Feldstein
    Seminars in Liver Disease.2021; 41(04): 421.     CrossRef
  • From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
    Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee
    Clinical and Molecular Hepatology.2021; 27(2): 257.     CrossRef
  • Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
    Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Tracey G. Simon, Andrew T. Chan, Seong Gyu Hwang
    Scientific Reports.2021;[Epub]     CrossRef
  • Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
    Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
    Advances in Therapy.2021; 38(5): 2130.     CrossRef
  • Genetic risk scores and personalization of care in fatty liver disease
    Cristiana Bianco, Federica Tavaglione, Stefano Romeo, Luca Valenti
    Current Opinion in Pharmacology.2021; 61: 6.     CrossRef
  • NAFLD and Cardiometabolic Risk Factors: The Liver Fibrosis Trajectory Through the Lens of Biological Interactions
    Carlos J. Pirola, Silvia Sookoian
    Hepatology.2021; 73(2): 479.     CrossRef
  • Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis
    Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar, Bing Niu
    BioMed Research International.2021;[Epub]     CrossRef
  • Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
    Emir Muzurović, Brigita Smolović, Snežana Vujošević, Milan Petakov
    Current Vascular Pharmacology.2021; 19(5): 582.     CrossRef
  • 14,086 View
  • 302 Download
  • 51 Web of Science
  • Crossref

Viral hepatitis

Personalized treatment of hepatitis B
Anna S. Lok
Clin Mol Hepatol 2015;21(1):1-6.
Published online March 25, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.1.1

There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individual patient's clinical and social circumstances. Personalized management of hepatitis B can be applied based on prediction of the individual patient's risk of cirrhosis and hepatocellular carcinoma to guide the frequency and intensity of monitoring and urgency of treatment. It can also be applied to decisions regarding when to start treatment, which drug to use, and when to stop based on the individual patient's disease characteristics, preference, comorbidities and other mitigating circumstances.

Citations

Citations to this article as recorded by  Crossref logo
  • Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms
    Sheila F. Lumley, Chris Kent, Daisy Jennings, Haiting Chai, George Airey, Elizabeth Waddilove, Marion Delphin, Amy Trebes, Anna L. McNaughton, Khadija Said Mohammed, Sam A. J. Wilkinson, Yanxia Wu, George MacIntyre-Cockett, Beatrice Kimono, Kwizera Moses
    Scientific Reports.2025;[Epub]     CrossRef
  • Hepatitis B virus genotype distribution and mutation patterns: Insights and clinical implications for hepatitis B virus positive patients
    Manisha M Ratnaparkhi, Chanda R Vyawahare, Nageswari R Gandham
    World Journal of Experimental Medicine.2025;[Epub]     CrossRef
  • Genetic intersection of human leukocyte antigen-DP/DQ and hepatitis B virus-related liver disease: Insights from a multi-clustering study
    Jin-Wei Zhang
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Personalized medicine and nutrition in hepatology for preventing chronic liver disease in Mexico
    Arturo Panduro, Sonia Roman, Irene M. Mariscal-Martinez, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Claudia Ojeda-Granados, Omar Ramos-Lopez, Luis A. Torres-Reyes
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Position statement on the use of Tenofovir Alafenamide for the treatment of chronic Hepatitis B Virus infection in Africa
    Edward John Gane, Allah Kouadio Emile, Onyekwere Charles Asabamaka, Mongo Onkouo, Oudou Njoya, Okon Anassi Jean Baptiste, SOMDA Küssome Paulin, Sombie Arsene Roger, Tadesse T Mekonen
    Gastroenterology & Hepatology: Open Access.2021; 11(2): 57.     CrossRef
  • Progress and Challenges in the Use of a Liver-on-a-Chip for Hepatotropic Infectious Diseases
    Kasem Kulkeaw, Worakamol Pengsart
    Micromachines.2021; 12(7): 842.     CrossRef
  • An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia
    Michael R. Charlton, Altaf Alam, Akash Shukla, Bekhbold Dashtseren, Cosmas Rinaldi Adithya Lesmana, Davadoorj Duger, Diana Alcantara Payawal, Do Duy Cuong, Ganbolor Jargalsaikhan, Ian Homer Yee Cua, Jose Decena Sollano, Karam Romeo Singh, Kaushal Madan, K
    Journal of Gastroenterology.2020; 55(9): 811.     CrossRef
  • ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens
    Katherine E. Squires, Douglas L. Mayers, Gregory R. Bluemling, Alexander A. Kolykhalov, David B. Guthrie, Prabhakar Reddy, Debbie G. Mitchell, Manohar T. Saindane, Zachary M. Sticher, Vindhya Edpuganti, Abel De La Rosa
    Antimicrobial Agents and Chemotherapy.2020;[Epub]     CrossRef
  • Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM
    M. Aniji, N. Kavitha, S. Balamuralitharan
    Advances in Difference Equations.2020;[Epub]     CrossRef
  • The risk of hepatocellular carcinoma among chronic hepatitis B virus‐infected patients outside current treatment criteria
    Dong Hyun Sinn, Sung Eun Kim, Beom Kyung Kim, Ji Hoon Kim, Moon Seok Choi
    Journal of Viral Hepatitis.2019; 26(12): 1465.     CrossRef
  • Development and validation of an LC–MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies
    Baxter Hepburn Kachingwe, Yow-Shieng Uang, Tsurng-Juhn Huang, Li-Hsuan Wang, Shwu-Jiuan Lin
    Journal of Food and Drug Analysis.2018; 26(1): 401.     CrossRef
  • Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5′-UTR of TRIM22
    Keo-Heun Lim, Eun-Sook Park, Doo Hyun Kim, Kyung Cho Cho, Kwang Pyo Kim, Yong Kwang Park, Sung Hyun Ahn, Seung Hwa Park, Kee-Hwan Kim, Chang Wook Kim, Hong Seok Kang, Ah Ram Lee, Soree Park, Heewoo Sim, Juhee Won, Kieun Seok, Jueng Soo You, Jeong-Hoon Lee
    Gut.2018; 67(1): 166.     CrossRef
  • Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial
    H. J. Yim, I. H. Kim, S. J. Suh, Y. K. Jung, J. H. Kim, Y. S. Seo, J. E. Yeon, C. W. Kim, S. Y. Kwon, S. H. Park, M. S. Lee, S. H. Um, K. S. Byun
    Journal of Viral Hepatitis.2018; 25(11): 1321.     CrossRef
  • Durability of the virological response after lamivudine discontinuation in lamivudine‐resistant patients with a complete virological response after lamivudine and adefovir combination therapy
    Mi Na Kim, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang‐Hyub Han
    Journal of Medical Virology.2017; 89(1): 85.     CrossRef
  • Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
    Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Seung Up Kim
    Liver International.2017; 37(12): 1788.     CrossRef
  • Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang-Hyub Han
    Medicine.2016; 95(20): e3434.     CrossRef
  • Multidrug resistance protein 4 is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogues
    Wei Liu, Hongxuan Song, Qian Chen, Chunli Xu, Wenjing Zhang, Yutian Liu, Baoju Wang, Dongping Xu, Mengji Lu, Dongliang Yang, Xin Zheng
    Liver International.2016; 36(9): 1284.     CrossRef
  • Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
    Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
    Clinical Gastroenterology and Hepatology.2016; 14(11): 1647.     CrossRef
  • Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay
    Atsuya Yamashita, Yuusuke Fujimoto, Mayumi Tamaki, Andi Setiawan, Tomohisa Tanaka, Kaori Okuyama-Dobashi, Hirotake Kasai, Koichi Watashi, Takaji Wakita, Masaaki Toyama, Masanori Baba, Nicole De Voogd, Shinya Maekawa, Nobuyuki Enomoto, Junichi Tanaka, Kohj
    Marine Drugs.2015; 13(11): 6759.     CrossRef
  • Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics
    Hisashi Narimatsu
    Expert Review of Proteomics.2015; 12(6): 683.     CrossRef
  • Emerging Challenges in Managing Hepatitis B in HIV Patients
    Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José M. Peña, José V. Fernández-Montero, Laura Benítez, Isabella Esposito, Pablo Barreiro
    Current HIV/AIDS Reports.2015; 12(3): 344.     CrossRef
  • Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol
    Lei Wang
    World Journal of Gastroenterology.2015; 21(32): 9544.     CrossRef
  • 13,024 View
  • 149 Download
  • 21 Web of Science
  • Crossref

Case Report

Autoimmune liver disease

Co-development of autoimmune hepatitis and Sjögren's syndrome triggered by the administration of herbal medicines
Hyo Jeong Oh, Young Mi Mok, Moon Seong Baek, Ji Kyeong Lee, Bong Soo Seo, Tae Hyeon Kim, Keum Ha Choi, In Kyeom Hwang, Ji Eun Ra, Yong-Reol Oh, Yong Sung Kim, Eun Young Cho, Haak Cheoul Kim, Young Woo Sohn
Clin Mol Hepatol 2013;19(3):305-308.
Published online September 30, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.3.305

Autoimmune hepatitis (AIH) has been reported in association with Sjögren's syndrome (SS). Drug-induced AIH has been rarely reported. A rare case of the co-development of AIH and SS in a 53-year-old woman after the consumption of herbal medicines is described. After admission, the patient complained of dryness in her mouth, and she was subsequently diagnosed with SS, which had not been detected previously. The patient's bilirubin and aminotransferase levels initially decreased following conservative management; however, they later began to progressively increase. A diagnosis of AIH was made based on the scoring system proposed by the International Autoimmune Hepatitis Group. The patient was administered a combination of prednisolone and azathioprine, and the results of follow-up liver-function tests were found to be within the normal range. This is an unusual case of AIH and SS triggered simultaneously by the administration of herbal medicines.

Citations

Citations to this article as recorded by  Crossref logo
  • Clinical manifestations and immune correlations in anti-centromere antibody-positive and anti-SSA/Ro antibody-positive primary Sjögren’s syndrome: A retrospective analysis
    Songyan Zou, Riyi Zhang, Dongdong Yang, Xiaodong Li, Naixiang Huang, Fuyi Xie, Yinyu Mu, Alessandro Granito
    PLOS One.2025; 20(8): e0322845.     CrossRef
  • Epidemiology and surveillance of autoimmune hepatitis in Asia
    Tomohiro Katsumi, Yoshiyuki Ueno
    Liver International.2022; 42(9): 2015.     CrossRef
  • Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management
    Ben L. Da, Gil Ben-Yakov, David Kleiner, Christopher Koh
    Current Hepatology Reports.2018; 17(3): 235.     CrossRef
  • The clinical phenotypes of autoimmune hepatitis: A comprehensive review
    Qixia Wang, Fan Yang, Qi Miao, Edward L. Krawitt, M. Eric Gershwin, Xiong Ma
    Journal of Autoimmunity.2016; 66: 98.     CrossRef
  • Autoimmune hepatitis
    Farhad Sahebjam, John M. Vierling
    Frontiers of Medicine.2015; 9(2): 187.     CrossRef
  • Corticoid Therapy for Overlapping Syndromes in an HIV-positive Patient
    Yu Kaku, Shoko Kodama, Makiko Higuchi, Akihiro Nakamura, Masataka Nakamura, Tomoe Kaieda, Soichiro Takahama, Rumi Minami, Tomoya Miyamura, Eiichi Suematsu, Masahiro Yamamoto
    Internal Medicine.2015; 54(2): 223.     CrossRef
  • 16,729 View
  • 103 Download
  • Crossref

Review

Drug induced liver injury

Drug-induced liver injury: present and future
Ki Tae Suk, Dong Joon Kim
Korean J Hepatol 2012;18(3):249-257.
Published online September 25, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.3.249

Liver injury due to prescription and nonprescription medications is a growing medical, scientific, and public health problem. Worldwide, the estimated annual incidence rate of drug-induced liver injury (DILI) is 13.9-24.0 per 100,000 inhabitants. DILI is one of the leading causes of acute liver failure in the US. In Korea, the annual extrapolated incidence of cases hospitalized at university hospital is 12/100,000 persons/year. Most cases of DILI are the result of idiosyncratic metabolic responses or unexpected reactions to medication. There is marked geographic variation in relevant agents; antibiotics, anticonvulsants, and psychotropic drugs are the most common offending agents in the West, whereas in Asia, 'herbs' and 'health foods or dietary supplements' are more common. Different medical circumstances also cause discrepancy in definition and classification of DILI between West and Asia. In the concern of causality assessment, the application of the Roussel Uclaf Causality Assessment Method (RUCAM) scale frequently undercounts the cases caused by 'herbs' due to a lack of previous information and incompatible time criteria. Therefore, a more objective and reproducible tool that could be used for the diagnosis of DILI caused by 'herbs' is needed in Asia. In addition, a reporting system similar to the Drug-Induced Liver Injury Network (DILIN) in the US should be established as soon as possible in Asia.

Citations

Citations to this article as recorded by  Crossref logo
  • IC-MAC: A novel NIR fluorescent probe for monitoring the glutathione fluctuations in drug-induced liver injury
    Xiao Li, Chengqing Zhao, Zhiyuan Wang, Suntao Shi, Huiling Gao, Jiang Wu, Baoxin Zhang
    Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2026; 347: 126980.     CrossRef
  • DILIConsult: A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
    Alfred Zheng Ting Ho, Jeren Zheng Feng Law, Aiwen Wang, Daniel Yan Zheng Lim, Jasmine Chiat Ling Ong
    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2026;[Epub]     CrossRef
  • Double-barreled drug-induced liver injury and the unmasking of latent primary biliary cholangitis: A case of amoxicillin–clavulanate and warfarin interaction
    Omkolsoum Alhaddad, Maha Elsabaawy, Manar Samara, Karim Wagdy, Hala Elsisy, Nermine Ehsan, Hanaa Badran, Imam Waked
    Arab Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Association of Gene Polymorphisms and Serum Levels of ALAS1 with the Risk of Anti‐Tuberculosis Drug‐Induced Liver Injury
    Bing Han, Yiwen He, Min Zhu, Meiling Zhang, Lihuan Lu, Xiaoyan Xu, Xiaomin He, Honggang Yi, Shaowen Tang
    The Journal of Clinical Pharmacology.2025; 65(2): 197.     CrossRef
  • Merestinib inhibits cuproptosis by targeting NRF2 to alleviate acute liver injury
    Xianyu Luo, Maoyuan Linghu, Xinru Zhou, Yi Ru, Qian Huang, Didi Liu, Shurong Ji, Yinchu Ma, Yingli Luo, Yi Huang
    Free Radical Biology and Medicine.2025; 229: 68.     CrossRef
  • Drug-Induced Liver Injury Associated with Turmeric and Piperine: A Case and Review
    Atul Shrestha, Sarah Elliott, Joshua Haron Abasszade, Kyle Wu, Thomas Worland, Ian Simpson, Anouk Dev
    Case Reports in Gastroenterology.2025; 19(1): 96.     CrossRef
  • A Rare Case of Drug-Induced Liver Injury (DILI) From Topiramate
    Raymart Macasaet, FNU Payal, Karan Yagnik, Malay Rathod, David Aquino, Shilpan Shah
    Cureus.2025;[Epub]     CrossRef
  • Application of humanized mice to toxicology studies: properties of chimeric mice with humanized liver (PXB-mice) for hepatotoxicity
    Nazneen Sultana, Takeshi Izawa, Tomomi Kamei, Sho Fujiwara, Yuri Ito, Yuki Takami, Mitsuru Kuwamura
    Journal of Toxicologic Pathology.2025; 38(2): 183.     CrossRef
  • The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials
    Seyed Reza Taha, Andarz Fazlollahpour-Naghibi, Mahdieh Shariat Zadeh, Kimia Bagheri, Hamed Rahmani Youshanlouei, Reza Mosaddeghi-Heris, Seyyed Sina Hejazian, Amirreza Khalaji, Seyedeh Shaghayegh Alavi, Payam Fattahi, Saba Mehrtabar
    Current Pharmaceutical Biotechnology.2025; 26(7): 957.     CrossRef
  • iDILI-MT: identifying drug-induced liver injury compounds with a multi-head Transformer
    Wanrong Zheng, Fobao Lai
    PeerJ Computer Science.2025; 11: e2973.     CrossRef
  • Network toxicology and cell experiments reveal the mechanism of saikochromone A-induced hepatotoxicity
    Ying Zhang, Fengmei Li, Xiang Ji, Limin Shao, Qian Lyu, Qi Shao
    Toxicon.2025; 267: 108588.     CrossRef
  • Complementary and Alternative Medicine-Induced Combined Hepatorenal Toxicity: A Case Report
    George S Zacharia, Vedashree Ravte, Abhilasha Jyala, Elona Shehi
    Cureus.2025;[Epub]     CrossRef
  • A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI)
    Ajay Mili, Sumit Birangal, Krishnadas Nandakumar, Richard Lobo
    Molecular Diversity.2024; 28(3): 1709.     CrossRef
  • Predicting drug-induced liver injury using graph attention mechanism and molecular fingerprints
    Jifeng Wang, Li Zhang, Jianqiang Sun, Xin Yang, Wei Wu, Wei Chen, Qi Zhao
    Methods.2024; 221: 18.     CrossRef
  • InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism
    Soyeon Lee, Sunyong Yoo
    Journal of Cheminformatics.2024;[Epub]     CrossRef
  • Novel fast dissolving freeze dried sublingual baicalin tablets for enhanced hepatoprotective effect: in-vitro characterization, cell viability, and in-vivo evaluation
    Farida N. Abdelrazek, Rodayna A. Shalaby, Sally A. Fahim, Reham M. Essam, Shady E. Anis, Yasmin M. Attia, Nevine S. Abd El Malak
    Pharmaceutical Development and Technology.2024; 29(4): 371.     CrossRef
  • Peroxynitrite imaging in ferroptosis-mediated drug-induced liver injury with a near-infrared fluorescence probe
    Ruixin Liu, Haijing Jiang, Wenjie Yang, Zhijuan Zheng, Xiaoming Wang, Zhenhua Tian, Danyang Wang, Dongfang Kan, Dan Zhang, Zhixin Tang
    Analytica Chimica Acta.2024; 1309: 342673.     CrossRef
  • Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System
    Tigran Makunts, Ruben Abagyan
    Frontiers in Psychiatry.2024;[Epub]     CrossRef
  • Network Pharmacology Prediction and Experimental Validation of Ferulic Acid’s Protective Effects against Diclofenac‐Induced Liver Injury
    Fatema S. Alatawi, Awatif M. E. Omran, Mohsen S. Alatawi, Eman Rashad, Noha A. E. Yasin, Ahmed F. Soliman, Ignazio Restivo
    Journal of Food Biochemistry.2024;[Epub]     CrossRef
  • Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway
    Clàudia Gil-Pitarch, Marina Serrano-Maciá, Jorge Simon, Laura Mosca, Carolina Conter, Claudia M. Rejano-Gordillo, L. Estefanía Zapata-Pavas, Patricia Peña-Sanfélix, Mikel Azkargorta, Rubén Rodríguez-Agudo, Sofía Lachiondo-Ortega, Maria Mercado-Gómez, Tere
    Cell Reports Medicine.2024; 5(7): 101653.     CrossRef
  • Toward an Explainable Large Language Model for the Automatic Identification of the Drug-Induced Liver Injury Literature
    Chunwei Ma, Russell D. Wolfinger
    Chemical Research in Toxicology.2024; 37(9): 1524.     CrossRef
  • Cefepime-Induced Mixed Hepatocellular and Cholestatic Liver Injury: A Case Report
    Mahyar Toofantabrizi, Anuj Timshina, Raj M Dongol
    Cureus.2024;[Epub]     CrossRef
  • GRK2 mediates cisplatin-induced acute liver injury via the modulation of NOX4
    Qianlei Wang, Mengyang Li, Fei Duan, Kangjun Xiao, Qing Qing Sun, Jiang rui Cheng, Lei Ni, Zhengkun Xu, Bingfa Xu, Feng Xiao, Jiajie Kuai, Wei Wei, Chun Wang
    Cell Biology and Toxicology.2024;[Epub]     CrossRef
  • Prediction of bioactive compounds hepatotoxicity using in silico and in vitro analysis
    Kwanyong Choi, Soyeon Lee, Sunyong Yoo, Hyoung-Yun Han, Soo-yeon Park, Ji Yeon Kim
    Applied Biological Chemistry.2024;[Epub]     CrossRef
  • The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study
    Wenpei Liu, Nannan Wang, Jia Zhu, Meiling Zhang, Lihuan Lu, Hongqiu Pan, Xiaomin He, Honggang Yi, Shaowen Tang
    Therapies.2023; 78(3): 259.     CrossRef
  • Remdesivir-Associated Acute Liver Failure in a COVID-19 Patient: A Case Report and Literature Review
    Mohammad A Ahmed-Khan, George Matar, Kyle Coombes, Kayvon Moin, Bishoy M Joseph, Carly M Funk
    Cureus.2023;[Epub]     CrossRef
  • Molecular Mechanisms of Hepatotoxicity
    Antonietta Messina, Jean-Charles Duclos-Vallée
    International Journal of Molecular Sciences.2023; 24(4): 3791.     CrossRef
  • Drug-Induced Liver Injury in Tuberculosis: Mechanisms of Development and Diagnostic Methods
    D. S. Sukhanov, E. V. Timofeev, Yu. S. Alekseeva, D. Yu. Azovtsev
    Juvenis Scientia.2023; 9(1): 24.     CrossRef
  • Hepatoprotective Properties of Cuminum cyminum Seeds Powder as Post-Treatment for Acetaminophen-Induced Injury
    Afsaneh Mozaffarinia, Ali Gol, Aghileh Mohammadzadeh
    Journal of Advances in Medical and Biomedical Research.2023; 31(145): 170.     CrossRef
  • Protection of Liver Functions and Improvement of Kidney Functions by Twelve Weeks Consumption of Cuban Policosanol (Raydel®) with a Decrease of Glycated Hemoglobin and Blood Pressure from a Randomized, Placebo-Controlled, and Double-Blinded Study with Hea
    Kyung-Hyun Cho, Ji-Eun Kim, Tomohiro Komatsu, Yoshinari Uehara
    Life.2023; 13(6): 1319.     CrossRef
  • Genetic and Epigenetic Basis of Drug-Induced Liver Injury
    Snigdha Singh, P.V.S.N. Kiran Kumar, J. Pradeep Kumar, Sojit Tomo, Dharamveer Yadav, Praveen Sharma, Mahadev Rao, Mithu Banerjee
    Seminars in Liver Disease.2023; 43(02): 163.     CrossRef
  • Cell-Membrane-Localizing Fluorescence Probes for Aminopeptidase N
    Yun Jae Yang, Mingchong Dai, Kyo Han Ahn
    ACS Sensors.2023; 8(7): 2791.     CrossRef
  • Hepatic Effect of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside, the Signature Component of Traditional Chinese Medicine Heshouwu: Advances and Prospects
    Cheng-Yu Wang, Ying-Huan Hu, Zhen-Xiao Sun
    Current Drug Metabolism.2023; 24(1): 16.     CrossRef
  • Shifting perspectives in liver diseases after kidney transplantation
    Iva Kosuta, Ana Ostojic, Ana Vujaklija Brajkovic, Jaksa Babel, Bojana Simunov, Maja Sremac, Anna Mrzljak
    World Journal of Hepatology.2023; 15(7): 883.     CrossRef
  • Liquiritigenin Confers Liver Protection by Enhancing NRF2 Signaling through Both Canonical and Non-canonical Signaling Pathways
    Mengjiao Shi, Jian Zhang, Miaomiao Li, Yaping Zhao, Ying Guo, Jiayi Xu, Rongrong Liu, Zongfang Li, Dongmei Ren, Pengfei Liu
    Journal of Medicinal Chemistry.2023; 66(16): 11324.     CrossRef
  • Cyclopia intermedia E. Mey protects against ROS-induced liver injury in HepG2/C3A cells.
    Shanika Reddy, Khaled Rashed, Jeanine L. Marnewick, Fanie G. Rautenbach, Trevor Koekemoer, Maryna van de Venter
    South African Journal of Botany.2023; 162: 794.     CrossRef
  • MAGPIX and FLEXMAP 3D Luminex platforms for direct detection of miR-122-5p through dynamic chemical labelling
    Antonio Marín-Romero, Valerie Regele, Dajana Kolanovic, Manuela Hofner, Juan José Díaz-Mochón, Christa Nöhammer, Salvatore Pernagallo
    The Analyst.2023; 148(22): 5658.     CrossRef
  • A Case Report of UDCA and Injinho-tang Co-administration for Liver Damage Caused by Rifampin
    Seyeon Lee, Hansung Yoon, Kibeom Ku, Mariah Kim, Irang Nam, Minhwa Kim, Changwoo Han
    The Journal of Internal Korean Medicine.2023; 44(5): 1011.     CrossRef
  • Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen
    Brandon J. Sonn, Kennon J. Heard, Susan M. Heard, Angelo D’Alessandro, Kate M. Reynolds, Richard C. Dart, Barry H. Rumack, Andrew A. Monte
    Clinical Toxicology.2022; 60(2): 221.     CrossRef
  • Evolution of 3D bioprinting-from the perspectives of bioprinting companies
    Dongxu Ke, Changmei Niu, Xi Yang
    Bioprinting.2022; 25: e00193.     CrossRef
  • Exploring Indicators of Hepatotoxicity-Related Post-Marketing Regulatory Actions: A Retrospective Analysis of Drug Approval Data
    Salwa M. Almomen, Mona A. Almaghrabi, Saja M. Alhabardi, Adel A. Alrwisan
    Saudi Journal of Health Systems Research.2022; 2(1): 27.     CrossRef
  • Incidence of Elevated Aminotransferases With or Without Bilirubin Elevation During Treatment With Immune Checkpoint Inhibitors: A Retrospective Study of Patients From Community Oncology Clinics in the United States
    Christopher Kim, Shao Zu, Hosein Kouros-Mehr, Sophia Khaldoyanidi
    Cureus.2022;[Epub]     CrossRef
  • The role of the genetic variant FECH rs11660001 in the occurrence of anti‐tuberculosis drug‐induced liver injury
    Meiling Zhang, Jia Zhu, Nannan Wang, Wenpei Liu, Lihuan Lu, Hongqiu Pan, Xiaomin He, Honggang Yi, Shaowen Tang
    Journal of Clinical Pharmacy and Therapeutics.2022; 47(8): 1276.     CrossRef
  • Rational design of dual ratiometric photoacoustic and fluorescent probe for reliable imaging and quantitative detection of endogenous CO during drug-induced liver injury and repair
    Li Liu, Jingyuan Xu, Shuping Zhang, Hui Chen, Liping Wang, Xing-can Shen, Hua Chen
    Sensors and Actuators B: Chemical.2022; 367: 132171.     CrossRef
  • A Comprehensive Review of Experimental Animal Models of Hepatopathy.
    Ramesh Kumar Gupta, Sachin Chaudhary, Abdel-Nasser El-Shorbagi, Udaivir Singh Sara, Prashant Shukla, Sudhansu Ranjan Swain, Jagannath Sahoo, P. N. Murthy P. N. Murthy
    Biomedical and Pharmacology Journal.2022; 15(2): 563.     CrossRef
  • COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases—A Concise Review
    Jorge Aquino-Matus, Misael Uribe, Norberto Chavez-Tapia
    Tropical Medicine and Infectious Disease.2022; 7(8): 187.     CrossRef
  • Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis
    Nannan Wang, Xinyu Chen, Zhuolu Hao, Jia Guo, Xuwen Wang, Xijing Zhu, Honggang Yi, Qingliang Wang, Shaowen Tang, Maoshui Wang
    Journal of Tropical Medicine.2022; 2022: 1.     CrossRef
  • Safety data and withdrawal of hepatotoxic drugs
    Samy Babai, Laurent Auclert, Hervé Le-Louët
    Therapies.2021; 76(6): 715.     CrossRef
  • An ensemble learning approach for modeling the systems biology of drug-induced injury
    Joaquim Aguirre-Plans, Janet Piñero, Terezinha Souza, Giulia Callegaro, Steven J. Kunnen, Ferran Sanz, Narcis Fernandez-Fuentes, Laura I. Furlong, Emre Guney, Baldo Oliva
    Biology Direct.2021;[Epub]     CrossRef
  • Turmeric-Induced Hepatotoxicity: Report of 2 Cases
    Aalam Sohal, Dhuha Alhankawi, Sunny Sandhu, JayaKrishna Chintanaboina
    International Medical Case Reports Journal.2021; Volume 14: 849.     CrossRef
  • Herb-induced liver injury: Systematic review and meta-analysis
    Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Ajacio Bandeira de Mello Brandão, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera
    World Journal of Clinical Cases.2021; 9(20): 5490.     CrossRef
  • Hepatotoxicity Secondary to Levofloxacin Use
    Ladan Panahi, Salim Surani Surani, George Udeani, Niraj P Patel, Jacob Sellers
    Cureus.2021;[Epub]     CrossRef
  • Comparative hepatoprotective activity of detoxified roots of Plumbago zeylanica L. and Plumbago rosea L. in Wistar rats
    A.R. Akhilraj, Sudhakar Bhat, B. Priyalatha, K.S. Vimala
    Journal of Ayurveda and Integrative Medicine.2021; 12(3): 452.     CrossRef
  • Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records
    Hayato Akimoto, Takuya Nagashima, Kimino Minagawa, Takashi Hayakawa, Yasuo Takahashi, Satoshi Asai
    Biological and Pharmaceutical Bulletin.2021; 44(10): 1514.     CrossRef
  • Food and Nutrition in the Pathogenesis of Liver Damage
    Andrea Mega, Luca Marzi, Michael Kob, Andrea Piccin, Annarosa Floreani
    Nutrients.2021; 13(4): 1326.     CrossRef
  • Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach
    Mohamed Abd Elaziz, Yasmine S. Moemen, Aboul Ella Hassanien, Shengwu Xiong
    Applied Soft Computing.2020; 97: 105509.     CrossRef
  • Drug-Induced Liver Injury Resources and Reporting for the Clinician
    Marisa Isaacson, Michael Babich
    Clinics in Liver Disease.2020; 24(1): 131.     CrossRef
  • Immune dysregulation increases the incidence of delayed‐type drug hypersensitivity reactions
    Dean J. Naisbitt, Anna Olsson‐Brown, Andrew Gibson, Xiaoli Meng, Monday O. Ogese, Arun Tailor, Paul Thomson
    Allergy.2020; 75(4): 781.     CrossRef
  • Drug-Induced Liver Injury in Critically Ill Children Taking Antiepileptic Drugs: A Retrospective Study
    Kannan Sridharan, Amal Al Daylami, Reema Ajjawi, Husain A.M. Al Ajooz
    Current Therapeutic Research.2020; 92: 100580.     CrossRef
  • Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt
    Omkolthoum Alhaddad, Maha Elsabaawy, Eman Abdelsameea, Ayat Abdallah, Ahmed Shabaan, Nermine Ehsan, Ahmed Elrefaey, Dalia Elsabaawy, Mohsen Salama
    Scientific Reports.2020;[Epub]     CrossRef
  • Protective effect of lyophilized sapodilla (Manilkara zapota) fruit extract against CCl4-induced liver damage in rats
    Sara T. Alrashood, Abdulrahman K. Al-Asmari, Abdullah K. Alotaibi, Rajamohamed A. Manthiri, Syed Rafatullah, Rana M. Hasanato, Haseeb A. Khan, Khalid E. Ibrahim, Adil F. Wali
    Saudi Journal of Biological Sciences.2020; 27(9): 2373.     CrossRef
  • Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010–2019)
    Lixin Ke, Cuncun Lu, Rui Shen, Tingting Lu, Bin Ma, Yunpeng Hua
    Frontiers in Pharmacology.2020;[Epub]     CrossRef
  • Dendrobium nobile Lindl. alkaloids-mediated protection against CCl4-induced liver mitochondrial oxidative damage is dependent on the activation of Nrf2 signaling pathway
    Jinxin Zhou, Ya Zhang, Shiyue Li, Qian Zhou, Yuanfu Lu, Jingshan Shi, Jie Liu, Qin Wu, Shaoyu Zhou
    Biomedicine & Pharmacotherapy.2020; 129: 110351.     CrossRef
  • Ameliorative effect of extract of Tecoma stans (L.) Juss. ex kunth leaves against CCl4 - and acetaminophen—induced liver damage in rats
    C. Larbie, B. O. Emikpe, S. A. Akpor, E. Adams, C. O. Adjei, A. A. Oyagbemi, T. A. Jarikre
    Advances in Traditional Medicine.2020; 20(4): 555.     CrossRef
  • Paper-Based Cell Culture: Paving the Pathway for Liver Tissue Model Development on a Cellulose Paper Chip
    Tarun Agarwal, Mimi R. Borrelli, Pooyan Makvandi, Milad Ashrafizadeh, Tapas Kumar Maiti
    ACS Applied Bio Materials.2020; 3(7): 3956.     CrossRef
  • Amplification-free profiling of microRNA-122 biomarker in DILI patient serums, using the Luminex MAGPIX system
    Antonio Marín-Romero, Mavys Tabraue-Chávez, James W. Dear, Rosario M. Sánchez-Martín, Hugh Ilyine, Juan J. Guardia-Monteagudo, Mario A. Fara, Francisco J. López-Delgado, Juan J. Díaz-Mochón, Salvatore Pernagallo
    Talanta.2020; : 121265.     CrossRef
  • Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury: A Cohort Study
    Jiaxi Zhao, Joseph E. Blais, Celine S. L. Chui, In-Hye Suh, Esa Y. H. Chen, Wai-Kay Seto, Michael T. Mok, Vincent K. C. Yan, Wallis C.Y. Lau, Ian C. K. Wong, Esther W. Chan
    American Journal of Gastroenterology.2020; 115(9): 1513.     CrossRef
  • Untargeted Metabolomics Reveals Anaerobic Glycolysis as a Novel Target of the Hepatotoxic Antidepressant Nefazodone
    Evelin Krajnc, Michele Visentin, Zhibo Gai, Bruno Stieger, Sophia L. Samodelov, Stephanie Häusler, Gerd A. Kullak-Ublick
    The Journal of Pharmacology and Experimental Therapeutics.2020; 375(2): 239.     CrossRef
  • Hepatic adverse drug reactions in Malaysia: An 18‐year review of the national centralized reporting system
    Fei Yee Lee, Hin‐Seng Wong, Huan‐Keat Chan, Norleen Mohamed Ali, Muhammad Radzi Abu Hassan, Haniza Omar, Noor Aliza Abdul Mutalib
    Pharmacoepidemiology and Drug Safety.2020; 29(12): 1669.     CrossRef
  • The changing epidemiology of liver diseases in the Asia–Pacific region
    Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng
    Nature Reviews Gastroenterology & Hepatology.2019; 16(1): 57.     CrossRef
  • Optimized protocol for induction of cytochrome P450 enzymes 1A2 and 3A4 in human primary-like hepatocyte cell strain HepaFH3 to study in vitro toxicology
    Sarah Kammerer, Jan-Heiner Küpper, J.-W. Park, A. Krüger, F. Jung
    Clinical Hemorheology and Microcirculation.2019; 70(4): 563.     CrossRef
  • Diagnosing Drug-Induced Liver Injury by Multispectral Optoacoustic Tomography and Fluorescence Imaging Using a Leucine-Aminopeptidase-Activated Probe
    Yong Huang, Yu Qi, Chenyue Zhan, Fang Zeng, Shuizhu Wu
    Analytical Chemistry.2019; 91(13): 8085.     CrossRef
  • A Case Report of Efficacy of Saenggan-tang on a Patient with Drug Induced Liver Injury
    So-yeon An, Seong-hee Joo, So-yeong Hur, Eun-gyeong Jang, Jang-hoon Lee, Young-chul Kim
    The Journal of Internal Korean Medicine.2019; 40(2): 201.     CrossRef
  • Liver X Receptor α–Induced Cannabinoid Receptor 2 Inhibits Ubiquitin‐Specific Peptidase 4 Through miR‐27b, Protecting Hepatocytes From TGF‐β
    Hong Min Wu, Tae Hyun Kim, Ayoung Kim, Ja Hyun Koo, Min Sung Joo, Sang Geon Kim
    Hepatology Communications.2019; 3(10): 1373.     CrossRef
  • MRI-based preclinical discovery of DILI: A lesson from paracetamol-induced hepatotoxicity
    Ireneusz P. Grudzinski, Monika Ruzycka, Andrzej Cieszanowski, Wojciech Szeszkowski, Iwona Badurek, Anna Malkowska, Magdalena Bamburowicz-Klimkowska
    Regulatory Toxicology and Pharmacology.2019; 108: 104478.     CrossRef
  • Hepatic macrophages in drug-induced liver injury
    Zhao Shan, Cynthia Ju
    Liver Research.2019; 3(3-4): 170.     CrossRef
  • Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events
    Elena Genova, Federica Cavion, Marianna Lucafò, Luigina De Leo, Marco Pelin, Gabriele Stocco, Giuliana Decorti
    World Journal of Stem Cells.2019; 11(12): 1020.     CrossRef
  • Prevalence and Risk Factors for Drug-Induced Liver Injury Among Patients With Rheumatic Diseases Treated With Biological Therapy: A Single-Center Experience
    K. BRAZDILOVA, T. KOLLER, Z. KILLINGER, J. PAYER
    Physiological Research.2019; : S157.     CrossRef
  • Endogenous Antioxidant and LOX-Mediated Systems Contribute to the Hepatoprotective Activity of Aqueous Partition of Methanol Extract of Muntingia calabura L. Leaves against Paracetamol Intoxication
    Zainul Amiruddin Zakaria, Nur Diyana Mahmood, Siti Syariah Mamat, Nurliana Nasir, Maizatul Hasyima Omar
    Frontiers in Pharmacology.2018;[Epub]     CrossRef
  • Herb-Induced Liver Injuries in Developing Nations: An Update
    Cecilia Nwadiuto Amadi, Orish Ebere Orisakwe
    Toxics.2018; 6(2): 24.     CrossRef
  • Botanicals and Hepatotoxicity
    Marina M. Roytman, Peter Poerzgen, Victor Navarro
    Clinical Pharmacology & Therapeutics.2018; 104(3): 458.     CrossRef
  • Application of Dendrimers for the Treatment of Infectious Diseases
    Zandile Mhlwatika, Blessing Atim Aderibigbe
    Molecules.2018; 23(9): 2205.     CrossRef
  • Human hepatocyte systems for in vitro toxicology analysis
    Sarah Kammerer, Jan-Heiner Küpper
    Journal of Cellular Biotechnology.2018; 3(2): 85.     CrossRef
  • Drug and herbal hepatotoxicity: an overview of clinical classifications
    Mária Szántová, Jozef Sedlačko, Martina Jakabovičová
    Vnitřní lékařství.2018; 64(4): 384.     CrossRef
  • A modified multiparametric assay using HepaRG cells for predicting the degree of drug‐induced liver injury risk
    Takafumi Tomida, Hayao Okamura, Tsuyoshi Yokoi, Yoshihiro Konno
    Journal of Applied Toxicology.2017; 37(3): 382.     CrossRef
  • In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties
    Robert W. Yucha, Kan He, Qin Shi, Lining Cai, Yukie Nakashita, Cindy Q. Xia, Mingxiang Liao
    Toxicological Sciences.2017; 157(2): 487.     CrossRef
  • Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Rolf Teschke, Johannes Schulze, Axel Eickhoff, Gaby Danan
    International Journal of Molecular Sciences.2017; 18(4): 803.     CrossRef
  • Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial
    Masoumeh Asgarshirazi, Mamak Shariat, Mahdi Sheikh
    Hepatobiliary & Pancreatic Diseases International.2017; 16(3): 296.     CrossRef
  • In vitro and in vivo study of the application of volvox spheres to co-culture vehicles in liver tissue engineering
    Siou Han Chang, Han Hsiang Huang, Pei Leun Kang, Yu Chian Wu, Ming-Huang Chang, Shyh Ming Kuo
    Acta Biomaterialia.2017; 63: 261.     CrossRef
  • Liver injury after aluminum potassium sulfate and tannic acid treatment of hemorrhoids
    Kenichi Yoshikawa, Reimi Kawashima, Yuki Hirose, Keiko Shibata, Takafumi Akasu, Noriko Hagiwara, Takeharu Yokota, Nami Imai, Akira Iwaku, Go Kobayashi, Hirohiko Kobayashi, Akiyoshi Kinoshita, Nao Fushiya, Hiroyuki Kijima, Kazuhiko Koike, Masayuki Saruta
    World Journal of Gastroenterology.2017; 23(27): 5034.     CrossRef
  • Artificial liver support in pigs with acetaminophen-induced acute liver failure
    Guo-Lin He, Lei Feng, Lei Cai, Chen-Jie Zhou, Yuan Cheng, Ze-Sheng Jiang, Ming-Xin Pan, Yi Gao
    World Journal of Gastroenterology.2017; 23(18): 3262.     CrossRef
  • Successful salvage treatment of acute graft-versus-host disease after liver transplantation by withdrawal of immunosuppression: a case report
    Wei Qiu, Guo-Yue Lv, Chao Jiang, Ping Zhang, Xiao-Dong Sun, Xiao-Ju Shi, Xue-Yan Liu, Guang-Yi Wang
    Korean Journal of Hepato-Biliary-Pancreatic Surgery.2016; 20(1): 38.     CrossRef
  • Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis
    Ufuk Bariş Kuzu, Erkin Öztaş, Nesrin Turhan, Fatih Saygili, Nuretdin Suna, Hakan Yildiz, Mustafa Kaplan, Muhammet Yener Akpinar, Meral Akdoğan, Sabite Kaçar, Zeki Mesut Yalin Kiliç, Aydin Şeref Köksal, Bülent Ödemiş, Ertuğrul Kayaçetin
    Hepatology Research.2016; 46(4): 277.     CrossRef
  • Systematic Review of Adverse Effects from Herbal Drugs Reported in Randomized Controlled Trials
    Ji Young Lee, Seung Ah Jun, Sung Shin Hong, Yo Chan Ahn, Dong Soo Lee, Chang Gue Son
    Phytotherapy Research.2016; 30(9): 1412.     CrossRef
  • N‐acetylcysteine for non‐paracetamol drug‐induced liver injury: a systematic review
    Mohamed Farouk Chughlay, Nicole Kramer, C. Wendy Spearman, Mahmoud Werfalli, Karen Cohen
    British Journal of Clinical Pharmacology.2016; 81(6): 1021.     CrossRef
  • Beneficial effect of corticosteroids for patients with severe drug‐induced liver injury
    Ping Fang Hu, Pei Qin Wang, Han Chen, Xiao Fan Hu, Qiu Ping Xie, Jian Shi, Lin Lin, Wei Fen Xie
    Journal of Digestive Diseases.2016; 17(9): 618.     CrossRef
  • Research Advances on Hepatotoxicity of Herbal Medicines in China
    Changxiao Liu, Huirong Fan, Yazhuo Li, Xiaohe Xiao
    BioMed Research International.2016; 2016: 1.     CrossRef
  • A Severe Hepatotoxicity by Antituberculosis Drug, and its Recovery in Oriental Hospital
    Chang-Gue Son
    Journal of Korean Medicine.2016; 37(2): 119.     CrossRef
  • Profile of Acute Liver Failure from North-east India and Its Differences from other Parts of the Country
    Premashish Kar, Anup K Das, Tarjina Begum, Anupam Dutta
    Euroasian Journal of Hepato-Gastroenterology.2016; 6(2): 111.     CrossRef
  • I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
    Rong Lin, Omar Banafea, Jin Ye
    BMC Gastroenterology.2015;[Epub]     CrossRef
  • Development and Regulatory Application of Microrna Biomarkers
    Julian Krauskopf, Marcha Verheijen, Jos C Kleinjans, Theo M de Kok, Florian Caiment
    Biomarkers in Medicine.2015; 9(11): 1137.     CrossRef
  • Drug-induced liver injury in children
    Mansi D. Amin, Sanjiv Harpavat, Daniel H. Leung
    Current Opinion in Pediatrics.2015; 27(5): 625.     CrossRef
  • Clinical Features of Drug-induced Liver Injury According to Etiology
    Byoung Moo Lee, Woong Cheul Lee, Jae Young Jang, Pyoung Ahn, Jin Nyoung Kim, Soung Won Jeong, Eui Ju Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim
    Journal of Korean Medical Science.2015; 30(12): 1815.     CrossRef
  • Blood Pyrrole-Protein Adducts—A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans
    Jianqing Ruan, Hong Gao, Na Li, Junyi Xue, Jie Chen, Changqiang Ke, Yang Ye, Peter Pi-Cheng Fu, Jiang Zheng, Jiyao Wang, Ge Lin
    Journal of Environmental Science and Health, Part C.2015; 33(4): 404.     CrossRef
  • La historia oscura de la rosa amarilla: un reporte de caso de toxicidad hepática asociado al consumo de Cochlospermum vitifolium como remedio herbolario
    L. Martínez-Rodriguez, K. Murguía-Hernández, I. García-Juárez, M. Uribe-Esquivel, E. Gómez-Reyes
    Revista de Gastroenterología de México.2015; 80(3): 220.     CrossRef
  • Agomelatine-induced liver injury in a patient with choledocholithiasis
    Piotr Eder, Agnieszka Permoda-Osip, Przemyslaw Majewski, Krzysztof Linke, Janusz K. Rybakowski
    Acta Neuropsychiatrica.2015; 27(1): 56.     CrossRef
  • Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population
    J Jiang, X Zhang, R Huo, X Li, Y Yang, Z Gai, M Xu, L Shen, L Cai, C Wan, B Li, L He, S Qin
    The Pharmacogenomics Journal.2015; 15(4): 326.     CrossRef
  • The dark story of the yellow rose: A case report of hepatoxicity associated with Cochlospermum vitifolium consumption as herbal remedy
    L. Martínez-Rodriguez, K. Murguía-Hernández, I. García-Juárez, M. Uribe-Esquivel, E. Gómez-Reyes
    Revista de Gastroenterología de México (English Edition).2015; 80(3): 220.     CrossRef
  • MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics
    Y. Yang, S. Nadanaciva, Y. Will, J. L. Woodhead, B. A. Howell, P. B. Watkins, S. Q. Siler
    Pharmaceutical Research.2015; 32(6): 1975.     CrossRef
  • N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol
    Mohamed Farouk Chughlay, Nicole Kramer, Mahmoud Werfalli, Wendy Spearman, Mark Emmanuel Engel, Karen Cohen
    Systematic Reviews.2015;[Epub]     CrossRef
  • Autophagy in drug-induced liver toxicity
    Si Chen, William B. Melchior, Yuanfeng Wu, Lei Guo
    Journal of Food and Drug Analysis.2014; 22(2): 161.     CrossRef
  • Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans
    Franck A. Atienzar, Eric I. Novik, Helga H. Gerets, Amit Parekh, Claude Delatour, Alvaro Cardenas, James MacDonald, Martin L. Yarmush, Stéphane Dhalluin
    Toxicology and Applied Pharmacology.2014; 275(1): 44.     CrossRef
  • Chelidonium majus-Induced Acute Hepatitis
    Sung Gyu Im, Sun Hong Yoo, Dong Ok Jeon, Hyo Jin Cho, Jin Young Choi, Soya Paik, Young Min Park
    The Ewha Medical Journal.2014; 37(1): 60.     CrossRef
  • Efficacy and Tolerability of Benzodiazepines for the Treatment of Behavioral and Psychological Symptoms of Dementia
    Rajesh R. Tampi, Deena J. Tampi
    American Journal of Alzheimer's Disease & Other Dementias®.2014; 29(7): 565.     CrossRef
  • Female gender as a susceptibility factor for drug-induced liver injury
    David E Amacher
    Human & Experimental Toxicology.2014; 33(9): 928.     CrossRef
  • Drug-Induced Cholestasis
    Kalyan Ram Bhamidimarri, Eugene Schiff
    Clinics in Liver Disease.2013; 17(4): 519.     CrossRef
  • Clinical Manifestations and Treatment of Drug-induced Hepatotoxicity
    Christin M. Giordano, Xaralambos B. Zervos
    Clinics in Liver Disease.2013; 17(4): 565.     CrossRef
  • Hepatitis B Virus Inhibits Liver Regeneration Via Epigenetic Regulation of Urokinase-Type Plasminogen Activator
    Eun-Sook Park, Yong Kwang Park, Chan Young Shin, Seung Hwa Park, Sung Hyun Ahn, Doo Hyun Kim, Keo-Heun Lim, So Young Kwon, Kwang Pyo Kim, Sung-Il Yang, Baik L. Seong, Kyun-Hwan Kim
    Hepatology.2013; 58(2): 762.     CrossRef
  • 10.1016/b978-0-323-26339-9.00019-6

    CrossRef Listing of Deleted DOIs.2000;[Epub]     CrossRef
  • 27,815 View
  • 335 Download
  • Crossref

Original Article

The value of serum retinol-binding protein 4 Levels for determining disease severity in patients with chronic Liver disease
Jung Hyun Kwon, M.D., Seong Tae Park1, Gi Dae Kim, Ph.D.1, Chan Ran You, M.D., Jin Dong Kim, M.D., Hyun Young Woo, M.D., Jeong Won Jang, M.D.1, Chang Wook Kim, M.D., Si Hyun Bae, M.D., Jong Young Choi, M.D., Seung Kew Yoon, M.D.
Korean J Hepatol 2009;15(1):59-69.
Published online March 31, 2009
DOI: https://doi.org/10.3350/kjhep.2009.15.1.59
Backgrounds/Aims
Serum retinol-binding protein 4 (RBP4) is known to be a specific transport protein for retinol, and has recently been reported to be associated with insulin resistance. Hyaluronic acid (HA) is a well-known marker of liver fibrosis. In this study, the degree to which serum RBP4 levels can be used to predict disease severity in patients with chronic liver disease (CLD) was evaluated. Methods: Serum levels of RBP4 and HA were measured in 573 CLD patients [235 with chronic hepatitis (CH), 230 with liver cirrhosis Child-Pugh grade (Child) A, and 108 with liver cirrhosis with Child B and C] and 40 normal controls. Results: The mean age of the whole cohort was 53.1 years and the causes of CLD were hepatitis B virus (61.9%), hepatitis C virus (9.8%), alcohol (9.0%), and nonalcoholic steatohepatitis (3.8%). Serum levels of RBP4 significantly reduced and HA increased with disease condition, from none (normal controls) to advanced cirrhosis (normal control: RBP4 4.3±0.1 mg/dL, HA 25.3±28.1 ng/mL; CH: RBP4 3.6±0.1 mg/dL, HA 75.5±7.8 ng/mL; cirrhosis with Child A: RBP4 2.6±0.1 mg/dL, HA 184.4±14.5 ng/mL; and cirrhosis with Child B and C: RBP4 1.6±0.1 mg/dL, HA 656.5±86.7 ng/mL; P<0.001, respectively). Serum RBP4 level was a distinguishing factor at the early stage of CLD between CH and Child A cirrhosis (post-hoc test; P<0.001) and was correlated with histological fibrosis score (n=80, P<0.05) and several biochemical factors. Antiviral therapy (n=45, median interval 1,205 days) resulted in an improvement in serum RBP4 levels (P=0.001). Conclusions: The results of our study suggest that RBP4 is a serologic marker for disease severity in patients with CLD. It could also be useful as an early marker of CLD and of the relative success of antiviral therapy. (Korean J Hepatol 2008;15:59-69)

Citations

Citations to this article as recorded by  Crossref logo
  • Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals
    Bryan M Gannon, Samantha L Huey, Neel H Mehta, Nidhi Shrestha, Lucero Lopez-Perez, Ricardo X Martinez, Lisa M Rogers, Maria Nieves Garcia-Casal, Saurabh Mehta
    Cochrane Database of Systematic Reviews.2025;[Epub]     CrossRef
  • Optimised expression and purification of RBP4 and preparation of anti‐RBP4 monoclonal antibody
    Hui Li, Xiao He, Sha Wen, Lichao Yang, Qiuli Chen, Yasi Li, Shiping Huang, Xuejing Huang, Fengjie Wan, Min He
    FEBS Open Bio.2022; 12(2): 430.     CrossRef
  • Proteomic Analysis of Human Serum for Patients at Different Pathological Stages of Hepatic Fibrosis
    Kang Zhao, Jucun Huang, Hongmei Xia, Jianjun Zhang, Liming Liu, K. H. Mok
    BioMed Research International.2021;[Epub]     CrossRef
  • Dynamic changes of serum protein in rats with acute intoxication of Chinese cobra snake venom by proteomic analysis
    Hui Yan, Ping Xiang, Jingshuo Zhang, Liqi Xie, Min Shen
    Forensic Sciences Research.2020; 5(4): 309.     CrossRef
  • The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals


    Hanan Mahmoud Fayed, Hasan Sedeek Mahmoud, Abdallah Elaiw Mohamed Ali
    Clinical and Experimental Gastroenterology.2020; Volume 13: 53.     CrossRef
  • Case report of The liver transplant patient's cerebral infarction treated with Korean Medicine
    Sang Eun Park
    Herbal Formula Science.2016; 24(3): 225.     CrossRef
  • Vitamin A and retinol-binding protein deficiency among chronic liver disease patients
    Gabriela Villaça Chaves, Wilza Arantes Ferreira Peres, José Carlos Gonçalves, Andréa Ramalho
    Nutrition.2015; 31(5): 664.     CrossRef
  • Clinical significance of serum retinol binding protein‐4 levels in patients with systemic sclerosis
    T. Toyama, Y. Asano, T. Takahashi, N. Aozasa, K. Akamata, S. Noda, T. Taniguchi, Y. Ichimura, H. Sumida, Z. Tamaki, Y. Masui, Y. Tada, M. Sugaya, S. Sato, T. Kadono
    Journal of the European Academy of Dermatology and Venereology.2013; 27(3): 337.     CrossRef
  • HEV-Capsid Protein Interacts With Cytochrome P4502C8 and Retinol-Binding Protein 4
    Quan Shen, Wen Zhang, Yanjun Kang, Yan Chen, Li Cui, Zhibiao Yang, Xiuguo Hua
    Hepatitis Monthly.2011; 11(11): 913.     CrossRef
  • Comparative Analysis of Serum Proteomes of Moyamoya Disease and Normal Controls
    Eun-Jeong Koh, Han-Na Kim, Tian-Ze Ma, Ha-Young Choi, Yong-Geun Kwak
    Journal of Korean Neurosurgical Society.2010; 48(1): 8.     CrossRef
  • 6,346 View
  • 66 Download
  • Crossref

Case Report

Four cases of toxic Liver injury associated with Dictamnus dasycarpus
Jong Soon Jang, M.D., Eui Geun Seo, M.D., Cheol Han, M.D., Hee Bok Chae, M.D., Soon Je Kim, M.D.1, Jae Dong Lee, M.D.1, Joon Ho Wang, M.D.1
Korean J Hepatol 2008;14(2):206-212.
Published online June 20, 2008
DOI: https://doi.org/10.3350/kjhep.2008.14.2.206
We report four cases of toxic hepatitis that occurred after taking a decoction made by boiling down the root of Dictamnus dasycarpus. The four patients had a median age of 60 years, common symptoms of jaundice and general weakness, and stated that they had not consumed alcohol for at least 5 years. The markers of hepatitis A, B, and C were all negative in the patients. Abdominal ultrasonography revealed common bile ducts with normal diameters. Two of the cases were a mother and daughter, and the other two were sporadic. All of them had consumed a decoction made by boiling down the root of Dictamnus dasycarpus five or six times daily until several days before admission. Dictamnus dasycarpus induced liver injury presenting with a benign course lasting less than 1 month after cessation of the causative agent. We suggest that this natural product can cause acute hepatitis in rural areas. (Korean J Hepatol 2008;14:206-212)

Citations

Citations to this article as recorded by  Crossref logo
  • Integration of transcriptomics and metabolomics profiling reveals the metabolic pathways affected in dictamnine-induced hepatotoxicity in mice
    Zhuo-Qing Li, Ling-Li Wang, Jing Zhou, Xian Zheng, Yan Jiang, Ping Li, Hui-Jun Li
    Journal of Proteomics.2020; 213: 103603.     CrossRef
  • Cytochrome P450-Mediated Bioactivation: Implication for the Liver Injury Induced by Fraxinellone, A Bioactive Constituent from Dictamni Cortex
    Haining Zhou, Qingwang Liu, Juan Zhang, Jianning Yao, Chunfeng Wang, Yanzhen Zhang, Yanle Li, Xuexiu Zhang, Lianfeng Zhang
    Chemical Research in Toxicology.2020; 33(7): 1960.     CrossRef
  • Fraxinellone: From pesticidal control to cancer treatment
    Christian Bailly, Gérard Vergoten
    Pesticide Biochemistry and Physiology.2020; 168: 104624.     CrossRef
  • Detection and Structural Characterization of Nucleophiles Trapped Reactive Metabolites of Limonin Using Liquid Chromatography-Mass Spectrometry
    Yujie Deng, Yudong Fu, Shumin Xu, Ping Wang, Nailong Yang, Chengqian Li, Qing Yu
    Journal of Analytical Methods in Chemistry.2018; 2018: 1.     CrossRef
  • Subchronic Toxicity Studies of Cortex Dictamni Extracts in Mice and Its Potential Hepatotoxicity Mechanisms in Vitro
    Qiongyin Fan, Baosheng Zhao, Chunguo Wang, Jingxuan Zhang, Jinying Wu, Ting Wang, Anlong Xu
    Molecules.2018; 23(10): 2486.     CrossRef
  • Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs
    Rolf Teschke, Dominique Larrey, Dieter Melchart, Gaby Danan
    Medicines.2016; 3(3): 18.     CrossRef
  • Identification of antioxidant activity of two new aromatic ring butyrolactone derivatives from Dictamnus dasycarpus Turcz.
    Li-Na GUO, Yue-Hu PEI, Fei-Xiang XIE, Lei LIU, Huan CONG, Hong-Xia CUI, Xiao-Li WANG, Wen-Jing LI, Bai-Yu JIAN, Ji-Cheng LIU
    Chinese Journal of Natural Medicines.2016; 14(11): 876.     CrossRef
  • Characteristics of Toxicity Occurring in Outpatients at Korean Medical Clinics in Korean
    Ki-Bum Lee, Yeongchul Park, Sundong Lee
    Journal of Korean Medicine.2016; 37(1): 135.     CrossRef
  • Hepatotoxicity of herbal and dietary supplements: an update
    Felix Stickel, Daniel Shouval
    Archives of Toxicology.2015; 89(6): 851.     CrossRef
  • Liver Injury Induced by Herbal Extracts Containing Mistletoe and Kudzu
    Hyo Jin Kim, Hyunah Kim, Ji Hyune Ahn, Hyoun Ju Suk
    The Journal of Alternative and Complementary Medicine.2015; 21(3): 180.     CrossRef
  • An ethnopharmacological and historical analysis of “Dictamnus”, a European traditional herbal medicine
    V. Martínez-Francés, D. Rivera, M. Heinrich, C. Obón, S. Ríos
    Journal of Ethnopharmacology.2015; 175: 390.     CrossRef
  • Medicinal uses, phytochemistry and pharmacology of the genus Dictamnus (Rutaceae)
    Mengying Lv, Ping Xu, Yuan Tian, Jingyu Liang, Yiqiao Gao, Fengguo Xu, Zunjian Zhang, Jianbo Sun
    Journal of Ethnopharmacology.2015; 171: 247.     CrossRef
  • Systematic review on herb-induced liver injury in Korea
    Woo-Jin Lee, Hae-Won Kim, Hyun-Yong Lee, Chang-Gue Son
    Food and Chemical Toxicology.2015; 84: 47.     CrossRef
  • Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases
    Rolf Teschke, Li Zhang, Hongzhu Long, Alexander Schwarzenboeck, Wolfgang Schmidt-Taenzer, Alexander Genthner, Albrecht Wolff, Christian Frenzel, Johannes Schulze, Axel Eickhoff
    Annals of Hepatology.2015; 14(1): 7.     CrossRef
  • Phytotherapy in the management of psoriasis: a review of the efficacy and safety of oral interventions and the pharmacological actions of the main plants
    Shiqiang Deng, Brian H. May, Anthony L. Zhang, Chuanjian Lu, Charlie C. L. Xue
    Archives of Dermatological Research.2014; 306(3): 211.     CrossRef
  • Comparison of Anti-inflammatory Activities among Ethanol Extracts of Sophora flavescens, Glycyrrhiza uralensis and Dictamnus dasycarpus, and their Mixtures in RAW 246.7 Murine Macrophages
    Min Ho Han, Moon Hee Lee, Su Hyun Hong, Yung Hyun Choi, Ju Sung Moon, Myung Kyu Song, Min Ju Kim, Su Jin Shin, Hye Jin Hwang
    Journal of Life Science.2014; 24(3): 329.     CrossRef
  • Acute Oral Toxicity Study of Dictamnus dasycarpus Turcz in SD Rats
    Ji-Hyun Seok, Hang-Sik Roh, Ja-Young Jeong, Hun-Yong Ha
    The Journal of Korean Oriental Medical Ophthalmology and Otolaryngology and Dermatology.2014; 27(1): 68.     CrossRef
  • Topical herbal medicine combined with pharmacotherapy for psoriasis: a systematic review and meta-analysis
    Shiqiang Deng, Brian H. May, Anthony L. Zhang, Chuanjian Lu, Charlie C. L. Xue
    Archives of Dermatological Research.2013; 305(3): 179.     CrossRef
  • Add-On Effect of Chinese Herbal Medicine Bath to Phototherapy for Psoriasis Vulgaris: A Systematic Review
    Jason Jingjie Yu, Claire Shuiqing Zhang, Anthony Lin Zhang, Brian May, Charlie Changli Xue, Chuanjian Lu
    Evidence-Based Complementary and Alternative Medicine.2013; 2013: 1.     CrossRef
  • Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: A retrospective study
    Na-Hee Kim, Hwan-Yong Jung, Seung-Yeon Cho, Seong-Uk Park, Jung-Mi Park, Chang-Nam Ko
    Phytomedicine.2011; 18(14): 1208.     CrossRef
  • Different Transport Activity of Human TriallelicMDR1893Ala/Ser/Thr Variant and its Association with Herb Extracts
    Jeong‐Hyun Kim, Soon Re Kim, Im‐Sook Song, Ho‐Jung Shin, Han‐Seop Kim, Jung‐Ha Lee, Seong‐Gyu Ko, Yong‐Cheol Shin
    Phytotherapy Research.2011; 25(8): 1141.     CrossRef
  • Chemoprevention of oral cancer in animal models, and effect on leukoplakias in human patients with ZengShengPing, a mixture of medicinal herbs
    Zheng Sun, Xiaobing Guan, Ning Li, Xiaoyong Liu, Xiaoxin Chen
    Oral Oncology.2010; 46(2): 105.     CrossRef
  • Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatment of T-cell-dependent hepatitis in mice
    Yang Sun, Yu Qin, Fang-Yuan Gong, Xue-Feng Wu, Zi-Chun Hua, Ting Chen, Qiang Xu
    Biochemical Pharmacology.2009; 77(11): 1717.     CrossRef
  • 7,456 View
  • 74 Download
  • Crossref
Original Article
The Survey for the Actual Condition of Drug Medication and Development of Health Care Cost Associated with Toxic Liver Injury in Korean; A Multicenter Study for the Detection and the Development of Nationwide Reporting System of Toxic Liver Injury
Tae Woo Yoo, M.D., Byung Ik Kim, M.D., Jin Bong Kim, M.D.1, Dong Joon Kim, M.D.1, Jae Woo Kim.2, Soon Koo Baik.2, Kwang Seok Kim, M.D.3, Gab Jin Cheon, M.D.3
Korean J Hepatol 2007;13(1):34-43.
Backgrounds/Aims
In Korea, interests in health and health care costs have been increased along with the increase of mean survival rate and income level. The aim of this study is to investigate the actual condition of drug medication and burden of health care cost. Methods: A total of 1,434 subjects in four tertiary medical centers were enrolled in this study. The questionnaires were obtained between March 2005 and September 2005. Based on this information, the actual condition of drug medication and health care cost were analyzed.
Results
The mean age of the subjects was 55.0±11.4 years (16-87 years). The male and female ratio was 1.74:1. The subjects with drug medication except for doctor’s prescription are presently 26.6% and were 40.9% in the past. Traditional medicine (39.6%) and health food (29.9%) are more frequently used than herbal medicine (5.8%) and medical supplies (4.2%) now. In the past, herbal medicine (14.6%) was more frequently used compared with the present. The side effects of drug medication were developed in 90 subjects (7.5%). The total mean health care costs were 895,000 won/year, the herbal medicine, 834,000 won/year, the health food, 950,000 won/year, and the traditional medicine, 324,000 won/year. Conclusions: In this study, the subjects with other drug medications without doctor’s prescription were as high as ever. The frequency of the use of the herbal medicine was decreased. However, the frequency for the use of the health food and traditional medicine have relatively increased. The side effects and additional large amounts of health care costs were occurred. (Korean J Hepatol 2007;13:34-43)
  • 3,472 View
  • 34 Download